EP3625353B1 - Méthodes et systèmes de tri de gouttelettes et de billes - Google Patents

Méthodes et systèmes de tri de gouttelettes et de billes Download PDF

Info

Publication number
EP3625353B1
EP3625353B1 EP18802877.3A EP18802877A EP3625353B1 EP 3625353 B1 EP3625353 B1 EP 3625353B1 EP 18802877 A EP18802877 A EP 18802877A EP 3625353 B1 EP3625353 B1 EP 3625353B1
Authority
EP
European Patent Office
Prior art keywords
droplets
particles
subset
droplet
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18802877.3A
Other languages
German (de)
English (en)
Other versions
EP3625353A4 (fr
EP3625353A1 (fr
Inventor
Rajiv Bharadwaj
Michael Schnall-Levin
Anthony Makarewicz
Steven Short
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
10X Genomics Inc
Original Assignee
10X Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 10X Genomics Inc filed Critical 10X Genomics Inc
Priority to EP22209419.5A priority Critical patent/EP4215616A1/fr
Publication of EP3625353A1 publication Critical patent/EP3625353A1/fr
Publication of EP3625353A4 publication Critical patent/EP3625353A4/fr
Application granted granted Critical
Publication of EP3625353B1 publication Critical patent/EP3625353B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects thereof, e.g. conductivity or capacity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G01N15/1484—Electro-optical investigation, e.g. flow cytometers microstructural devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers
    • B01F33/301—Micromixers using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions
    • B01F33/3011—Micromixers using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions using a sheathing stream of a fluid surrounding a central stream of a different fluid, e.g. for reducing the cross-section of the central stream or to produce droplets from the central stream
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0652—Sorting or classification of particles or molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
    • G01N15/1023—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G01N15/1468—Electro-optical investigation, e.g. flow cytometers with spatial resolution of the texture or inner structure of the particle
    • G01N15/147—Electro-optical investigation, e.g. flow cytometers with spatial resolution of the texture or inner structure of the particle the analysis being performed on a sample stream
    • G01N15/149—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N2015/0023—Investigating dispersion of liquids
    • G01N2015/003—Investigating dispersion of liquids in liquids, e.g. emulsion
    • G01N2015/1028—

Definitions

  • a sample may be processed for various purposes, such as identification of a type of moiety within the sample.
  • the sample may be a biological sample.
  • Biological samples may be processed, such as for detection of a disease (e.g., cancer) or identification of a particular species.
  • PCR polymerase chain reaction
  • Biological samples may be processed using various reaction environments, such as partitions.
  • Partitions may be wells or droplets. Droplets or wells may enable biological samples to be partitioned and processed separately. For example, such droplets may be fluidically isolated from other droplets, enabling accurate control of respective environments in the droplets.
  • a plurality of droplets can be generated such that one or more droplets include cells and/or particles.
  • the cells and/or particles can be of interest for use in various (e.g., single cell) applications, such as nucleic acid amplification and/or sequencing applications.
  • WO 2010/009365 describes droplet libraries as well as systems and methods for the formation of libraries of droplets. WO 2010/009365 also describes methods utilizing said droplet libraries in biological, chemical, or diagnostic assays.
  • An aspect of the invention provides a method for sorting droplets, comprising: (a) bringing a first phase in contact with a second phase to generate a plurality of droplets, wherein the first phase and second phase are immiscible, wherein the plurality of droplets comprises field-attractable particles and wherein the plurality of droplets comprises (i) a first subset of droplets each including, and not more than, one biological particle, and (ii) a second subset of droplets each including more than one biological particle, wherein the biological particle is a cell, a derivative of a cell, or a constituent of a cell; (b) directing the plurality of droplets along a first channel towards an intersection of the first channel with a second channel and a third channel; and (c) subjecting the plurality of droplets comprising the field-attractable particles to an electric or magnetic field under conditions sufficient to separate all or a portion of the first subset of the plurality of droplets from all or a portion of the second subset of the plurality of
  • the first subset of the plurality of droplets includes particles having coupled thereto molecules comprising barcode sequences.
  • the particles having coupled thereto molecular barcodes are beads.
  • the beads are gel beads.
  • each droplet of the first subset of the plurality of droplets comprises more field attractable particles than each droplet of the second subset of the plurality of droplets which includes more than one biological particle.
  • forces induced on the first subset are greater than forces induced on droplets of the second subset which includes more than one biological particle.
  • the field-attractable particles are magnetic-field attractable particles. In some embodiments, the field-attractable particles are paramagnetic particles.
  • the field-attractable particles are electric-field attractable particles. In some embodiments, the field-attractable particles are conductive particles.
  • the method further comprises, subsequent to (c), subjecting nucleic acid molecules derived from the biological particles in the first subset to nucleic acid sequencing.
  • the method further comprises, subsequent to (c), subjecting the first subset of the plurality of droplets to conditions sufficient to yield extension products of the nucleic acid molecules from the biological particles in the first subset, and subjecting the extension products or derivatives thereof to nucleic acid sequencing.
  • the conditions of the electric or magnetic field sufficient to separate the all or the portion of the first subset of the plurality of droplets and the all or the portion of the second subset of the plurality of droplets are determined based at least in part on a ratio between sizes of the plurality of droplets and sizes of the biological particles in the first subset of the plurality of droplets.
  • the plurality of droplets is directed along the first channel using a pressure pulse.
  • the method further comprises subjecting individual droplets of the first subset of the plurality of droplets to a stimulus to facilitate polymerization.
  • the stimulus is applied prior to the intersection.
  • the method further comprises (i) detecting the individual droplets and (ii) subjecting the individual droplets to the stimulus upon detecting the individual droplets.
  • the method further comprises detecting individual droplets of said first subset of said plurality of droplets, and subjecting said individual droplets to a stimulus to facilitate polymerization upon detecting said individual droplets, wherein, optionally, (a) said stimulus is applied prior to said intersection; (b) said stimulus is applied subsequent to said intersection; or (c) said stimulus is an optical stimulus or chemical stimulus.
  • the biological particles are cells enclosed within or comprising a gel or polymer matrix.
  • barcode generally refers to a label, or identifier, that conveys or is capable of conveying information about an analyte.
  • a barcode can be part of an analyte.
  • a barcode can be independent of an analyte.
  • a barcode can be a tag attached to an analyte (e.g., nucleic acid molecule) or a combination of the tag in addition to an endogenous characteristic of the analyte (e.g., size of the analyte or end sequence(s)).
  • a barcode may be unique. Barcodes can have a variety of different formats.
  • barcodes can include: polynucleotide barcodes; random nucleic acid and/or amino acid sequences; and synthetic nucleic acid and/or amino acid sequences.
  • a barcode can be attached to an analyte in a reversible or irreversible manner.
  • a barcode can be added to, for example, a fragment of a deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sample before, during, and/or after sequencing of the sample. Barcodes can allow for identification and/or quantification of individual sequencing-reads.
  • real time can refer to a response time of less than about 1 second, a tenth of a second, a hundredth of a second, a millisecond, or less.
  • the response time may be greater than 1 second.
  • real time can refer to simultaneous or substantially simultaneous processing, detection or identification.
  • subject generally refers to an animal, such as a mammal (e.g., human) or avian (e.g., bird), or other organism, such as a plant.
  • the subject can be a vertebrate, a mammal, a rodent (e.g., a mouse), a primate, a simian or a human. Animals may include, but are not limited to, farm animals, sport animals, and pets.
  • a subject can be a healthy or asymptomatic individual, an individual that has or is suspected of having a disease (e.g., cancer) or a pre-disposition to the disease, and/or an individual that is in need of therapy or suspected of needing therapy.
  • a subject can be a patient.
  • a subject can be a microorganism or microbe (e.g., bacteria, fungi, archaea, viruses).
  • genomic information generally refers to genomic information from a subject, which may be, for example, at least a portion or an entirety of a subject's hereditary information.
  • a genome can be encoded either in DNA or in RNA.
  • a genome can comprise coding regions (e.g., that code for proteins) as well as non-coding regions.
  • a genome can include the sequence of all chromosomes together in an organism.
  • the human genome ordinarily has a total of 46 chromosomes. The sequence of all of these together may constitute a human genome.
  • adaptor(s) can be used synonymously.
  • An adaptor or tag can be coupled to a polynucleotide sequence to be “tagged” by any approach, including ligation, hybridization, or other approaches.
  • sequence of nucleotide bases in one or more polynucleotides can be, for example, nucleic acid molecules such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), including variants or derivatives thereof (e.g., single stranded DNA). Sequencing can be performed by various systems currently available, such as, without limitation, a sequencing system by Illumina ® , Pacific Biosciences (PacBio ® ), Oxford Nanopore ® , or Life Technologies (Ion Torrent ® ).
  • sequencing may be performed using nucleic acid amplification, polymerase chain reaction (PCR) (e.g., digital PCR, quantitative PCR, or real time PCR), or isothermal amplification.
  • PCR polymerase chain reaction
  • Such systems may provide a plurality of raw genetic data corresponding to the genetic information of a subject (e.g., human), as generated by the systems from a sample provided by the subject.
  • sequencing reads also "reads" herein).
  • a read may include a string of nucleic acid bases corresponding to a sequence of a nucleic acid molecule that has been sequenced.
  • systems and methods provided herein may be used with proteomic information.
  • the bead may be a solid or semi-solid particle.
  • the bead may be a gel bead.
  • the gel bead may include a polymer matrix (e.g., matrix formed by polymerization or cross-linking).
  • the polymer matrix may include one or more polymers (e.g., polymers having different functional groups or repeat units). Polymers in the polymer matrix may be randomly arranged, such as in random copolymers, and/or have ordered structures, such as in block copolymers. Cross-linking can be via covalent, ionic, or inductive, interactions, or physical entanglement.
  • the bead may be a macromolecule.
  • the bead may be formed of nucleic acid molecules bound together.
  • the bead may be formed via covalent or non-covalent assembly of molecules (e.g., macromolecules), such as monomers or polymers.
  • Such polymers or monomers may be natural or synthetic.
  • Such polymers or monomers may be or include, for example, nucleic acid molecules (e.g., DNA or RNA).
  • the bead may be formed of a polymeric material.
  • the bead may be magnetic or non-magnetic.
  • the bead may be rigid.
  • the bead may be flexible and/or compressible.
  • the bead may be disruptable or dissolvable.
  • the bead may be a solid particle (e.g., a metal-based particle including but not limited to iron oxide, gold or silver) covered with a coating comprising one or more polymers. Such coating may be disruptable or dissolvable.
  • sample generally refers to a biological sample of a subject.
  • the biological sample may comprise any number of macromolecules, for example, cellular macromolecules.
  • the sample may be a cell sample.
  • the sample may be a cell line or cell culture sample.
  • the sample can include one or more cells.
  • the sample can include one or more microbes.
  • the biological sample may be a nucleic acid sample or protein sample.
  • the biological sample may also be a carbohydrate sample or a lipid sample.
  • the biological sample may be derived from another sample.
  • the sample may be a tissue sample, such as a biopsy, core biopsy, needle aspirate, or fine needle aspirate.
  • the sample may be a fluid sample, such as a blood sample, urine sample, or saliva sample.
  • the sample may be a skin sample.
  • the sample may be a cheek swab.
  • the sample may be a plasma or serum sample.
  • the sample may be a cell-free or cell free sample.
  • a cell-free sample may include extracellular polynucleotides. Extracellular polynucleotides may be isolated from a bodily sample that may be selected from the group consisting of blood, plasma, serum, urine, saliva, mucosal excretions, sputum, stool and tears.
  • the term "biological particle,” as used herein, refers to a cell, a derivative of a cell, or a constituent of a cell.
  • the biological particle may be a macromolecule.
  • the biological particle may be a small molecule.
  • the biological particle may be an organelle.
  • the biological particle may be a rare cell from a population of cells.
  • the biological particle may be any type of cell, including without limitation prokaryotic cells, eukaryotic cells, bacterial, fungal, plant, mammalian, or other animal cell type, mycoplasmas, normal tissue cells, tumor cells, or any other cell type, whether derived from single cell or multicellular organisms.
  • the biological particle may be or may include DNA, RNA, organelles, proteins, or any combination thereof.
  • the biological particle may be or may include a matrix (e.g., a gel or polymer matrix) comprising a cell or one or more constituents from a cell (e.g., cell bead), such as DNA, RNA, organelles, proteins, or any combination thereof, from the cell.
  • the biological particle may be obtained from a tissue of a subject.
  • the biological particle may be a hardened cell. Such hardened cell may or may not include a cell wall or cell membrane.
  • the biological particle may include one or more constituents of a cell, but may not include other constituents of the cell. An example of such constituents is a nucleus or an organelle.
  • a cell may be a live cell.
  • the live cell may be capable of being cultured, for example, being cultured when enclosed in a gel or polymer matrix, or cultured when comprising a gel or polymer matrix.
  • the macromolecular constituent may comprise a nucleic acid.
  • the biological particle may be a macromolecule.
  • the macromolecular constituent may comprise DNA.
  • the macromolecular constituent may comprise RNA.
  • the RNA may be coding or non-coding.
  • the RNA may be messenger RNA (mRNA), ribosomal RNA (rRNA) or transfer RNA (tRNA), for example.
  • the RNA may be a transcript.
  • the RNA may be small RNA that are less than 200 nucleic acid bases in length, or large RNA that are greater than 200 nucleic acid bases in length.
  • Small RNAs may include 5.8S ribosomal RNA (rRNA), 5S rRNA, transfer RNA (tRNA), microRNA (miRNA), small interfering RNA (siRNA), small nucleolar RNA (snoRNAs), Piwi-interacting RNA (piRNA), tRNA-derived small RNA (tsRNA) and small rDNA-derived RNA (srRNA).
  • the RNA may be double-stranded RNA or single-stranded RNA.
  • the RNA may be circular RNA
  • the macromolecular constituent may comprise a protein.
  • the macromolecular constituent may comprise a peptide.
  • the macromolecular constituent may comprise a polypeptide.
  • molecular tag generally refers to a molecule capable of binding to a macromolecular constituent.
  • the molecular tag may bind to the macromolecular constituent with high affinity.
  • the molecular tag may bind to the macromolecular constituent with high specificity.
  • the molecular tag may comprise a nucleotide sequence.
  • the molecular tag may comprise a nucleic acid sequence.
  • the nucleic acid sequence may be at least a portion or an entirety of the molecular tag.
  • the molecular tag may be a nucleic acid molecule or may be part of a nucleic acid molecule.
  • the molecular tag may be an oligonucleotide or a polypeptide.
  • the molecular tag may comprise a DNA aptamer.
  • the molecular tag may be or comprise a primer.
  • the molecular tag may be, or comprise, a protein.
  • the molecular tag may comprise a polypeptide.
  • the molecular tag may be a barcode.
  • partition refers to a space or volume that may be suitable to contain one or more species or conduct one or more reactions.
  • a partition may be a physical compartment, such as a droplet or well. The partition may isolate space or volume from another space or volume.
  • the droplet may be a first phase (e.g., aqueous phase) in a second phase (e.g., oil) immiscible with the first phase.
  • the droplet may be a first phase in a second phase that does not phase separate from the first phase, such as, for example, a capsule or liposome in an aqueous phase.
  • a partition may comprise one or more other (inner) partitions.
  • a partition may be a virtual compartment that can be defined and identified by an index (e.g., indexed libraries) across multiple and/or remote physical compartments.
  • a physical compartment may comprise a plurality of virtual compartments.
  • the efficiency of many single cell applications can increase by improving cell throughput. For example, this can be achieved by sorting a plurality of droplets that may or may not contain cells and/or particles therein to collect only the droplets that contain the cells and/or particles therein.
  • the plurality of droplets may be sorted to isolate singularly occupied droplets from non-singularly occupied droplets (e.g., unoccupied, multiply occupied, etc.).
  • higher efficiency can be achieved by isolating a plurality of cell beads from a plurality of particles that may or may not contain cells therein.
  • the plurality of particles may be sorted to isolate singularly occupied cell beads (e.g., particles containing cells or their derivatives) from non-singularly occupied cell beads (e.g., unoccupied particles, multiply occupied cell beads, etc.).
  • singularly occupied cell beads e.g., particles containing cells or their derivatives
  • non-singularly occupied cell beads e.g., unoccupied particles, multiply occupied cell beads, etc.
  • the isolated population of droplets that contain (e.g., singularly contain) the cells and/or particles therein, and/or cell beads that contain (e.g., singularly contain) the cells therein can then be subject to further applications, such as nucleic acid amplification and/or sequencing applications.
  • the methods and systems generally operate by generating a plurality of droplets such that each of the plurality of droplets comprises field-attractable particles.
  • a given droplet in the plurality of droplets may or may not include therein one or more cells and/or other particles (e.g., cell beads, gel beads, etc.).
  • the other particles e.g., gel beads
  • the plurality of droplets comprising field attractable particles can comprise a first subset of droplets that include one or more cells and/or other particles and a second subset of droplets that do not include any cells and/or other particles.
  • a given droplet in the first subset of droplets that includes one or more cells and/or other particles can comprise a sufficiently discrepant number or concentration of field-attractable particles than a given droplet in the second subset of droplets that does not include any cells and/or other particles such that when the plurality of droplets is subject to an electric or magnetic field, the first subset of droplets and the second subset of droplets are separated from each other.
  • singularly occupied droplets may be separated from unoccupied droplets and otherwise multiply occupied droplets.
  • a plurality of droplets can be generated with or without field-attractable particles.
  • a given droplet in the plurality of droplets may or may not include one or more cells and/or particles.
  • the plurality of droplets can comprise a first subset of droplets that include one or more cells and/or particles and a second subset of droplets that do not include any cells and/or particles.
  • the plurality of droplets can be subject to a pressure pulse and the first subset of droplets and the second subset of droplets can be separated from each other via hydrodynamic forces.
  • singularly occupied droplets may be separated from unoccupied droplets and otherwise multiply occupied droplets.
  • the methods and systems described herein provide for the compartmentalization, depositing, or partitioning of macromolecular constituent contents of individual biological particles from a sample material containing biological particles into discrete compartments or partitions (referred to interchangeably herein as partitions), where each partition maintains separation of its own contents from the contents of other partitions.
  • the partition can be a droplet in an emulsion.
  • the partition can be a well.
  • the partition can be a bead, such as a gel bead and/or a cell bead.
  • a partition may or may not contain biological particles and/or macromolecular constituents thereof.
  • Each partition may contain at least some field attractable particles.
  • the amount and/or concentration of field attractable particles in each partition can vary depending on whether the partition contains biological particles (or other particles, such as beads). In an example, a partition may not contain field attractable particles.
  • unique identifiers such as barcodes
  • Barcodes may be delivered, for example on an oligonucleotide, to a partition via any suitable mechanism.
  • Barcoded oligonucleotides can be delivered to a partition via a microcapsule.
  • barcoded oligonucleotides can be initially associated with the microcapsule and then released from the microcapsule upon application of a stimulus which allows the oligonucleotides to dissociate or to be released from the microcapsule.
  • a microcapsule in some instances, can comprise a bead.
  • a bead may be porous, non-porous, solid, semi-solid, semi-fluidic, fluidic, and/or a combination thereof.
  • a bead may be dissolvable, disruptable, and/or degradable.
  • a bead may not be degradable.
  • the bead may be a gel bead.
  • a gel bead may be a hydrogel bead.
  • a gel bead may be formed from molecular precursors, such as a polymeric or monomeric species.
  • a semi-solid bead may be a liposomal bead.
  • Solid beads may comprise metals including iron oxide, gold, and silver.
  • the bead may be a silica bead.
  • the bead can be rigid. In other cases, the bead may be flexible and/or compressible.
  • the bead may contain molecular precursors (e.g., monomers or polymers), which may form a polymer network via polymerization of the precursors.
  • a precursor may be an already polymerized species capable of undergoing further polymerization via, for example, a chemical cross-linkage.
  • a precursor can comprise one or more of an acrylamide or a methacrylamide monomer, oligomer, or polymer.
  • the bead may comprise prepolymers, which are oligomers capable of further polymerization.
  • polyurethane beads may be prepared using prepolymers.
  • the bead may contain individual polymers that may be further polymerized together.
  • beads may be generated via polymerization of different precursors, such that they comprise mixed polymers, co-polymers, and/or block co-polymers.
  • a bead may comprise natural and/or synthetic materials.
  • a polymer can be a natural polymer or a synthetic polymer.
  • a bead can comprise both natural and synthetic polymers.
  • natural polymers include proteins and sugars such as deoxyribonucleic acid, rubber, cellulose, starch (e.g., amylose, amylopectin), proteins, enzymes, polysaccharides, silks, polyhydroxyalkanoates, chitosan, dextran, collagen, carrageenan, ispaghula, acacia, agar, gelatin, shellac, sterculia gum, xanthan gum, Corn sugar gum, guar gum, gum karaya, agarose, alginic acid, alginate, or natural polymers thereof.
  • proteins and sugars such as deoxyribonucleic acid, rubber, cellulose, starch (e.g., amylose, amylopectin), proteins, enzymes, polysaccharides,
  • Examples of synthetic polymers include acrylics, nylons, silicones, spandex, viscose rayon, polycarboxylic acids, polyvinyl acetate, polyacrylamide, polyacrylate, polyethylene glycol, polyurethanes, polylactic acid, silica, polystyrene, polyacrylonitrile, polybutadiene, polycarbonate, polyethylene, polyethylene terephthalate, poly(chlorotrifluoroethylene), poly(ethylene oxide), poly(ethylene terephthalate), polyethylene, polyisobutylene, poly(methyl methacrylate), poly(oxymethylene), polyformaldehyde, polypropylene, polystyrene, poly(tetrafluoroethylene), poly(vinyl acetate), poly(vinyl alcohol), poly(vinyl chloride), poly(vinylidene dichloride), poly(vinylidene difluoride), poly(vinyl fluoride) and/or combinations (e.g., co-polymers) thereof.
  • a chemical cross-linker may be a precursor used to cross-link monomers during polymerization of the monomers and/or may be used to attach oligonucleotides (e.g., barcoded oligonucleotides) to the bead.
  • polymers may be further polymerized with a cross-linker species or other type of monomer to generate a further polymeric network.
  • Non-limiting examples of chemical cross-linkers include cystamine, gluteraldehyde, dimethyl suberimidate, N-Hydroxysuccinimide crosslinker BS3, formaldehyde, carbodiimide (EDC), SMCC, Sulfo-SMCC, vinylsilane, N,N'diallyltartardiamide (DATD), N,N'-Bis(acryloyl)cystamine (BAC), or homologs thereof.
  • the crosslinker used in the present disclosure contains cystamine.
  • Crosslinking may be permanent or reversible, depending upon the particular crosslinker used. Reversible crosslinking may allow for the polymer to linearize or dissociate under appropriate conditions. In some cases, reversible cross-linking may also allow for reversible attachment of a material bound to the surface of a bead. In some cases, a cross-linker may form disulfide linkages. In some cases, the chemical cross-linker forming disulfide linkages may be cystamine or a modified cystamine.
  • disulfide linkages can be formed between molecular precursor units (e.g., monomers, oligomers, or linear polymers) or precursors incorporated into a bead and oligonucleotides.
  • Cystamine is an organic agent comprising a disulfide bond that may be used as a crosslinker agent between individual monomeric or polymeric precursors of a bead.
  • Polyacrylamide may be polymerized in the presence of cystamine or a species comprising cystamine (e.g., a modified cystamine) to generate polyacrylamide gel beads comprising disulfide linkages (e.g., chemically degradable beads comprising chemically-reducible cross-linkers).
  • the disulfide linkages may permit the bead to be degraded (or dissolved) upon exposure of the bead to a reducing agent.
  • chitosan a linear polysaccharide polymer
  • glutaraldehyde via hydrophilic chains to form a bead.
  • Crosslinking of chitosan polymers may be achieved by chemical reactions that are initiated by heat, pressure, change in pH, and/or radiation.
  • the bead may comprise covalent or ionic bonds between polymeric precursors (e.g., monomers, oligomers, linear polymers), oligonucleotides, primers, and other entities.
  • the covalent bonds can be carbon-carbon bonds or thioether bonds.
  • a bead may comprise an acrydite moiety, which in certain aspects may be used to attach one or more oligonucleotides (e.g., barcode sequence, barcoded oligonucleotide, primer, or other oligonucleotide) to the bead.
  • an acrydite moiety can refer to an acrydite analogue generated from the reaction of acrydite with one or more species, such as, the reaction of acrydite with other monomers and cross-linkers during a polymerization reaction.
  • Acrydite moieties may be modified to form chemical bonds with a species to be attached, such as an oligonucleotide (e.g., barcode sequence, barcoded oligonucleotide, primer, or other oligonucleotide).
  • Acrydite moieties may be modified with thiol groups capable of forming a disulfide bond or may be modified with groups already comprising a disulfide bond.
  • the thiol or disulfide via disulfide exchange) may be used as an anchor point for a species to be attached or another part of the acrydite moiety may be used for attachment.
  • attachment can be reversible, such that when the disulfide bond is broken (e.g., in the presence of a reducing agent), the attached species is released from the bead.
  • an acrydite moiety can comprise a reactive hydroxyl group that may be used for attachment.
  • Functionalization of beads for attachment of oligonucleotides may be achieved through a wide range of different approaches, including activation of chemical groups within a polymer, incorporation of active or activatable functional groups in the polymer structure, or attachment at the pre-polymer or monomer stage in bead production.
  • precursors e.g., monomers, cross-linkers
  • precursors that are polymerized to form a bead may comprise acrydite moieties, such that when a bead is generated, the bead also comprises acrydite moieties.
  • the acrydite moieties can be attached to a nucleic acid molecule (e.g., oligonucleotide), which may include a priming sequence (e.g., a primer for amplifying target nucleic acids, random primer, primer sequence for messenger RNA) and/or one or more barcode sequences.
  • the one more barcode sequences may include sequences that are the same for all nucleic acid molecules coupled to a given bead and/or sequences that are different across all nucleic acid molecules coupled to the given bead.
  • the nucleic acid molecule may be incorporated into the bead.
  • the nucleic acid molecule can comprise a functional sequence, for example, for attachment to a sequencing flow cell, such as, for example, a P5 sequence for Illumina ® sequencing.
  • the nucleic acid molecule or derivative thereof e.g., oligonucleotide or polynucleotide generated from the nucleic acid molecule
  • can comprise another functional sequence such as, for example, a P7 sequence for attachment to a sequencing flow cell for Illumina sequencing.
  • the nucleic acid molecule can comprise a barcode sequence.
  • the primer can further comprise a unique molecular identifier (UMI).
  • UMI unique molecular identifier
  • the primer can comprise an R1 primer sequence for Illumina sequencing.
  • the primer can comprise an R2 primer sequence for Illumina sequencing.
  • nucleic acid molecules e.g., oligonucleotides, polynucleotides, etc.
  • uses thereof as may be used with compositions, devices, methods and systems of the present disclosure, are provided in U.S. Patent Pub. Nos. 2014/0378345 and 2015/0376609 .
  • FIG. 19 illustrates an example of a barcode carrying bead.
  • a nucleic acid molecule 1902 such as an oligonucleotide, can be coupled to a bead 1904 by a releasable linkage 1906 , such as, for example, a disulfide linker.
  • the same bead 1904 may be coupled (e.g., via releasable linkage) to one or more other nucleic acid molecules 1918 , 1920 .
  • the nucleic acid molecule 1902 may be or comprise a barcode. As noted elsewhere herein, the structure of the barcode may comprise a number of sequence elements.
  • the nucleic acid molecule 1902 may comprise a functional sequence 1908 that may be used in subsequent processing.
  • the functional sequence 1908 may include one or more of a sequencer specific flow cell attachment sequence (e.g., a P5 sequence for Illumina ® sequencing systems) and a sequencing primer sequence (e.g., a R1 primer for Illumina ® sequencing systems).
  • the nucleic acid molecule 1902 may comprise a barcode sequence 1910 for use in barcoding the sample (e.g., DNA, RNA, protein, etc.).
  • the barcode sequence 1910 can be bead-specific such that the barcode sequence 1910 is common to all nucleic acid molecules (e.g., including nucleic acid molecule 1902 ) coupled to the same bead 1904 .
  • the barcode sequence 1910 can be partition-specific such that the barcode sequence 1910 is common to all nucleic acid molecules coupled to one or more beads that are partitioned into the same partition.
  • the nucleic acid molecule 1902 may comprise a specific priming sequence 1912 , such as an mRNA specific priming sequence (e.g., poly-T sequence), a targeted priming sequence, and/or a random priming sequence.
  • the nucleic acid molecule 1902 may comprise an anchoring sequence 1914 to ensure that the specific priming sequence 1912 hybridizes at the sequence end (e.g., of the mRNA).
  • the anchoring sequence 1914 can include a random short sequence of nucleotides, such as a 1-mer, 2-mer, 3-mer or longer sequence, which can ensure that a poly-T segment is more likely to hybridize at the sequence end of the poly-A tail of the mRNA.
  • the nucleic acid molecule 1902 may comprise a unique molecular identifying sequence 1916 (e.g., unique molecular identifier (UMI)).
  • the unique molecular identifying sequence 1916 may comprise from about 5 to about 8 nucleotides. Alternatively, the unique molecular identifying sequence 1916 may compress less than about 5 or more than about 8 nucleotides.
  • the unique molecular identifying sequence 1916 may be a unique sequence that varies across individual nucleic acid molecules (e.g., 1902, 1918, 1920, etc.) coupled to a single bead (e.g., bead 1904). In some cases, the unique molecular identifying sequence 1916 may be a random sequence (e.g., such as a random N-mer sequence).
  • the UMI may provide a unique identifier of the starting mRNA molecule that was captured, in order to allow quantitation of the number of original expressed RNA.
  • FIG. 19 shows three nucleic acid molecules 1902, 1918, 1920 coupled to the surface of the bead 1904, an individual bead may be coupled to any number of individual nucleic acid molecules, for example, from one to tens to hundreds of thousands or even millions of individual nucleic acid molecules.
  • the respective barcodes for the individual nucleic acid molecules can comprise both common sequence segments or relatively common sequence segments (e.g., 1908, 1910, 1912, etc.) and variable or unique sequence segments (e.g., 1916) between different individual nucleic acid molecules coupled to the same bead.
  • a biological particle e.g., cell, DNA, RNA, etc.
  • the barcoded nucleic acid molecules 1902, 1918, 1920 can be released from the bead 1904 in the partition.
  • the poly-T segment (e.g., 1912) of one of the released nucleic acid molecules e.g., 1902
  • Reverse transcription may result in a cDNA transcript of the mRNA, but which transcript includes each of the sequence segments 1908, 1910, 1916 of the nucleic acid molecule 1902.
  • the nucleic acid molecule 1902 comprises an anchoring sequence 1914, it will more likely hybridize to and prime reverse transcription at the sequence end of the poly-A tail of the mRNA.
  • all of the cDNA transcripts of the individual mRNA molecules may include a common barcode sequence segment 1910.
  • the transcripts made from the different mRNA molecules within a given partition may vary at the unique molecular identifying sequence 1912 segment (e.g., UMI segment).
  • UMI segment unique molecular identifying sequence
  • the number of different UMIs can be indicative of the quantity of mRNA originating from a given partition, and thus from the biological particle (e.g., cell).
  • the transcripts can be amplified, cleaned up and sequenced to identify the sequence of the cDNA transcript of the mRNA, as well as to sequence the barcode segment and the UMI segment. While a poly-T primer sequence is described, other targeted or random priming sequences may also be used in priming the reverse transcription reaction. Likewise, although described as releasing the barcoded oligonucleotides into the partition, in some cases, the nucleic acid molecules bound to the bead (e.g., gel bead) may be used to hybridize and capture the mRNA on the solid phase of the bead, for example, in order to facilitate the separation of the RNA from other cell contents.
  • the nucleic acid molecules bound to the bead e.g., gel bead
  • the nucleic acid molecules bound to the bead may be used to hybridize and capture the mRNA on the solid phase of the bead, for example, in order to facilitate the separation of the RNA from other cell contents.
  • precursors comprising a functional group that is reactive or capable of being activated such that it becomes reactive can be polymerized with other precursors to generate gel beads comprising the activated or activatable functional group.
  • the functional group may then be used to attach additional species (e.g., disulfide linkers, primers, other oligonucleotides, etc.) to the gel beads.
  • additional species e.g., disulfide linkers, primers, other oligonucleotides, etc.
  • some precursors comprising a carboxylic acid (COOH) group can co-polymerize with other precursors to form a gel bead that also comprises a COOH functional group.
  • acrylic acid a species comprising free COOH groups
  • acrylamide acrylamide
  • bis(acryloyl)cystamine can be co-polymerized together to generate a gel bead comprising free COOH groups.
  • the COOH groups of the gel bead can be activated (e.g., via 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-Hydroxysuccinimide (NHS) or 4-(4,6-Dimethoxy-1,3,5-tiiazin-2-yl)-4-methylmorpholinium chloride (DMTMM)) such that they are reactive (e.g., reactive to amine functional groups where EDC/NHS or DMTMM are used for activation).
  • EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
  • NHS N-Hydroxysuccinimide
  • DTMM 4-(4,6-Dime
  • the activated COOH groups can then react with an appropriate species (e.g., a species comprising an amine functional group where the carboxylic acid groups are activated to be reactive with an amine functional group) comprising a moiety to be linked to the bead.
  • an appropriate species e.g., a species comprising an amine functional group where the carboxylic acid groups are activated to be reactive with an amine functional group
  • Beads comprising disulfide linkages in their polymeric network may be functionalized with additional species via reduction of some of the disulfide linkages to free thiols.
  • the disulfide linkages may be reduced via, for example, the action of a reducing agent (e.g., DTT, TCEP, etc.) to generate free thiol groups, without dissolution of the bead.
  • Free thiols of the beads can then react with free thiols of a species or a species comprising another disulfide bond (e.g., via thiol-disulfide exchange) such that the species can be linked to the beads (e.g., via a generated disulfide bond).
  • free thiols of the beads may react with any other suitable group.
  • free thiols of the beads may react with species comprising an acrydite moiety.
  • the free thiol groups of the beads can react with the acrydite via Michael addition chemistry, such that the species comprising the acrydite is linked to the bead.
  • uncontrolled reactions can be prevented by inclusion of a thiol capping agent such as N-ethylmalieamide or iodoacetate.
  • Activation of disulfide linkages within a bead can be controlled such that only a small number of disulfide linkages are activated. Control may be exerted, for example, by controlling the concentration of a reducing agent used to generate free thiol groups and/or concentration of reagents used to form disulfide bonds in bead polymerization.
  • a low concentration e.g., molecules of reducing agent:gel bead ratios of less than or equal to about 1:100,000,000,000, less than or equal to about 1:10,000,000,000, less than or equal to about 1:1,000,000,000, less than or equal to about 1:100,000,000, less than or equal to about 1:10,000,000, less than or equal to about 1:1,000,000, less than or equal to about 1:100,000, less than or equal to about 1:10,000
  • reducing agent may be used for reduction.
  • Controlling the number of disulfide linkages that are reduced to free thiols may be useful in ensuring bead structural integrity during functionalization.
  • optically-active agents such as fluorescent dyes may be coupled to beads via free thiol groups of the beads and used to quantify the number of free thiols present in a bead and/or track a bead.
  • addition of moieties to a gel bead after gel bead formation may be advantageous.
  • addition of an oligonucleotide (e.g., barcoded oligonucleotide) after gel bead formation may avoid loss of the species during chain transfer termination that can occur during polymerization.
  • smaller precursors e.g., monomers or cross linkers that do not comprise side chain groups and linked moieties
  • functionalization after gel bead synthesis can minimize exposure of species (e.g., oligonucleotides) to be loaded with potentially damaging agents (e.g., free radicals) and/or chemical environments.
  • the generated gel may possess an upper critical solution temperature (UCST) that can permit temperature driven swelling and collapse of a bead.
  • UCT upper critical solution temperature
  • Such functionality may aid in oligonucleotide (e.g., a primer) infiltration into the bead during subsequent functionalization of the bead with the oligonucleotide.
  • Post-production functionalization may also be useful in controlling loading ratios of species in beads, such that, for example, the variability in loading ratio is minimized.
  • Species loading may also be performed in a batch process such that a plurality of beads can be functionalized with the species in a single batch.
  • beads can be non-covalently loaded with one or more reagents.
  • the beads can be non-covalently loaded by, for instance, subjecting the beads to conditions sufficient to swell the beads, allowing sufficient time for the reagents to diffuse into the interiors of the beads, and subjecting the beads to conditions sufficient to de-swell the beads.
  • the swelling of the beads may be accomplished, for instance, by placing the beads in a thermodynamically favorable solvent, subjecting the beads to a higher or lower temperature, subjecting the beads to a higher or lower ion concentration, and/or subjecting the beads to an electric field.
  • the swelling of the beads may be accomplished by any swelling method as is known to one having skill in the art.
  • the de-swelling of the beads may be accomplished, for instance, by transferring the beads in a thermodynamically unfavorable solvent, subjecting the beads to lower or high temperatures, subjecting the beads to a lower or higher ion concentration, and/or removing an electric field.
  • the de-swelling of the beads may be accomplished by any de-swelling method as is known to one having skill in the art. Transferring the beads may cause pores in the bead to shrink. The shrinking may then hinder reagents within the beads from diffusing out of the interiors of the beads. The hindrance may be due to steric interactions between the reagents and the interiors of the beads.
  • the transfer may be accomplished microfluidically. For instance, the transfer may be achieved by moving the beads from one co-flowing solvent stream to a different co-flowing solvent stream.
  • the swellability and/or pore size of the beads may be adjusted by changing the polymer composition of the bead.
  • an acrydite moiety linked to precursor, another species linked to a precursor, or a precursor itself comprises a labile bond, such as chemically, thermally, or photosensitive bonds e.g., disulfide bonds, UV sensitive bonds, or the like.
  • a labile bond such as chemically, thermally, or photosensitive bonds e.g., disulfide bonds, UV sensitive bonds, or the like.
  • the bead may also comprise the labile bond.
  • the labile bond may be, for example, useful in reversibly linking (e.g., covalently linking) species (e.g., barcodes, primers, etc.) to a bead.
  • a thermally labile bond may include a nucleic acid hybridization based attachment, e.g., where an oligonucleotide is hybridized to a complementary sequence that is attached to the bead, such that thermal melting of the hybrid releases the oligonucleotide, e.g., a barcode containing sequence, from the bead or microcapsule.
  • a nucleic acid hybridization based attachment e.g., where an oligonucleotide is hybridized to a complementary sequence that is attached to the bead, such that thermal melting of the hybrid releases the oligonucleotide, e.g., a barcode containing sequence, from the bead or microcapsule.
  • labile bonds may result in the generation of a bead capable of responding to varied stimuli.
  • Each type of labile bond may be sensitive to an associated stimulus (e.g., chemical stimulus, light, temperature, etc.) such that release of species attached to a bead via each labile bond may be controlled by the application of the appropriate stimulus.
  • Such functionality may be useful in controlled release of species from a gel bead.
  • another species comprising a labile bond may be linked to a gel bead after gel bead formation via, for example, an activated functional group of the gel bead as described above.
  • barcodes that are releasably, cleavably or reversibly attached to the beads described herein include barcodes that are released or releasable through cleavage of a linkage between the barcode molecule and the bead, or that are released through degradation of the underlying bead itself, allowing the barcodes to be accessed or accessible by other reagents, or both.
  • the barcodes that are releasable as described herein may sometimes be referred to as being activatable, in that they are available for reaction once released.
  • an activatable barcode may be activated by releasing the barcode from a bead (or other suitable type of partition described herein).
  • Other activatable configurations are also envisioned in the context of the described methods and systems.
  • labile bonds that may be coupled to a precursor or bead include an ester linkage (e.g., cleavable with an acid, a base, or hydroxylamine), a vicinal diol linkage (e.g., cleavable via sodium periodate), a Diels-Alder linkage (e.g., cleavable via heat), a sulfone linkage (e.g., cleavable via a base), a silyl ether linkage (e.g., cleavable via an acid), a glycosidic linkage (e.g., cleavable via an amylase), a peptide linkage (e.g., cleavable via a protease), or a phosphodiester linkage (e.g., cleavable via a nuclease (
  • Species that do not participate in polymerization may also be encapsulated in beads during bead generation (e.g., during polymerization of precursors). Such species may be entered into polymerization reaction mixtures such that generated beads comprise the species upon bead formation. In some cases, such species may be added to the gel beads after formation.
  • Such species may include, for example, oligonucleotides, reagents for a nucleic acid amplification reaction (e.g., primers, polymerases, dNTPs, co-factors (e.g., ionic co-factors)) including those described herein, reagents for enzymatic reactions (e.g., enzymes, co-factors, substrates), or reagents for a nucleic acid modification reactions such as polymerization, ligation, or digestion. Trapping of such species may be controlled by the polymer network density generated during polymerization of precursors, control of ionic charge within the gel bead (e.g., via ionic species linked to polymerized species), or by the release of other species. Encapsulated species may be released from a bead upon bead degradation and/or by application of a stimulus capable of releasing the species from the bead.
  • reagents for a nucleic acid amplification reaction e.g.,
  • Beads may be of uniform size or heterogeneous size.
  • the diameter of a bead may be at least about Imicrometers ( ⁇ m), 5 ⁇ m, 10 ⁇ m, 20 ⁇ m, 30 ⁇ m, 40 ⁇ m, 50 ⁇ m, 60 ⁇ m, 70 ⁇ m, 80 ⁇ m, 90 ⁇ m, 100 ⁇ m, 250 ⁇ m, 500 ⁇ m, 1mm, or greater.
  • a bead may have a diameter of less than about 1 ⁇ m, 5 ⁇ m, 10 ⁇ m, 20 ⁇ m, 30 ⁇ m, 40 ⁇ m, 50 ⁇ m, 60 ⁇ m, 70 ⁇ m, 80 ⁇ m, 90 ⁇ m, 100 ⁇ m, 250 ⁇ m, 500 ⁇ m, 1mm, or less.
  • a bead may have a diameter in the range of about 40-75 ⁇ m, 30-75 ⁇ m, 20-75 ⁇ m, 40-85 ⁇ m, 40-95 ⁇ m, 20-100 ⁇ m, 10-100 ⁇ m, 1-100 ⁇ m, 20-250 ⁇ m, or 20-500 ⁇ m.
  • beads can be provided as a population or plurality of beads having a relatively monodisperse size distribution. Where it may be desirable to provide relatively consistent amounts of reagents within partitions, maintaining relatively consistent bead characteristics, such as size, can contribute to the overall consistency.
  • the beads described herein may have size distributions that have a coefficient of variation in their cross-sectional dimensions of less than 50%, less than 40%, less than 30%, less than 20%, and in some cases less than 15%, less than 10%, less than 5%, or less.
  • Beads may be of any suitable shape. Examples of bead shapes include, but are not limited to, spherical, non-spherical, oval, oblong, amorphous, circular, cylindrical, and variations thereof.
  • the beads may be degradable, disruptable, or dissolvable spontaneously or upon exposure to one or more stimuli (e.g., temperature changes, pH changes, exposure to particular chemical species or phase, exposure to light, reducing agent, etc.).
  • a bead may be dissolvable, such that material components of the beads are solubilized when exposed to a particular chemical species or an environmental change, such as a change temperature or a change in pH.
  • a gel bead can be degraded or dissolved at elevated temperature and/or in basic conditions.
  • a bead may be thermally degradable such that when the bead is exposed to an appropriate change in temperature (e.g., heat), the bead degrades.
  • Degradation or dissolution of a bead bound to a species e.g., a oligonucleotide, e.g., barcoded oligonucleotide
  • a species e.g., a oligonucleotide, e.g., barcoded oligonucleotide
  • a degradable bead may comprise one or more species with a labile bond such that, when the bead/species is exposed to the appropriate stimuli, the bond is broken and the bead degrades.
  • the labile bond may be a chemical bond (e.g., covalent bond, ionic bond) or may be another type of physical interaction (e.g., van der Waals interactions, dipole-dipole interactions, etc.).
  • a crosslinker used to generate a bead may comprise a labile bond.
  • the labile bond can be broken and the bead degraded. For example, upon exposure of a polyacrylamide gel bead comprising cystamine crosslinkers to a reducing agent, the disulfide bonds of the cystamine can be broken and the bead degraded.
  • a degradable bead may be useful in more quickly releasing an attached species (e.g., an oligonucleotide, a barcode sequence, a primer, etc) from the bead when the appropriate stimulus is applied to the bead as compared to a bead that does not degrade.
  • an attached species e.g., an oligonucleotide, a barcode sequence, a primer, etc
  • the species may have greater mobility and accessibility to other species in solution upon degradation of the bead.
  • a species may also be attached to a degradable bead via a degradable linker (e.g., disulfide linker).
  • the degradable linker may respond to the same stimuli as the degradable bead or the two degradable species may respond to different stimuli.
  • a barcode sequence may be attached, via a disulfide bond, to a polyacrylamide bead comprising cystamine.
  • the bead Upon exposure of the barcoded-bead to a reducing agent, the bead degrades and the barcode sequence is released upon breakage of both the disulfide linkage between the barcode sequence and the bead and the disulfide linkages of the cystamine in the bead.
  • a degradable bead may be introduced into a partition, such as a droplet of an emulsion or a well, such that the bead degrades within the partition and any associated species (e.g., oligonucleotides) are released within the droplet when the appropriate stimulus is applied.
  • the free species e.g., oligonucleotides
  • a polyacrylamide bead comprising cystamine and linked, via a disulfide bond, to a barcode sequence, may be combined with a reducing agent within a droplet of a water-in-oil emulsion.
  • the reducing agent breaks the various disulfide bonds resulting in bead degradation and release of the barcode sequence into the aqueous, inner environment of the droplet.
  • heating of a droplet comprising a bead-bound barcode sequence in basic solution may also result in bead degradation and release of the attached barcode sequence into the aqueous, inner environment of the droplet.
  • degradation may refer to the disassociation of a bound or entrained species from a bead, both with and without structurally degrading the physical bead itself.
  • entrained species may be released from beads through osmotic pressure differences due to, for example, changing chemical environments.
  • alteration of bead pore sizes due to osmotic pressure differences can generally occur without structural degradation of the bead itself.
  • an increase in pore size due to osmotic swelling of a bead can permit the release of entrained species within the bead.
  • osmotic shrinking of a bead may cause a bead to better retain an entrained species due to pore size contraction.
  • degradable beads it may be desirable to avoid exposing such beads to the stimulus or stimuli that cause such degradation prior to the desired time, in order to avoid premature bead degradation and issues that arise from such degradation, including for example poor flow characteristics and aggregation.
  • beads comprise reducible cross-linking groups, such as disulfide groups
  • reducing agents e.g., DTT or other disulfide cleaving reagents.
  • treatment to the beads described herein will, in some cases be provided free of reducing agents, such as DTT.
  • reducing agent free (or DTT free) enzyme preparations in treating the beads described herein.
  • enzymes include, e.g., polymerase enzyme preparations, reverse transcriptase enzyme preparations, ligase enzyme preparations, as well as many other enzyme preparations that may be used to treat the beads described herein.
  • the terms "reducing agent free” or "DTT free” preparations can refer to a preparation having less than about 1/10th, less than about 1/50th, or even less than about 1/100th of the lower ranges for such materials used in degrading the beads.
  • the reducing agent free preparation can have less than about 0.01 millimolar (mM), 0.005 mM, 0.001 mM DTT, 0.0005 mM DTT, or even less than about 0.0001 mM DTT. In many cases, the amount of DTT can be undetectable.
  • Numerous chemical triggers may be used to trigger the degradation of beads. Examples of these chemical changes may include, but are not limited to pH-mediated changes to the integrity of a component within the bead, degradation of a component of a bead via cleavage of cross-linked bonds, and depolymerization of a component of a bead.
  • a bead may be formed from materials that comprise degradable chemical crosslinkers, such as BAC or cystamine. Degradation of such degradable crosslinkers may be accomplished through a number of mechanisms.
  • a bead may be contacted with a chemical degrading agent that may induce oxidation, reduction or other chemical changes.
  • a chemical degrading agent may be a reducing agent, such as dithiothreitol (DTT).
  • reducing agents may include ⁇ -mercaptoethanol, (2S)-2-amino-1,4-dimercaptobutane (dithiobutylamine or DTBA), tris(2-carboxyethyl) phosphine (TCEP), or combinations thereof.
  • a reducing agent may degrade the disulfide bonds formed between gel precursors forming the bead, and thus, degrade the bead.
  • a change in pH of a solution such as an increase in pH, may trigger degradation of a bead.
  • exposure to an aqueous solution, such as water may trigger hydrolytic degradation, and thus degradation of the bead.
  • Beads may also be induced to release their contents upon the application of a thermal stimulus.
  • a change in temperature can cause a variety of changes to a bead. For example, heat can cause a solid bead to liquefy. A change in heat may cause melting of a bead such that a portion of the bead degrades. In other cases, heat may increase the internal pressure of the bead components such that the bead ruptures or explodes. Heat may also act upon heat-sensitive polymers used as materials to construct beads.
  • a chemical degrading agent may be a reducing agent, such as DTT, wherein DTT may degrade the disulfide bonds formed between a crosslinker and gel precursors, thus degrading the bead.
  • a reducing agent may be added to degrade the bead, which may or may not cause the bead to release its contents.
  • reducing agents may include dithiothreitol (DTT), ⁇ -mercaptoethanol, (2S)-2-amino-1,4-dimercaptobutane (dithiobutylamine or DTBA), tris(2-carboxyethyl) phosphine (TCEP), or combinations thereof.
  • the reducing agent may be present at a concentration of about 0.1mM, 0.5mM, 1mM, 5mM, 10mM.
  • the reducing agent may be present at a concentration of at least about 0.1mM, 0.5mM, 1mM, 5mM, 10mM, or greater than 10 mM.
  • the reducing agent may be present at concentration of at most about 10mM, 5mM, 1mM, 0.5mM, 0.1mM, or less.
  • any suitable number of molecular tag molecules can be associated with a bead such that, upon release from the bead, the molecular tag molecules (e.g., primer, e.g., barcoded oligonucleotide) are present in the partition at a pre-defined concentration.
  • the pre-defined concentration may be selected to facilitate certain reactions for generating a sequencing library, e.g., amplification, within the partition.
  • the pre-defined concentration of the primer can be limited by the process of producing oligonucleotide bearing beads.
  • the compartments or partitions can be flowable within fluid streams.
  • the partitions may comprise, for example, micro-vesicles that have an outer barrier surrounding an inner fluid center or core.
  • the partitions may comprise a porous matrix that is capable of entraining and/or retaining materials within its matrix.
  • the partitions can comprise droplets of aqueous fluid within a non-aqueous continuous phase, e.g., an oil phase.
  • the partitions can comprise droplets of a first phase within a second phase, wherein the first and second phases are immiscible.
  • a variety of different vessels are described in, for example, U.S. Patent Application Publication No. 2014/0155295 .
  • Emulsion systems for creating stable droplets in non-aqueous or oil continuous phases are described in detail in, e.g., U.S. Patent Application Publication No. 2010/0105112 .
  • allocating individual biological particles to discrete partitions may generally be accomplished by introducing a flowing stream of biological particles in an aqueous fluid into a flowing stream of a non-aqueous fluid, such that droplets are generated at the junction of the two streams.
  • the occupancy of the resulting partitions e.g., number of biological particles per partition
  • the relative flow rates of the immiscible fluids can be selected such that, on average, the partitions contain less than one biological particle per partition, in order to ensure that those partitions that are occupied, are primarily singularly occupied.
  • the relative flow rates of the fluids can be selected such that a majority of partitions are occupied, e.g., allowing for only a small percentage of unoccupied partitions.
  • the flows and channel architectures can be controlled as to ensure a desired number of singularly occupied partitions, less than a certain level of unoccupied partitions and/or less than a certain level of multiply occupied partitions.
  • the systems and methods described herein can be operated such that a majority of occupied partitions include no more than one biological particle per occupied partition.
  • the partitioning process is conducted such that fewer than 25% of the occupied partitions contain more than one biological particle, and in many cases, fewer than 20% of the occupied partitions have more than one biological particle. In some cases, fewer than 10% or even fewer than 5% of the occupied partitions include more than one biological particle per partition.
  • the Poissonian distribution may expectedly increase the number of partitions that may include multiple biological particles. As such, at most about 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, 5% or less of the generated partitions can be unoccupied.
  • the flow of one or more of the cells, or other fluids directed into the partitioning zone can be conducted such that, in many cases, no more than about 50% of the generated partitions, no more than about 25% of the generated partitions, or no more than about 10% of the generated partitions are unoccupied.
  • These flows can be controlled so as to present non-Poissonian distribution of single occupied partitions while providing lower levels of unoccupied partitions.
  • the above noted ranges of unoccupied partitions can be achieved while still providing any of the single occupancy rates described above.
  • the use of the systems and methods described herein creates resulting partitions that have multiple occupancy rates of less than about 25%, less than about 20%, less than about 15%, less than about 10%, and in many cases, less than about 5%, while having unoccupied partitions of less than about 50%, less than about 40%, less than about 30%, less than about 20%, less than about 10%, less than about 5%, or less.
  • the occupied partitions can be sorted from the unoccupied partitions.
  • singularly occupied partitions may be isolated from non-singularly occupied partitions (e.g., multiply occupied partitions and unoccupied partitions).
  • sorting can be achieved by including field attractable particles during the generation of droplets in an emulsion. For example, a flowing stream of aqueous fluid containing biological particles and field attractable particles can be introduced into a flowing stream of a non-aqueous fluid, such that droplets are generated at the junction of the two streams.
  • the above-described occupancy rates are also applicable to partitions that include both biological particles and additional reagents, including, but not limited to, microcapsules carrying barcoded oligonucleotides.
  • the occupied partitions e.g., at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 99% of the occupied partitions
  • multiply occupied partitions e.g., containing two, three, four or more cells and/or microcapsules (e.g., beads) comprising barcoded oligonucleotides within a single partition.
  • the flow characteristics of the biological particle and/or bead containing fluids and partitioning fluids may be controlled to provide for such multiply occupied partitions.
  • the flow parameters may be controlled to provide a desired occupancy rate at greater than about 50% of the partitions, greater than about 75%, and in some cases greater than about 80%, 90%, 95%, or higher.
  • additional microcapsules are used to deliver additional reagents to a partition.
  • the flow and frequency of the different beads into the channel or junction may be controlled to provide for the desired ratio of microcapsules from each source, while ensuring the desired pairing or combination of such beads into a partition with the desired number of biological particles.
  • the partitions described herein may comprise small volumes, e.g., less than about 10 microliters ( ⁇ L), 5 ⁇ L, 1 ⁇ L, 900 picoliters (pL), 800 pL, 700 pL, 600 pL, 500 pL, 400pL, 300 pL, 200 pL, 100pL, 50 pL, 20 pL, 10 pL, 1 pL, 500 nanoliters (nL), 100 nL, 50 nL, or less.
  • small volumes e.g., less than about 10 microliters ( ⁇ L), 5 ⁇ L, 1 ⁇ L, 900 picoliters (pL), 800 pL, 700 pL, 600 pL, 500 pL, 400pL, 300 pL, 200 pL, 100pL, 50 pL, 20 pL, 10 pL, 1 pL, 500 nanoliters (nL), 100 nL, 50 nL, or less.
  • the droplets may have overall volumes that are less than about 1000 pL, 900 pL, 800 pL, 700 pL, 600 pL, 500 pL, 400pL, 300 pL, 200 pL, 100pL, 50 pL, 20 pL, 10 pL, 1 pL, or less.
  • sample fluid volume e.g., including co-partitioned biological particles
  • the sample fluid volume within the partitions may be less than about 90% of the above described volumes, less than about 80%, less than about 70%, less than about 60%, less than about 50%, less than about 40%, less than about 30%, less than about 20%, or less than about 10% the above described volumes.
  • partitioning species may generate a population or plurality of partitions.
  • any suitable number of partitions can be generated to generate the plurality of partitions.
  • a plurality of partitions may be generated that comprises at least about 1,000 partitions, at least about 5,000 partitions, at least about 10,000 partitions, at least about 50,000 partitions, at least about 100,000 partitions, at least about 500,000 partitions, at least about 1,000,000 partitions, at least about 5,000,000 partitions at least about 10,000,000 partitions, at least about 50,000,000 partitions, at least about 100,000,000 partitions, at least about 500,000,000 partitions, at least about 1,000,000,000 partitions, or more.
  • the plurality of partitions may comprise both unoccupied partitions (e.g., empty partitions) and occupied partitions.
  • Microfluidic channel networks can be utilized to generate partitions as described herein.
  • Alternative mechanisms may also be employed in the partitioning of individual biological particles, including porous membranes through which aqueous mixtures of cells are extruded into non-aqueous fluids.
  • FIG.1 shows an example of a microfluidic channel structure for partitioning individual biological particles.
  • the majority of occupied partitions can include no more than one biological particle per occupied partition and, in some cases, some of the generated partitions can be unoccupied (of any biological particle).
  • some of the occupied partitions may include more than one biological particle.
  • the partitioning process may be controlled such that fewer than about 25% of the occupied partitions contain more than one biological particle, and in many cases, fewer than about 20% of the occupied partitions have more than one biological particle, while in some cases, fewer than about 10% or even fewer than about 5% of the occupied partitions include more than one biological particle per partition.
  • the channel structure can include channel segments 102, 104, 106 and 108 communicating at a channel junction 110 .
  • a first aqueous fluid 112 that includes suspended biological particles (e.g., cells) 114 and suspended field-attractable particles 115 , may be transported along channel segment 102 into junction 110 , while a second fluid 116 that is immiscible with the aqueous fluid 112 is delivered to the junction 110 from each of channel segments 104 and 106 to create discrete droplets 118, 120 of the first aqueous fluid 112 flowing into channel segment 108 , and flowing away from junction 110 .
  • suspended biological particles e.g., cells
  • a second fluid 116 that is immiscible with the aqueous fluid 112 is delivered to the junction 110 from each of channel segments 104 and 106 to create discrete droplets 118, 120 of the first aqueous fluid 112 flowing into channel segment 108 , and flowing away from junction 110 .
  • a discrete droplet generated may include an individual biological particle 114 and field-attractable particles 115 (such as droplets 118 ).
  • a discrete droplet generated may include more than one individual biological particle 114 and field-attractable particles 115 (not shown in FIG. 1 ).
  • a discrete droplet may contain field-attractable particles 115 but no biological particle 114 (such as droplet 120 ).
  • the field-attractable particles 115 may be paramagnetic particles. In some cases, the field-attractable particles may be superparamagnetic particles.
  • the field-attractable particles can comprise polystyrene magnetic particles (e.g., polystyrene core particle coated with at least a layer of magnetite (e.g., iron oxide) and polystyrene), amino magnetic particles, carboxyl magnetic particles, dimethylamino magnetic particles, hydroxy ethyl magnetic particles, and/or a combination of the above.
  • a paramagnetic particle can comprise a polymer matrix of amine silane, glucuronic acid, bromoacetyl, chitosan, carboxymethyldextran, citric acid, starch, DEAE-starch, phosphate-starch, dextran, dextran-sulfate, lipid, oleic acid, diphosphate, polyaspartic acid, polyacrylamide, polyacrylic acid, polydimethylamine, polyethylene glycole alpha-methoxy-omega-amine, polyethylene glycol alpha-,omega-diphosphate, poly(maleic acid-co-olefin), polystyrenesulfonate, polyvinyl alcohol, poly(4-vinylpyridine), poly-diallyldimethylamin, uncoated magnetite, and/or other matrices.
  • a paramagnetic particle may have micrometer or nanometer size.
  • a paramagnetic particle can have a maximum dimension (e.g., width, length, height, diameter, etc.) of at most about 20 micrometers ( ⁇ m), 10 ⁇ m, 9 ⁇ m, 8 ⁇ m, 7 ⁇ m, 6 ⁇ m, 5 ⁇ m, 4 ⁇ m , 3 ⁇ m, 2 ⁇ m, 1 ⁇ m, 0.5 ⁇ m, or less.
  • the paramagnetic particle can have a maximum dimension of at most about 500 nanometer (nm), 400 nm, 300 nm, 200 nm, 100 nm, 50 nm, 40 nm, 30 nm, 20 nm, 10 nm, 9 nm, 8 nm, 7 nm, 6 nm, 5 nm, 4 nm, 3 nm, 2 nm, 1 nm, or less.
  • a paramagnetic particle can have a maximum dimension that is greater than about 20 ⁇ m.
  • the paramagnetic particles may be responsive when exposed to magnetic fields.
  • the paramagnetic particles can be smooth surface particles, wherein a thick polymer layer coats the magnetite (e.g., iron oxide) layer.
  • the smooth surface can shield the magnetite from interfering with enzyme activities or other undesirable effects with other particles or cells caused by exposure to the magnetite.
  • the paramagnetic particles can be cross-linked particles, wherein the particles are coated with cross-linked polymer on the surfaces of the iron oxide crystals.
  • the cross-linked polymer can render the paramagnetic particle resistant to common organic solvents, such as acetone, acetonitrile, dimethlyformanide (DMF) and chloroform.
  • the magnetite content on each paramagnetic particle can be adjusted (e.g., to have higher or lower percentage) to be more responsive or less responsive to the same magnetic field.
  • the field-attractable particles can be diamagnetic particles or ferromagnetic particles.
  • the field-attractable particles 115 may be conductive particles.
  • a conductive particle may have micrometer or nanometer size.
  • a conductive particle can have a maximum dimension (e.g., width, length, height, diameter, etc.) of at most about 20 micrometers ( ⁇ m), 10 ⁇ m, 9 ⁇ m, 8 ⁇ m, 7 ⁇ m, 6 ⁇ m, 5 ⁇ m, 4 ⁇ m , 3 ⁇ m, 2 ⁇ m, 1 ⁇ m, 0.5 ⁇ m, or less.
  • the conductive particle can have a maximum dimension of at most about 500 nanometer (nm), 400 nm, 300 nm, 200 nm, 100 nm, 50 nm, 40 nm, 30 nm, 20 nm, 10 nm, 9 nm, 8 nm, 7 nm, 6 nm, 5 nm, 4 nm, 3 nm, 2 nm, 1 nm, or less.
  • a conductive particle can have a maximum dimension that is greater than about 20 ⁇ m.
  • a conductive particle can have a substantially spherical shape.
  • a conductive particle can have a different shape. The conductive particles may be responsive when exposed to electric fields.
  • the conductive (e.g., metal) content on each conductive particle can be adjusted (e.g., to have higher or lower percentage) to be more responsive or less responsive to the same electric field.
  • the field-attractable particles 115 can comprise both paramagnetic and conductive particles.
  • the first aqueous fluid 112 can have a substantially uniform concentration of field-attractable particles 115 as the first aqueous fluid 112 is introduced into junction 110 .
  • the concentration of the field-attractable particles 115 in the first aqueous fluid 112 in the channel segment 102 at time x can be substantially uniform with the concentration of field-attractable particles 115 in the first aqueous fluid 112 in the channel segment 102 at time x+ ⁇ (where x and ⁇ are positive).
  • the concentration of field-attractable particles 115 can be substantially uniform in only the volume of the first aqueous fluid 112 , that is, the volume not including the volume of each of the biological particles 114 suspended in the first aqueous fluid 112 .
  • This second fluid 116 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • an oil such as a fluorinated oil
  • fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • fluorosurfactants are described for example, in U.S. Patent Application Publication No. 2010/0105112 .
  • the generated droplets may comprise two subsets of droplets: (1) occupied droplets 118 , containing one or more biological particles 114 , and (2) unoccupied droplets 120 , not containing any biological particles 114 .
  • Each droplet generated, occupied or unoccupied may contain some number and/or concentration of field-attractable particles 115 .
  • the concentration of the field-attractable particles 115 in each of the unoccupied droplets 120 can be substantially uniform, wherein the concentration is a number of field-attractable particles per total droplet volume (and not just the volume of the first aqueous fluid 112 in the droplet).
  • the concentration of the field-attractable particles 115 in each of the occupied droplets 118 can be substantially uniform, wherein the concentration is a number of field-attractable particles per total droplet volume. In other instances, as can be easily appreciated, the concentration of the field-attractable particles 115 in each of the occupied droplets 118 can vary with size and/or the number of biological particles 114 contained in the droplet. In any case, the concentration of field-attractable particles in any of the unoccupied droplets 120 can be greater than the concentration of field-attractable particles in any of the occupied droplets 118 to account for the volume occupied by the biological particle 114 in the occupied droplets 118 .
  • the concentration of field-attractable particles in a droplet from the unoccupied droplets 120 can be greater than the concentration of field-attractable particles in a droplet from the occupied droplets 118 to account for the volume occupied by the biological particle 114 in the occupied droplets 118 .
  • an occupied droplet containing three biological particles can have a ratio of about: 1 ⁇ 3 R + R D 3 .
  • biological particles may be encapsulated within a microcapsule, such as a cell bead, that comprises an outer shell or layer or porous matrix in which is entrained one or more individual biological particles or small groups of biological particles, and may include other reagents.
  • Encapsulation of biological particles may be performed by a variety of processes. Such processes combine an aqueous fluid containing the biological particles and also containing the field-attractable particles to be analyzed with a polymeric precursor material that may be capable of being formed into a gel or other solid or semi-solid matrix upon application of a particular stimulus to the polymer precursor.
  • Such stimuli include, e.g., thermal stimuli (either heating or cooling), photo-stimuli (e.g., through photo-curing), chemical stimuli (e.g., through crosslinking, polymerization initiation of the precursor (e.g., through added initiators), or the like.
  • microcapsules comprising biological particles may be performed by a variety of methods.
  • air knife droplet or aerosol generators may be used to dispense droplets of precursor fluids into gelling solutions in order to form microcapsules that include individual biological particles or small groups of biological particles.
  • membrane based encapsulation systems may be used to generate microcapsules comprising encapsulated biological particles as described herein.
  • Microfluidic systems of the present disclosure such as that shown in FIG. 1 , may be readily used in encapsulating cells as described herein, such as to generate a plurality of particles, each particle comprising field-attractable particles.
  • the plurality of particles may comprise a first subset of particles occupied by biological particles (e.g., cell beads) and a second subset of particles unoccupied by biological particles.
  • the aqueous fluid comprising (i) the biological particles 114 , (ii) the field-attractable particles 115 , and (ii) the polymer precursor material (not shown) is flowed into channel junction 110 , where it is partitioned into droplets 118 or 120 comprising or not comprising the individual biological particles 114 , respectively, but always comprising the field-attractable particles 115 , through the flow of non-aqueous fluid 116 .
  • non-aqueous fluid 116 may also include an initiator to cause polymerization and/or crosslinking of the polymer precursor to form the microcapsule that includes the entrained biological particles.
  • initiator to cause polymerization and/or crosslinking of the polymer precursor to form the microcapsule that includes the entrained biological particles.
  • Examples of polymer precursor/initiator pairs include those described in U.S. Patent Application Publication No. 2014/0378345 .
  • the activation agent may comprise a cross-linking agent, or a chemical that activates a cross-linking agent within the formed droplets.
  • the activation agent may comprise a polymerization initiator.
  • the polymer precursor comprises a mixture of acrylamide monomer with a N,N'-bis-(acryloyl)cystamine (BAC) comonomer
  • an agent such as tetraethylmethylenediamine (TEMED) may be provided within the second fluid streams in channel segments 104 and 106 , which initiates the copolymerization of the acrylamide and BAC into a cross-linked polymer network or, hydrogel.
  • TEMED tetraethylmethylenediamine
  • the TEMED may diffuse from the second fluid 116 into the aqueous first fluid 112 comprising the linear polyacrylamide, which will activate the crosslinking of the polyacrylamide within the droplets, resulting in the formation of the gel, e.g., hydrogel, microcapsules (e.g., droplet 118 , 120 ), as solid or semi-solid beads or particles entraining the cells 114 .
  • the gel e.g., hydrogel, microcapsules (e.g., droplet 118 , 120 ), as solid or semi-solid beads or particles entraining the cells 114 .
  • encapsulated biological particles can be selectively releasable from the microcapsule, e.g., through passage of time, or upon application of a particular stimulus, that degrades the microcapsule sufficiently to allow the cell, or its contents to be released from the microcapsule, e.g., into a partition, such as a droplet.
  • degradation of the microcapsule may be accomplished through the introduction of an appropriate reducing agent, such as DTT or the like, to cleave disulfide bonds that cross link the polymer matrix (See, e.g., U.S. Patent Application Publication No. 2014/0378345 ).
  • an appropriate reducing agent such as DTT or the like
  • Encapsulated biological particles e.g., cell beads
  • Encapsulated biological particles can provide certain potential advantages of being storable, and more portable than droplet based partitioned biological particles. Furthermore, in some cases, it may be desirable to allow biological particles to be analyzed to incubate for a select period of time, in order to characterize changes in such biological particles over time, either in the presence or absence of different stimuli.
  • encapsulation of individual biological particles may allow for longer incubation than partitioning in emulsion droplets, although in some cases, droplet partitioned biological particles may also be incubated for different periods of time, e.g., at least 10 seconds, at least 30 seconds, at least 1 minute, at least 5 minutes, at least 10 minutes, at least 30 minutes, at least 1 hour, at least 2 hours, at least 5 hours, or at least 10 hours or more.
  • the encapsulation of biological particles may constitute the partitioning of the biological particles into which other reagents are co-partitioned.
  • encapsulated biological particles may be readily deposited into other partitions, e.g., droplets, as described above.
  • the biological particles may be partitioned along with lysis reagents in order to release the contents of the biological particles within the partition.
  • the lysis agents can be contacted with the biological particle suspension concurrently with, or immediately prior to the introduction of the biological particles into the partitioning junction/droplet generation zone, e.g., through an additional channel or channels upstream of channel junction 110 .
  • lysis agents include bioactive reagents, such as lysis enzymes that are used for lysis of different cell types, e.g., gram positive or negative bacteria, plants, yeast, mammalian, etc., such as lysozymes, achromopeptidase, lysostaphin, labiase, kitalase, lyticase, and a variety of other lysis enzymes available from, e.g., Sigma-Aldrich, Inc. (St Louis, MO), as well as other commercially available lysis enzymes.
  • Other lysis agents may additionally or alternatively be co-partitioned with the biological particles to cause the release of the biological particles's contents into the partitions.
  • surfactant based lysis solutions may be used to lyse cells, although these may be less desirable for emulsion based systems where the surfactants can interfere with stable emulsions.
  • lysis solutions may include non-ionic surfactants such as, for example, TritonX-100 and Tween 20.
  • lysis solutions may include ionic surfactants such as, for example, sarcosyl and sodium dodecyl sulfate (SDS).
  • Electroporation, thermal, acoustic or mechanical cellular disruption may also be used in certain cases, e.g., non-emulsion based partitioning such as encapsulation of biological particles that may be in addition to or in place of droplet partitioning, where any pore size of the encapsulate is sufficiently small to retain nucleic acid fragments of a desired size, following cellular disruption.
  • non-emulsion based partitioning such as encapsulation of biological particles that may be in addition to or in place of droplet partitioning, where any pore size of the encapsulate is sufficiently small to retain nucleic acid fragments of a desired size, following cellular disruption.
  • reagents can also be co-partitioned with the biological particles, including, for example, DNase and RNase inactivating agents or inhibitors, such as proteinase K, chelating agents, such as EDTA, and other reagents employed in removing or otherwise reducing negative activity or impact of different cell lysate components on subsequent processing of nucleic acids.
  • DNase and RNase inactivating agents or inhibitors such as proteinase K
  • chelating agents such as EDTA
  • the biological particles may be exposed to an appropriate stimulus to release the biological particles or their contents from a co-partitioned microcapsule.
  • a chemical stimulus may be co-partitioned along with an encapsulated biological particle to allow for the degradation of the microcapsule and release of the cell or its contents into the larger partition.
  • this stimulus may be the same as the stimulus described elsewhere herein for release of oligonucleotides from their respective microcapsule (e.g., bead).
  • this may be a different and non-overlapping stimulus, in order to allow an encapsulated biological particle to be released into a partition at a different time from the release of oligonucleotides into the same partition.
  • Additional reagents may also be co-partitioned with the biological particles, such as endonucleases to fragment a biological particle's DNA, DNA polymerase enzymes and dNTPs used to amplify the biological particle's nucleic acid fragments and to attach the barcode molecular tags to the amplified fragments.
  • Additional reagents may also include reverse transcriptase enzymes, including enzymes with terminal transferase activity, primers and oligonucleotides, and switch oligonucleotides (also referred to herein as "switch oligos" or "template switching oligonucleotides”) which can be used for template switching. In some cases, template switching can be used to increase the length of a cDNA.
  • template switching can be used to append a predefined nucleic acid sequence to the cDNA.
  • cDNA can be generated from reverse transcription of a template, e.g., cellular mRNA, where a reverse transcriptase with terminal transferase activity can add additional nucleotides, e.g., polyC, to the cDNA in a template independent manner.
  • Switch oligos can include sequences complementary to the additional nucleotides, e.g., polyG.
  • the additional nucleotides (e.g., polyC) on the cDNA can hybridize to the additional nucleotides (e.g., polyG) on the switch oligo, whereby the switch oligo can be used by the reverse transcriptase as template to further extend the cDNA.
  • Template switching oligonucleotides may comprise a hybridization region and a template region.
  • the hybridization region can comprise any sequence capable of hybridizing to the target.
  • the hybridization region comprises a series of G bases to complement the overhanging C bases at the 3' end of a cDNA molecule.
  • the series of G bases may comprise 1 G base, 2 G bases, 3 G bases, 4 G bases, 5 G bases or more than 5 G bases.
  • the template sequence can comprise any sequence to be incorporated into the cDNA.
  • the template region comprises at least 1 (e.g., at least 2, 3, 4, 5 or more) tag sequences and/or functional sequences.
  • Switch oligos may comprise deoxyribonucleic acids; ribonucleic acids; modified nucleic acids including 2-Aminopurine, 2,6-Diaminopurine (2-Amino-dA), inverted dT, 5-Methyl dC, 2'-deoxyInosine, Super T (5-hydroxybutynl-2'-deoxyuridine), Super G (8-aza-7-deazaguanosine), locked nucleic acids (LNAs), unlocked nucleic acids (UNAs, e.g., UNA-A, UNA-U, UNA-C, UNA-G), Iso-dG, Iso-dC, 2' Fluoro bases (e.g., Fluoro C, Fluoro U, Fluoro A, and Fluoro
  • the length of a switch oligo may be 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114,
  • the length of a switch oligo may be at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114
  • the length of a switch oligo may be at most 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114
  • the macromolecular components e.g., macromolecular constituents of biological particles, such as RNA, DNA, or proteins
  • the macromolecular component contents of individual biological particles can be provided with unique identifiers such that, upon characterization of those macromolecular components they may be attributed as having been derived from the same biological particle or particles.
  • unique identifiers such that, upon characterization of those macromolecular components they may be attributed as having been derived from the same biological particle or particles.
  • the ability to attribute characteristics to individual biological particles or groups of biological particles is provided by the assignment of unique identifiers specifically to an individual biological particle or groups of biological particles.
  • Unique identifiers e.g., in the form of nucleic acid barcodes, can be assigned or associated with individual biological particles or populations of biological particle, in order to tag or label the biological particle's macromolecular components (and as a result, its characteristics) with the unique identifiers. These unique identifiers can then be used to attribute the biological particle's components and characteristics to an individual biological particle or group of biological particles. In some embodiments, this is performed by co-partitioning the individual biological particle or groups of biological particles with the unique identifiers.
  • the unique identifiers are provided in the form of oligonucleotides that comprise nucleic acid barcode sequences that may be attached to or otherwise associated with the nucleic acid contents of individual biological particle, or to other components of the biological particle, and particularly to fragments of those nucleic acids.
  • the oligonucleotides are partitioned such that as between oligonucleotides in a given partition, the nucleic acid barcode sequences contained therein are the same, but as between different partitions, the oligonucleotides can, and do, have differing barcode sequences, or at least represent a large number of different barcode sequences across all of the partitions in a given analysis.
  • only one nucleic acid barcode sequence can be associated with a given partition, although in some cases, two or more different barcode sequences may be present.
  • the nucleic acid barcode sequences can include from 6 to about 20 or more nucleotides within the sequence of the oligonucleotides.
  • the length of a barcode sequence may be 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 nucleotides or longer.
  • the length of a barcode sequence may be at least 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 nucleotides or longer.
  • the length of a barcode sequence may be at most 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 nucleotides or shorter.
  • nucleotides may be completely contiguous, i.e., in a single stretch of adjacent nucleotides, or they may be separated into two or more separate subsequences that are separated by 1 or more nucleotides.
  • separated barcode subsequences can be from about 4 to about 16 nucleotides in length.
  • the barcode subsequence may be 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 nucleotides or longer.
  • the barcode subsequence may be at least 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 nucleotides or longer.
  • the barcode subsequence may be at most 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 nucleotides or shorter.
  • the co-partitioned oligonucleotides can also comprise other functional sequences useful in the processing of the nucleic acids from the co-partitioned biological particles.
  • These sequences include, e.g., targeted or random/universal amplification primer sequences for amplifying the genomic DNA from the individual biological particles within the partitions while attaching the associated barcode sequences, sequencing primers or primer recognition sites, hybridization or probing sequences, e.g., for identification of presence of the sequences or for pulling down barcoded nucleic acids, or any of a number of other potential functional sequences.
  • oligonucleotides may also be employed, including, e.g., coalescence of two or more droplets, where one droplet contains oligonucleotides, or microdispensing of oligonucleotides into partitions, e.g., droplets within microfluidic systems.
  • microcapsules such as beads (e.g., see FIG. 19 ) that each includes large numbers of the above described barcoded oligonucleotides releasably attached to the beads, where all of the oligonucleotides attached to a particular bead will include the same nucleic acid barcode sequence, but where a large number of diverse barcode sequences are represented across the population of beads used.
  • hydrogel beads e.g., comprising polyacrylamide polymer matrices
  • hydrogel beads are used as a solid support and delivery vehicle for the oligonucleotides into the partitions, as they are capable of carrying large numbers of oligonucleotide molecules, and may be configured to release those oligonucleotides upon exposure to a particular stimulus, as described elsewhere herein.
  • the population of beads will provide a diverse barcode sequence library that includes at least about 1,000 different barcode sequences, at least about 5,000 different barcode sequences, at least about 10,000 different barcode sequences, at least about 50,000 different barcode sequences, at least about 100,000 different barcode sequences, at least about 1,000,000 different barcode sequences, at least about 5,000,000 different barcode sequences, or at least about 10,000,000 different barcode sequences, or more. Additionally, each bead can be provided with large numbers of oligonucleotide molecules attached.
  • the number of molecules of oligonucleotides including the barcode sequence on an individual bead can be at least about 1,000 oligonucleotide molecules, at least about 5,000 oligonucleotide molecules, at least about 10,000 oligonucleotide molecules, at least about 50,000 oligonucleotide molecules, at least about 100,000 oligonucleotide molecules, at least about 500,000 oligonucleotides, at least about 1,000,000 oligonucleotide molecules, at least about 5,000,000 oligonucleotide molecules, at least about 10,000,000 oligonucleotide molecules, at least about 50,000,000 oligonucleotide molecules, at least about 100,000,000 oligonucleotide molecules, and in some cases at least about 1 billion oligonucleotide molecules, or more.
  • the resulting population of partitions can also include a diverse barcode library that includes at least about 1,000 different barcode sequences, at least about 5,000 different barcode sequences, at least about 10,000 different barcode sequences, at least at least about 50,000 different barcode sequences, at least about 100,000 different barcode sequences, at least about 1,000,000 different barcode sequences, at least about 5,000,000 different barcode sequences, or at least about 10,000,000 different barcode sequences.
  • each partition of the population can include at least about 1,000 oligonucleotide molecules, at least about 5,000 oligonucleotide molecules, at least about 10,000 oligonucleotide molecules, at least about 50,000 oligonucleotide molecules, at least about 100,000 oligonucleotide molecules, at least about 500,000 oligonucleotides, at least about 1,000,000 oligonucleotide molecules, at least about 5,000,000 oligonucleotide molecules, at least about 10,000,000 oligonucleotide molecules, at least about 50,000,000 oligonucleotide molecules, at least about 100,000,000 oligonucleotide molecules, and in some cases at least about 1 billion oligonucleotide molecules.
  • a mixed, but known barcode sequences set may provide greater assurance of identification in the subsequent processing, e.g., by providing a stronger address or attribution of the barcodes to a given partition, as a duplicate or independent confirmation of the output from a given partition.
  • the oligonucleotides are releasable from the beads upon the application of a particular stimulus to the beads.
  • the stimulus may be a photo-stimulus, e.g., through cleavage of a photo-labile linkage that releases the oligonucleotides.
  • a thermal stimulus may be used, where elevation of the temperature of the beads environment will result in cleavage of a linkage or other release of the oligonucleotides form the beads.
  • a chemical stimulus is used that cleaves a linkage of the oligonucleotides to the beads, or otherwise results in release of the oligonucleotides from the beads.
  • such compositions include the polyacrylamide matrices described above for encapsulation of biological particles, and may be degraded for release of the attached oligonucleotides through exposure to a reducing agent, such as DTT.
  • a second aqueous stream comprising barcode carrying beads suspended in a third fluid can be flowed through another channel (not shown in FIG. 1 ) towards the junction 110 .
  • the third fluid can be the same fluid material as the first aqueous fluid 112 .
  • a non-aqueous partitioning fluid 116 is introduced into channel junction 110 from each of side channels 104 and 106, and the combined streams are flowed into outlet channel 108 .
  • the two combined aqueous streams from channel segments 102 and the other channel carrying the third fluid are combined, and partitioned into droplets 118, 120.
  • the occupied droplets may contain either one or more biological particles, either one or more barcode carrying beads, or both at least a biological particle and at least a barcode carrying bead.
  • the unoccupied droplets may contain neither biological particles nor barcode carrying beads.
  • all droplets, both occupied and unoccupied droplets can comprise at least some concentration of field-attractable particles 115 .
  • partitioning can be optimized to achieve a desired occupancy level of beads, biological particles, or both, within the partitions that are generated.
  • FIG. 2A shows an example of a microfluidic channel structure for separating occupied droplets from unoccupied droplets.
  • the droplets may additionally contain one or more barcode carrying beads.
  • a droplet may have only a biological particle
  • a droplet may have only a barcode carrying bead
  • a droplet may have both a biological particle and a barcode carrying bead
  • a droplet may have neither biological particles nor barcode carrying beads.
  • the majority of occupied partitions can include no more than one biological particle per occupied partition and, in some cases, some of the generated partitions can be unoccupied (of any biological particle). In some cases, though, some of the occupied partitions may include more than one biological particle. In some cases, the partitioning process may be controlled such that fewer than 25% of the occupied partitions contain more than one biological particle, and in many cases, fewer than 20% of the occupied partitions have more than one biological particle, while in some cases, fewer than 10% or even fewer than 5% of the occupied partitions include more than one biological particle per partition.
  • the channel structure can include channel segments 202, 204, and 206 meeting at a channel intersection 211 .
  • the outflow channel 108 of the emulsion carrying the generated droplets in FIG. 1 can be upstream of the channel segment 202 , such that the generated droplets are directed to flow to the channel intersection 211 for subsequent sorting.
  • a controller 220 can be operatively coupled to a fluid flow unit 218 , to facilitate flow of fluid in the channel structure, and a field application unit 216 , to apply one or more fields to the channel structure.
  • a plurality of discrete droplets each comprising a first aqueous fluid 210 can flow as emulsions in a second fluid 208 , wherein the second fluid 208 is immiscible to the first aqueous fluid 210 .
  • the droplets being transported along channel segment 202 into intersection 211 can comprise a first subset of droplets 214 that are each occupied with at least a biological particle and/or a barcode carrying bead and a second subset of droplets 212 that are each unoccupied. Every droplet, including occupied and unoccupied droplets, can comprise some concentration of field-attractable particles. As described above, a given unoccupied droplet can have a higher concentration of field-attractable particles than a given occupied droplet to account for the volume occupied by a biological particle and/or a barcode bead in an occupied droplet.
  • the first subset of droplets 214 can be directed to flow along channel segment 206 and away from the intersection 211
  • the second subset of droplets 212 can be directed to flow along channel segment 204 and away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of droplets, including both occupied droplets and unoccupied droplets, to flow along the channel 202 towards the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of droplets, wherein a majority of the droplets is unoccupied droplets, to flow along the channel 204 away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of droplets, wherein a majority of the droplets is occupied droplets, to flow along the channel 206 away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of droplets, wherein a majority of the droplets is unoccupied droplets, to flow along the channel 206 away from the intersection 211 , and configured to subject the second fluid 208 containing a plurality of droplets, wherein a majority of the droplets is occupied droplets, to flow along the channel 204 away from the intersection 211 .
  • the fluid flow unit 218 can be operatively coupled to the controller 220 .
  • the fluid flow unit 218 may receive instructions from the controller 220 regarding fluid pressure and/or velocity.
  • the fluid flow unit 218 may comprise a compressor to provide positive pressure at an upstream location to direct the fluid from the upstream location to flow to a downstream location. In some instances, the fluid flow unit 218 may comprise a pump to provide negative pressure at a downstream location to direct the fluid from an upstream location to flow to the downstream location. In some instances, the fluid flow unit 218 may comprise both a compressor and a pump, each at different locations. In some instances, the fluid flow unit 218 may comprise different devices at different locations. The fluid flow unit 218 may comprise an actuator. While FIG. 2A depicts one fluid flow unit 218 , it may be appreciated that there may be a plurality of fluid flow units 218 , each in communication with the controller 220 and/or with each other.
  • the field application unit 216 can be configured to apply a force field to the channel structure. In some instances, the field application unit 216 can be configured to apply a force field at or near the intersection 211 such that the second subset of droplets (unoccupied droplets) are generally directed along the channel segment 204 and away from the intersection 211 , and the first subset of droplets (occupied droplets) are generally directed along the channel segment 206 and away from the intersection 211 , thereby isolating the two subsets of droplets.
  • the field application unit 216 can apply a magnetic field at or near the intersection 211 .
  • the field application unit 216 can be a magnet and/or a circuit (e.g., current carrying device) configured to generate a magnetic field.
  • a circuit e.g., current carrying device
  • each droplet may be attracted (e.g., due to paramagnetic particles) or repelled (e.g., due to diamagnetic particles) to or away, respectively, from the magnetic field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each droplet.
  • the magnetic force acting on a droplet can be proportional to a number (and/or a concentration) of field-attractable particles in the droplet.
  • the droplet is spherical and has the radius R D
  • a biological particle is spherical and has the radius R+
  • the concentration of field-attractable particles in the volume of aqueous fluid is substantially uniform
  • the above ratio may change with deviations from the above assumptions (e.g., non-spherical biological particle, non-spherical droplet, non-uniform concentration of field-attractable particles in volume of aqueous fluid, etc.).
  • the field application unit 216 can apply an electric field at or near the intersection 211 .
  • each droplet containing field-attractable particles e.g., conductive particles
  • each droplet may be attracted or repelled to or away, respectively, from the electric field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each droplet. That is, the electric force acting on a droplet, from the same electric field, can be proportional to a number (and/or a concentration) of field-attractable particles in the droplet.
  • the above ratio may change with deviations from the above assumptions (e.g., non-spherical biological particle, non-spherical droplet, non-uniform concentration of field-attractable particles in volume of aqueous fluid, etc.).
  • the fluid flow unit 218 can apply both an electric field and a magnetic field.
  • the field application unit 216 can be operatively coupled to the controller 220 .
  • the field application unit 216 may receive instructions from the controller 220 regarding force field strength, orientation, frequency, and/or other variables. While FIG. 2A depicts one field application unit 216 , it may be appreciated that there may be a plurality of field application units 216 , each in communication with the controller 220 , other controllers, and/or with each other. For example, there can be a plurality of field application units, each located at a different location.
  • the controller 220 may instruct the field application unit 216 to apply a force field sufficiently strong and in a sufficiently targeted direction towards the mixed (occupied and unoccupied) droplets such as to direct the unoccupied droplets in one channel and direct the occupied droplets to another channel.
  • the field application unit 216 can be placed in a location closer to a first channel (e.g., channel 204 ) than a second channel (e.g., channel 206 ) to direct the unoccupied droplets (which are subject to a stronger force from the same field) to the first channel, assuming that the field is strongest when closest to the field application unit 216 .
  • the stronger a force from the field acts on a droplet the more likely that the droplet will deviate from an initial flow direction (e.g., direction of flow in channel 202 ) into another channel having another direction.
  • the field application unit may be located at least in part downstream, from the intersection 211 , of a channel intended to isolate unoccupied droplets (e.g., channel 204 ).
  • a force field applied can be strong enough to direct the unoccupied droplets to flow to a first channel but weak enough to direct (or leave be) the occupied droplets to flow to a second channel.
  • a magnetic field applied by the field application unit 216 can have a magnetic flux density range from at least about 10 -5 Teslas (T) to about 1 T. Alternatively, the magnetic flux density can be less than or equal to about 10 -5 T and/or greater than or equal to about 1 T.
  • an electric field applied by the field application unit 216 can have an electric field strength of at least about 1 volt per meter (V/m), 2 V/m, 3 V/m, 4 V/m, 5 V/m, 10 V/m, or more. Alternatively, the electric field strength can be less than about 10 V/m, 5 V/m, 4 V/m, 3 V/m, 2 V/m, 1 V/m, or less.
  • FIG. 2B shows an example of a multi-stage microfluidic channel structure for separating singularly occupied droplets.
  • a first subset population of occupied droplets containing a single biological particle e.g., cell
  • a second subset population of unoccupied droplets not containing any biological particles e.g., cell
  • a third subset population of occupied droplets containing multiple (e.g., two or more) biological particles e.g., the droplets may additionally contain one or more barcode carrying beads.
  • a droplet may have only biological particle(s), a droplet may have only barcode carrying bead(s), a droplet may have both biological particle(s) and barcode carrying bead(s), or a droplet may have neither biological particle(s) nor barcode carrying bead(s).
  • the generated droplets may be sorted to isolate the first subset population, second subset population, and third subset population in multiple stages.
  • the channel structure can include channel segments 222 , 224 , 226 , 244 , and 246 .
  • Channel segments 222 , 224 , and 226 may meet at channel intersection 231 .
  • Channel segments 226 , 244 , and 246 may meet at channel intersection 233 .
  • the outflow channel 108 of the emulsion carrying the generated droplets in FIG. 1 can be upstream of the channel segment 222 , such that the generated droplets are directed to flow to the channel intersection 231 for subsequent sorting.
  • the generated droplets may comprise a first subset population of singularly occupied droplets (e.g., 230A ), a second subset population of unoccupied droplets (e.g., 230B ), and a third subset population of multiply occupied droplets (e.g., 230C ).
  • a first controller 240 can be operatively coupled to a fluid flow unit 238 , to facilitate flow of fluid in the channel structure, and a first field application unit 236 , to apply one or more fields to the channel structure.
  • a second controller 241 can be operatively coupled to a second field application unit 237 , to apply one or more fields to the channel structure.
  • a plurality of discrete droplets can flow as emulsions in a fluid 228 .
  • the droplets being transported along channel segment 222 into intersection 231 can comprise the first subset population of singularly occupied droplets (e.g., 230A ), the second subset population of unoccupied droplets (e.g., 230B ), and the third subset population of multiply occupied droplets (e.g., 230C ). Every droplet, including singularly occupied, multiply occupied, and unoccupied droplets, can comprise some concentration of field-attractable particles.
  • a given unoccupied droplet can have a higher concentration of field-attractable particles than a given occupied droplet to account for the volume occupied by a biological particle and/or a barcode bead in an occupied droplet.
  • a given singly occupied droplet can have a higher concentration of field-attractable particles than a given multiply occupied droplet to account for the differential volume occupied by the different numbers of biological particles (and/or barcode beads) in the droplet.
  • the first and third subsets of droplets can be directed to flow along channel segment 226 and away from the intersection 231
  • the second subset of droplets 230B can be directed to flow along channel segment 224 and away from the intersection 231 .
  • the fluid flow unit 238 can be configured to subject the fluid 228 containing a plurality of droplets including the occupied and/or unoccupied droplets (e.g., as emulsion suspensions) to or from intersections 231, 233 along channel segments 222, 224, 226, 244, and 246 .
  • the fluid flow unit 238 can be operatively coupled to the first controller 240 .
  • the fluid flow unit 238 may receive instructions from the first controller 240 regarding fluid pressure and/or velocity.
  • the fluid flow unit 238 may comprise a compressor to provide positive pressure at an upstream location to direct the fluid from the upstream location to flow to a downstream location. In some instances, the fluid flow unit 238 may comprise a pump to provide negative pressure at a downstream location to direct the fluid from an upstream location to flow to the downstream location. In some instances, the fluid flow unit 238 may comprise both a compressor and a pump, each at different locations. In some instances, the fluid flow unit 238 may comprise different devices at different locations. The fluid flow unit 238 may comprise an actuator. While FIG.
  • 2B depicts one fluid flow unit 238 , it may be appreciated that there may be a plurality of fluid flow units 238 , each in communication with the first controller 240 , other controllers (e.g., second controller 241 ), and/or with each other. For example, there can be a separate fluid flow unit to direct the fluid in channel 222 towards the intersection 231 , a separate fluid flow unit to direct the fluid in channel 224 away from the intersection 231 , and a separate fluid flow unit to direct the fluid in channel 226 away from the intersection 231 .
  • the first field application unit 236 can be configured to apply a force field to the channel structure.
  • the field application unit 236 can be configured to apply a force field at or near the intersection 231 such that the second subset of droplets (unoccupied droplets) are generally directed along the channel segment 224 and away from the intersection 231 , and the first and third subset of droplets (occupied droplets) are generally directed along the channel segment 226 and away from the intersection 231 , thereby separating the subsets of droplets.
  • the first field application unit 236 may apply a magnetic field at or near the intersection 231 .
  • each droplet may be attracted (e.g., due to paramagnetic particles) or repelled (e.g., due to diamagnetic particles) to or away, respectively, from the magnetic field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each droplet. That is, the magnetic force acting on a droplet, from the same magnetic field, can be proportional to a number (and/or a concentration) of field-attractable particles in the droplet.
  • the ratio of a number of field-attractable particles in a doubly occupied droplet (N 2 +) (wherein the occupied droplet contains two biological particles) to a
  • the first field application unit 236 can apply an electric field at or near the intersection 231 .
  • each droplet containing field-attractable particles e.g., conductive particles
  • each droplet may be attracted or repelled to or away, respectively, from the electric field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each droplet. That is, the electric force acting on a droplet, from the same electric field, can be proportional to a number (and/or a concentration) of field-attractable particles in the droplet.
  • the first field application unit 236 can be operatively coupled to the first controller 240 .
  • the first field application unit 236 may receive instructions from the first controller 240 regarding force field strength, orientation, frequency, and/or other variables.
  • the first controller 240 may instruct the first field application unit 236 to apply a force field sufficiently strong and in a sufficiently targeted direction towards the mixed (occupied and unoccupied) droplets such as to direct the unoccupied droplets in one channel and direct the occupied droplets to another channel.
  • the first field application unit 236 can be placed in a location closer to a first channel (e.g., channel 224 ) than a second channel (e.g., channel 226 ) to direct the unoccupied droplets (which are subject to a stronger force from the same field) to the first channel, assuming that the field is strongest when closest to the first field application unit 236 .
  • the stronger a force from the field acts on a droplet the more likely that the droplet will deviate from an initial flow direction (e.g., direction of flow in channel 222 ) into another channel having another direction.
  • the field application unit may be located at least in part downstream, from the intersection 231 , of a channel intended to isolate unoccupied droplets (e.g., channel 224 ).
  • a force field applied can be strong enough to direct the unoccupied droplets to flow to a first channel but weak enough to direct (or leave be) the occupied droplets (whether singularly, doubly, or otherwise multiply occupied) to flow to a second channel.
  • a magnetic field applied by the field application unit 236 can have a magnetic flux density range from at least about 10 -5 Teslas (T) to about 1 T.
  • the magnetic flux density can be less than or equal to about 10 -5 T and/or greater than or equal to about 1 T.
  • an electric field applied by the field application unit 236 can have an electric field strength of at least about 1 volt per meter (V/m), 2 V/m, 3 V/m, 4 V/m, 5 V/m, 10 V/m, or more.
  • the electric field strength can be less than about 10 V/m, 5 V/m, 4 V/m, 3 V/m, 2 V/m, 1 V/m, or less.
  • the first and third sets of droplets (e.g., 230A, C ) isolated to channel 226 may be subjected to a second stage of sorting at or near the intersection 233 .
  • the third subset of droplets e.g., 230C
  • the first subset of droplets 230A can be directed to flow along channel segment 244 and away from the intersection 233 .
  • the singularly occupied droplets first subset of droplets
  • the second field application unit 237 can be configured to apply a force field to the channel structure.
  • the field application unit 237 can be configured to apply a force field at or near the intersection 233 such that the first subset of droplets (singularly occupied droplets) are generally directed along the channel segment 244 and away from the intersection 233 , and the third subset of droplets (multiply occupied droplets) are generally directed along the channel segment 246 and away from the intersection 233 , thereby separating the first and third subsets of droplets.
  • the second field application unit 237 may apply a magnetic field at or near the intersection 233 .
  • the second field application unit 237 can apply an electric field at or near the intersection 233 .
  • the second field application unit 237 can be operatively coupled to the second controller 241 .
  • the second field application unit 237 may receive instructions from the second controller 241 regarding force field strength, orientation, frequency, and/or other variables.
  • the second controller 241 may instruct the second field application unit 237 to apply a force field sufficiently strong and in a sufficiently targeted direction towards the mixed (singularly occupied and multiply occupied) droplets such as to direct the singularly droplets in one channel and direct the multiply occupied droplets to another channel.
  • the second field application unit 237 can be placed in a location closer to a first channel (e.g., channel 244 ) than a second channel (e.g., channel 246 ) to direct the singularly occupied droplets (which are subject to a stronger force from the same field than multiply occupied droplets) to the first channel, assuming that the field is strongest when closest to the second field application unit 237 .
  • the stronger a force from the field acts on a droplet the more likely that the droplet will deviate from an initial flow direction (e.g., direction of flow in channel 226) into another channel having another direction.
  • the field application unit may be located at least in part downstream, from the intersection 233 , of a channel intended to isolate singularly occupied droplets (e.g., channel 244 ).
  • the second field application unit 236 can be operatively coupled to the first controller 240 .
  • a force field applied can be strong enough to direct the singularly occupied droplets to flow to a first channel but weak enough to direct (or leave be) the multiply occupied droplets (whether singularly, doubly, or otherwise multiply occupied) to flow to a second channel.
  • the force field applied by the second field application unit 237 may be stronger than the force field applied by the first field application unit 236 .
  • a magnetic field applied by the second field application unit 237 can have a magnetic flux density range from at least about 10 -5 Teslas (T) to about 1 T. Alternatively, the magnetic flux density can be less than or equal to about 10 -5 T and/or greater than or equal to about 1 T.
  • an electric field applied by the field application unit 236 can have an electric field strength of at least about 1 volt per meter (V/m), 2 V/m, 3 V/m, 4 V/m, 5 V/m, 10 V/m, or more.
  • the electric field strength can be less than about 10 V/m, 5 V/m, 4 V/m, 3 V/m, 2 V/m, 1 V/m, or less.
  • a plurality of particles may comprise a first subset of particles (e.g., cell beads) occupied by biological particles (e.g., cells) and a second subset of particles unoccupied by biological particles. Both occupied and unoccupied particles may comprise field-attractable particles. Occupied particles may include singularly occupied cell beads, each containing a single biological particle, and multiply occupied cell beads, each containing two or more biological particles.
  • such particles comprising the field-attractable particles may be generated from polymerizing the plurality of droplets comprising the field-attractable particles (e.g., in FIG. 1 ).
  • the plurality of particles may be directed to flow (e.g., as suspensions in a fluid, e.g., aqueous fluid) to the channel intersection 211 for subsequent sorting.
  • a controller 220 can be operatively coupled to a fluid flow unit 218 , to facilitate flow of fluid in the channel structure, and a field application unit 216 , to apply one or more fields to the channel structure.
  • a plurality of discrete particles can be directed to flow along channel segment 202 into intersection 211 .
  • the plurality of particles can comprise a first subset of particles (e.g., cell beads) that are each occupied with at least a biological particle and a second subset of particles that are each unoccupied. Every particle, including cell beads and unoccupied particles, can comprise some concentration of field-attractable particles.
  • a given unoccupied particle can have a higher concentration of field-attractable particles than a given cell bead (e.g., a given occupied particle) to account for the volume occupied by a biological particle in a cell bead.
  • the first subset of particles e.g., cell beads
  • the second subset of particles can be directed to flow along channel segment 204 and away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing the plurality of particles, including both cell beads and unoccupied particles, to flow along the channel 202 towards the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of particles, wherein a majority of the particles is unoccupied, to flow along the channel 204 away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of particles, wherein a majority of the particles is cell beads (e.g., occupied particles), to flow along the channel 206 away from the intersection 211 .
  • the fluid flow unit 218 can be configured to subject the second fluid 208 containing a plurality of particles wherein a majority of the particles is unoccupied particles, to flow along the channel 206 away from the intersection 211 , and configured to subject the second fluid 208 containing a plurality of particles, wherein a majority of the particles is cell beads, to flow along the channel 204 away from the intersection 211 .
  • the fluid flow unit 218 can be operatively coupled to the controller 220 .
  • the fluid flow unit 218 may receive instructions from the controller 220 regarding fluid pressure and/or velocity.
  • the field application unit 216 can be configured to apply a force field to the channel structure. In some instances, the field application unit 216 can be configured to apply a force field at or near the intersection 211 such that the second subset of particles (unoccupied particles) is generally directed along the channel segment 204 and away from the intersection 211 , and the first subset of particles (cell beads) is generally directed along the channel segment 206 and away from the intersection 211 , thereby isolating the two subsets of particles.
  • the field application unit 216 can apply a magnetic field at or near the intersection 211 .
  • the field application unit 216 can be a magnet and/or a circuit (e.g., current carrying device) configured to generate a magnetic field.
  • a circuit e.g., current carrying device
  • each particle may be attracted (e.g., due to paramagnetic particles) or repelled (e.g., due to diamagnetic particles) to or away, respectively, from the magnetic field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each particle.
  • the magnetic force acting on a particle, from the same magnetic field can be proportional to a number (and/or a concentration) of field-attractable particles in the particle.
  • the particle is spherical and has the radius R CB
  • a biological particle is spherical and has the radius R+
  • the concentration of field-attractable particles in the particle is substantially uniform
  • the above ratio may change with deviations from the above assumptions (e.g., non-spherical biological particle, non-spherical particle, non-uniform concentration of field-attractable particles in volume of particle, etc.).
  • the field application unit 216 can apply an electric field at or near the intersection 211 .
  • each particle containing field-attractable particles e.g., conductive particles
  • each particle may be attracted or repelled to or away, respectively, from the electric field.
  • the degree of attraction (or repulsion) can be proportional to a number (and/or a concentration) of field-attractable particles in each particle. That is, the electric force acting on a particle, from the same electric field, can be proportional to a number (and/or a concentration) of field-attractable particles in the particle.
  • the above ratio may change with deviations from the above assumptions (e.g., non-spherical biological particle, non-spherical particle, non-uniform concentration of field-attractable particles in volume of a particle, etc.).
  • the fluid flow unit 218 can apply both an electric field and a magnetic field.
  • the field application unit 216 can be operatively coupled to the controller 220 .
  • the field application unit 216 may receive instructions from the controller 220 regarding force field strength, orientation, frequency, and/or other variables.
  • the controller 220 may instruct the field application unit 216 to apply a force field sufficiently strong and in a sufficiently targeted direction towards the mixed (occupied and unoccupied) particles such as to direct the unoccupied particles in one channel and direct the occupied particles to another channel.
  • the field application unit 216 can be placed in a location closer to a first channel (e.g., channel 204 ) than a second channel (e.g., channel 206 ) to direct the unoccupied particles (which are subject to a stronger force from the same field) to the first channel, assuming that the field is strongest when closest to the field application unit 216 .
  • the stronger a force from the field acts on a particle the more likely that the particle will deviate from an initial flow direction (e.g., direction of flow in channel 202 ) into another channel having another direction.
  • the field application unit may be located at least in part downstream, from the intersection 211 , of a channel intended to isolate unoccupied particles (e.g., channel 204 ).
  • a force field applied can be strong enough to direct the unoccupied particles to flow to a first channel but weak enough to direct (or leave be) the occupied particles to flow to a second channel.
  • a magnetic field applied by the field application unit 216 can have a magnetic flux density range from at least about 10 -5 Teslas (T) to about 1 T. Alternatively, the magnetic flux density can be less than or equal to about 10 -5 T and/or greater than or equal to about 1 T.
  • an electric field applied by the field application unit 216 can have an electric field strength of at least about 1 volt per meter (V/m), 2 V/m, 3 V/m, 4 V/m, 5 V/m, 10 V/m, or more. Alternatively, the electric field strength can be less than about 10 V/m, 5 V/m, 4 V/m, 3 V/m, 2 V/m, 1 V/m, or less.
  • singularly occupied cell beads may be sorted from unoccupied particles and multiply occupied cell beads by using the systems and methods described with respect to FIG. 2B but introducing a plurality of particles (comprising a first subset of singularly occupied cell beads, a second subset of unoccupied particles, and a third subset of multiply occupied cell beads), each particle comprising field attractable particles, in place of the plurality of droplets comprising the field attractable particles.
  • FIG. 2A and FIG. 2B each depicts a channel structure wherein a second channel (e.g., channel 204 ) branches off a first channel (e.g., channel 202 ) at a sorting intersection (e.g., intersection 211 ) such that a third channel (channel 204 ) continues in the same direction as the first channel
  • a second channel e.g., channel 204
  • a sorting intersection e.g., intersection 211
  • the systems and methods disclosed herein may be application to different channel structures.
  • the third channel can be at a different angle (e.g., not 180°) than the first channel.
  • the channel structure may have more than two channels branching off the first channel, wherein the field application unit 216 is configured to separate the droplets into unoccupied droplets, droplets containing only one biological particle, droplets containing more than one biological particles, droplets containing only barcode carrying beads, droplets containing both a biological particle and barcode carrying beads, or other variations.
  • the channel structure may have more than two channels branching off the first channel, wherein the field application unit 216 is configured to separate the particles into unoccupied particles, particles containing only one biological particle, particles containing more than one biological particles, particles containing only barcode carrying beads, particles containing both a biological particle and barcode carrying beads, or other variations.
  • the weaker can be the force acting on the droplet or the particle by the field applied by the field application unit 216 , and thus the less the deviation in direction of flow relative to the direction of flow in the first channel.
  • the unoccupied droplets or particles may be capable of deviating the most (e.g., to a channel closest to the field application unit), a droplet or particle containing a single biological particle (e.g., singularly occupied cell bead) may be capable of deviating but not as much as the unoccupied droplets or particles (e.g., to a channel second closest to the field application unit), and a droplet or particle containing both a biological particle and a barcode carrying bead may be capable of deviating the least of the three types of droplets or particles (e.g., to a channel farthest from the field application unit).
  • a droplet or particle containing a single biological particle e.g., singularly occupied cell bead
  • a droplet or particle containing both a biological particle and a barcode carrying bead may be capable of deviating the least of the three types of droplets or particles (e.g., to a channel farthest from the field application unit).
  • FIGS. 2A-2B depict narrow channels allowing for the flow of droplets and/or particles only in single file
  • the systems and methods disclosed herein may be applicable to channels having a broader width (e.g., diameter) that allows for the flow of droplets and/or particles in more than single file.
  • FIG. 2A depicts one controller 220 operatively coupled to both the fluid flow unit 218 and the field application unit 216
  • a separate controller can be coupled to the fluid flow unit 218 and a separate controller can be coupled to the field application unit 216 .
  • the two separate controllers may or may not be in communication with each other.
  • there may be a plurality of controllers e.g., two controllers to a fluid flow unit 218 ), wherein each controller may or may not be in communication with each other.
  • the controller 220 may send instructions to the fluid flow unit 218 and/or the field application unit 216 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • FIG. 3 shows another example of a microfluidic channel structure for separating occupied droplets from unoccupied droplets.
  • the droplets may additionally contain one or more barcode carrying beads.
  • a droplet may have only a biological particle
  • a droplet may have only a barcode carrying bead
  • a droplet may have both a biological particle and a barcode carrying bead
  • a droplet may have neither biological particles nor barcode carrying beads.
  • the majority of occupied partitions can include no more than one biological particle per occupied partition and, in some cases, some of the generated partitions can be unoccupied (of any biological particle). In some cases, though, some of the occupied partitions may include more than one biological particle. In some cases, the partitioning process may be controlled such that fewer than about 25% of the occupied partitions contain more than one biological particle, and in many cases, fewer than about 20% of the occupied partitions have more than one biological particle, while in some cases, fewer than about 10% or even fewer than about 5% of the occupied partitions include more than one biological particle per partition.
  • the channel structure can include channel segments 302, 304, and 306 meeting at a channel intersection 311 .
  • the outflow channel 108 of the emulsion carrying the generated droplets in FIG. 1 can be upstream of the channel segment 302 , such that the generated droplets are directed to flow to the channel intersection 211 for subsequent sorting.
  • a controller 322 can be operatively coupled to a fluid flow unit 318 , to facilitate flow of fluid in the channel structure, a sensor 320 , to detect at least a characteristic of a droplet or a plurality of droplets, and a pressure application unit 316 , to apply a pressure pulse to the channel structure.
  • a plurality of discrete droplets each comprising a first aqueous fluid 310 can flow as emulsions in a second fluid 308 , wherein the second fluid 308 is immiscible to the first aqueous fluid 310 .
  • the droplets being transported along channel segment 302 into intersection 311 can comprise a first subset of droplets 314 that are each occupied with at least a biological particle and/or a barcode carrying bead and a second subset of droplets 312 that are each unoccupied. Every droplet, including occupied and unoccupied droplets, may or may not comprise some concentration of field-attractable particles.
  • FIG. 3 depicts each droplet as comprising field-attractable particles 315 , this is not required.
  • the first subset of droplets 314 can be directed to flow along channel segment 306 and away from the intersection 311, and the second subset of droplets 312 can be directed to flow along channel segment 304 and away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of droplets, including both occupied droplets and unoccupied droplets, to flow along the channel 302 towards the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of droplets, wherein a majority of the droplets is unoccupied droplets, to flow along the channel 304 away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of droplets, wherein a majority of the droplets is occupied droplets, to flow along the channel 306 away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of droplets, wherein a majority of the droplets is unoccupied droplets, to flow along the channel 306 away from the intersection 311 , and configured to subject the second fluid 308 containing a plurality of droplets, wherein a majority of the droplets is occupied droplets, to flow along the channel 304 away from the intersection 311.
  • the fluid flow unit 318 can be operatively coupled to the controller 322.
  • the fluid flow unit 318 may receive instructions from the controller 322 regarding fluid pressure and/or velocity.
  • the fluid flow unit 318 may comprise a compressor to provide positive pressure at an upstream location to direct the fluid from the upstream location to flow to a downstream location. In some instances, the fluid flow unit 318 may comprise a pump to provide negative pressure at a downstream location to direct the fluid from an upstream location to flow to the downstream location. In some instances, the fluid flow unit 318 may comprise both a compressor and a pump, each at different locations. In some instances, the fluid flow unit 318 may comprise different devices at different locations. The fluid flow unit 318 may comprise an actuator. While FIG. 3 depicts one fluid flow unit 318 , it may be appreciated that there may be a plurality of fluid flow units 318 , each in communication with the controller 322 and/or with each other.
  • the sensor 320 can be configured to sense at least a characteristic of a droplet or a plurality of droplets in the first channel segment 302. In some instances, the sensor 320 may detect the characteristic of a droplet as the droplet passes the sensor 320. The sensor 320 may be located upstream of the intersection 311. One or more characteristics detected by the sensor 320 of a droplet can be indicative of the type of droplet, such as whether the droplet is occupied or unoccupied, or whether the droplet contains a biological particle and/or a barcode carrying bead. In some instances, the sensor 320 can be an impedance sensor configured to measure bulk impedance when droplets pass by the sensor 320.
  • the sensor 320 can be an optical sensor configured to measure optical properties of a droplet, such as to distinguish whether the droplet is occupied or unoccupied.
  • the optical sensor and/or a supporting device may be configured to emit a detection signal configured to probe one or more droplets, including for example an electromagnetic signal (e.g., in any wavelength) and/or an acoustic signal.
  • the optical sensor and/or a supporting device may comprise an illumination source configured to illuminate the droplet or droplets with one or more types of electromagnetic radiation.
  • the electromagnetic radiation can include illumination in one or more of the visible spectrum, infrared spectrum, the ultraviolet spectrum, and ionizing radiation spectrum.
  • the ionizing radiation can include x-rays.
  • the sensor 320 may be one or more devices that are configured to provide one or more of optical sensing, thermal sensing, laser imaging, infrared imaging, capacitance sensing, mass sensing, vibration sensing across at least a portion of the electromagnetic spectrum, and magnetic induction sensing.
  • the sensor 320 can be operatively coupled to the controller 322.
  • the sensor 320 may transmit sensor data (e.g., on one or more characteristics of a droplet or a plurality of droplets) to the controller 322.
  • the controller 322 may then use such data to determine whether the droplet is occupied or unoccupied.
  • FIG. 3 depicts one sensor 320, it may be appreciated that there may be a plurality of sensors, each in communication with the controller 322 and/or with each other. For example, there can be a plurality of sensors upstream of the intersection 311 at different locations, for example, detecting one or more characteristics of a droplet or a plurality of droplets at different angles.
  • the pressure application unit 316 can be configured to apply a pressure pulse to the channel structure. In some instances, the pressure application unit 316 can be configured to apply a pressure pulse at or near the intersection 311 such that, via hydrodynamic forces, the second subset of droplets (unoccupied droplets) are generally directed along the channel segment 304 and away from the intersection 311, and the first subset of droplets (occupied droplets) are generally directed along the channel segment 306 and away from the intersection 311, thereby isolating the two subsets of droplets.
  • the pressure application unit 316 may comprise a compressor to provide positive pressure pulses at an upstream location to direct the fluid from the upstream location to flow to a downstream location. In some instances, the pressure application unit 316 may comprise a pump to provide negative pressure pulses at a downstream location to direct the fluid from an upstream location to flow to the downstream location. In some instances, the pressure application unit 316 may comprise both a compressor and a pump, each at different locations. In some instances, the pressure application unit 316 may comprise different devices at different locations. The pressure application unit 316 may comprise an actuator. While FIG. 3 depicts one pressure application unit 316, it may be appreciated that there may be a plurality of pressure application units, each in communication with the controller 322 and/or with each other.
  • the pressure application unit 316 and a fluid flow unit 318 may be the same device or same devices.
  • the pressure application unit 316 may be, entirely or at least in part, external to the microfluidic structure (e.g., microfluidic channels), as illustrated in FIG. 3 .
  • the pressure application unit 316 may be, entirely or at least in part, internal to and/or integral to the microfluidic structure.
  • a pressure pulse may be generated by deflection of membranes.
  • a pressure pulse may be generated from generation of air bubbles, wherein expansion of the bubble may displace fluid parcels.
  • Occupied droplets and unoccupied droplets may respond differently to a pressure pulse, for example due to varying predetermined particle and fluid characteristics.
  • singularly occupied droplets and multiply occupied droplets may respond differently to a pressure pulse.
  • the predetermined particle and fluid characteristics can include size of a droplet, mass of a droplet, viscosity of droplet suspension in the emulsion, deformability, and other characteristics. That is, a given singularly occupied droplet, a multiply occupied droplet, and an unoccupied droplet may respond differently when subject to hydrodynamic forces triggered by the pressure pulses.
  • the controller 322 may, based on a determination made from data received from the sensor 320 (e.g., determination on whether droplet is occupied or unoccupied), instruct the pressure application unit 316 to apply different pressure pulses, for example, by varying frequency of the pulses and/or changing pressure differential.
  • the pressure application unit 316 may apply a first type of pressure pulse when an occupied droplet is approaching the intersection 311 and a second type of pressure pulse when an unoccupied droplet is approaching the intersection 311.
  • the same pressure pulse can be applied for any type of droplet approaching the intersection 311, and the droplet may react (or respond) differently (e.g., deviating from a fluid flow direction at different angles) depending on whether the droplet is occupied or unoccupied.
  • the pressure application unit 316 can be operatively coupled to the controller 320.
  • the pressure application unit 316 may receive instructions from the controller 322 regarding pressure pulse strength, frequency, and/or other variables.
  • a plurality of particles may comprise a first subset of particles (e.g., cell beads) occupied by biological particles (e.g., cells) and a second subset of particles unoccupied by biological particles.
  • the plurality of particles may be directed to flow (e.g., as suspensions in a fluid, e.g., aqueous fluid) to the channel intersection 311 for subsequent sorting.
  • a controller 322 can be operatively coupled to a fluid flow unit 318, to facilitate flow of fluid in the channel structure, a sensor 320, to detect at least a characteristic of a particle or a plurality of particles, and a pressure application unit 316, to apply a pressure pulse to the channel structure.
  • the first subset of particles e.g., cell beads
  • the second subset of particles can be directed to flow along channel segment 304 and away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of particles, including both cell beads and unoccupied particles, to flow along the channel 302 towards the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of particles, wherein a majority of the particles is unoccupied particles, to flow along the channel 304 away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of particles, wherein a majority of the particles is occupied particles, to flow along the channel 306 away from the intersection 311.
  • the fluid flow unit 318 can be configured to subject the second fluid 308 containing a plurality of particles, wherein a majority of the particles is unoccupied particles, to flow along the channel 306 away from the intersection 311, and configured to subject the second fluid 308 containing a plurality of particles, wherein a majority of the particles is occupied particles, to flow along the channel 304 away from the intersection 311.
  • the fluid flow unit 318 can be operatively coupled to the controller 322.
  • the fluid flow unit 318 may receive instructions from the controller 322 regarding fluid pressure and/or velocity.
  • the sensor 320 can be configured to sense at least a characteristic of a particle or a plurality of particles in the first channel segment 302. In some instances, the sensor 320 may detect the characteristic of a particle as the particle passes the sensor 320. The sensor 320 may be located upstream of the intersection 311. One or more characteristics detected by the sensor 320 of a particle can be indicative of the type of particle, such as whether the particle is occupied or unoccupied, or whether the particle contains a biological particle and/or a barcode carrying bead. In some instances, the sensor 320 can be an impedance sensor configured to measure bulk impedance when particles pass by the sensor 320.
  • the sensor 320 can be an optical sensor configured to measure optical properties of a particle, such as to distinguish whether the particle is occupied or unoccupied.
  • the optical sensor and/or a supporting device may be configured to emit a detection signal configured to probe one or more particles, including for example an electromagnetic signal (e.g., in any wavelength) and/or an acoustic signal.
  • the optical sensor and/or a supporting device may comprise an illumination source configured to illuminate the particle or particles with one or more types of electromagnetic radiation.
  • the electromagnetic radiation can include illumination in one or more of the visible spectrum, infrared spectrum, the ultraviolet spectrum, and ionizing radiation spectrum.
  • the ionizing radiation can include x-rays.
  • the sensor 320 may be one or more devices that are configured to provide one or more of optical sensing, thermal sensing, laser imaging, infrared imaging, capacitance sensing, mass sensing, vibration sensing across at least a portion of the electromagnetic spectrum, and magnetic induction sensing.
  • the sensor 320 can be operatively coupled to the controller 322.
  • the sensor 320 may transmit sensor data (e.g., on one or more characteristics of a particle or a plurality of particles) to the controller 322.
  • the controller 322 may then use such data to determine whether the particle is occupied or unoccupied.
  • FIG. 3 depicts one sensor 320, it may be appreciated that there may be a plurality of sensors, each in communication with the controller 322 and/or with each other. For example, there can be a plurality of sensors upstream of the intersection 311 at different locations, for example, detecting one or more characteristics of a particle or a plurality of particles at different angles.
  • the pressure application unit 316 can be configured to apply a pressure pulse to the channel structure. In some instances, the pressure application unit 316 can be configured to apply a pressure pulse at or near the intersection 311 such that, via hydrodynamic forces, the second subset of particles (unoccupied particles) are generally directed along the channel segment 304 and away from the intersection 311, and the first subset of particles (cell beads) are generally directed along the channel segment 306 and away from the intersection 311, thereby isolating the two subsets of particles.
  • Occupied particles and unoccupied particles may respond differently to a pressure pulse, for example due to varying predetermined particle and fluid characteristics.
  • the predetermined particle and fluid characteristics can include size of a particle, mass of a particle, viscosity of particle suspension in the fluid, deformability, and other characteristics. That is, a given singularly occupied cell bead, multiply occupied cell bead, and an unoccupied particle may respond differently when subject to hydrodynamic forces triggered by the pressure pulses.
  • the controller 322 may, based on a determination made from data received from the sensor 320 (e.g., determination on whether particle is occupied or unoccupied), instruct the pressure application unit 316 to apply different pressure pulses, for example, by varying frequency of the pulses and/or changing pressure differential.
  • the pressure application unit 316 may apply a first type of pressure pulse when an occupied particle is approaching the intersection 311 and a second type of pressure pulse when an unoccupied particle is approaching the intersection 311.
  • the same pressure pulse can be applied for any type of particle approaching the intersection 311, and the particle may react (or respond) differently (e.g., deviating from a fluid flow direction at different angles) depending on whether the particle is occupied or unoccupied.
  • different pressure pulses may be applied as between occupied and unoccupied droplets, occupied and unoccupied particles, singularly occupied and multiply occupied droplets, and/or singularly occupied and multiply occupied cell beads.
  • the pressure application unit 316 can be operatively coupled to the controller 320.
  • the pressure application unit 316 may receive instructions from the controller 322 regarding pressure pulse strength, frequency, and/or other variables.
  • FIG. 3 depicts a channel structure wherein a second channel (channel 304 ) branches off a first channel (channel 302 ) such that a third channel (channel 304 ) continues in the same direction as the first channel
  • the systems and methods disclosed herein may be application to different channel structures.
  • the third channel can be at a different angle (e.g., not 180°) than the first channel.
  • the channel structure may have more than two channels branching off the first channel, wherein the pressure application unit 316 is configured to separate the droplets into unoccupied droplets, droplets containing only one biological particle, droplets containing more than one biological particles, droplets containing only barcode carrying beads, droplets containing both a biological particle and barcode carrying beads, or other variations.
  • the pressure application unit 316 can be configured to separate particles into unoccupied particles, particles containing only one biological particle, particles containing more than one biological particle, particles containing only barcode carrying beads, particles containing both a biological particle and barcode carrying beads, or other variations.
  • the unoccupied droplets or particles may be capable of deviating the most (e.g., to a first channel), a droplet or particle containing a single biological particle may be capable of deviating but not as much as the unoccupied droplets or particles (e.g., to a second channel), and a droplet or particle containing both a biological particle and a barcode carrying bead may be capable of deviating the least of the three types of droplets or particles (e.g., to a third channel).
  • FIG. 3 depicts narrow channels allowing for the flow of droplets or particles only in single file
  • the systems and methods disclosed herein may be applicable to channels having a broader width (e.g., diameter) that allows for the flow of droplets or particles in more than single file.
  • FIG. 3 depicts one controller 322 operatively coupled to all of the fluid flow unit 318, the sensor 320, and the pressure application unit 316
  • a separate controller can be coupled to the fluid flow unit 318
  • a separate controller can be coupled to the sensor 320
  • a separate controller can be coupled to the pressure application unit 216.
  • the three separate controllers may or may not be in communication with each other.
  • there may be a plurality of controllers e.g., two controllers to a fluid flow unit 318 ) , wherein each controller may or may not be in communication with each other.
  • the controller 322 may send instructions to the fluid flow unit 318, sensor 320, and/or the pressure application unit 316 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the controller 322 may receive data from the fluid flow unit 318, sensor 320, and/or the pressure application unit 316 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the components can be directly or indirectly be in communication with each other, with or without going through the controller 322.
  • the sensor 320 may be directly coupled to the pressure application unit 316.
  • the separation systems and methods disclosed herein may achieve super Poisson loading.
  • the droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are occupied droplets (e.g., containing at least one biological particle).
  • occupied droplets e.g., containing at least one biological particle.
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of droplets can be occupied droplets.
  • At least about 97%, 98%, 99%, or a higher percentage of a second subset of droplets that is isolated can be unoccupied droplets (e.g., not containing any biological particle and not containing any barcode carrying beads).
  • less than about 97% of the second subset of droplets can be unoccupied droplets.
  • the particles can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of particles that is isolated are cell beads (e.g., containing at least one biological particle).
  • Such occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of particles can be occupied particles (e.g., cell beads).
  • at least about 97%, 98%, 99%, or a higher percentage of a second subset of particles that is isolated can be unoccupied particles (e.g., not containing any biological particle and not containing any barcode carrying beads).
  • less than about 97% of the second subset of particles can be unoccupied particles.
  • the channel networks can be fluidly coupled to appropriate fluidic components.
  • the inlet channel segments e.g., channel segment 202 in FIG. 2A , channel segments 102, 104, 106 in FIG. 1
  • the inlet channel segments are fluidly coupled to appropriate sources of the materials they are to deliver to a channel junction (e.g., intersection 211 in FIG. 2A , junction 110 in FIG. 1 ) .
  • channel segment 202 will be fluidly coupled to a source of an aqueous suspension of biological particles (e.g., biological particles 114 in FIG. 1 ) to be analyzed and field-attractable particles (e.g., field-attractable particles 115 in FIG. 1 ).
  • Channel segments 104 and 106 may then be fluidly connected to one or more sources of the non-aqueous (or other immiscible) fluid.
  • sources may include any of a variety of different fluidic components, from simple reservoirs defined in or connected to a body structure of a microfluidic device, to fluid conduits that deliver fluids from off-device sources, manifolds, fluid flow units (e.g., actuators, pumps, compressors) or the like.
  • the outlet channel segment 206 may be fluidly coupled to a receiving vessel or conduit for the partitioned cells for subsequent processing. Again, this may be a reservoir defined in the body of a microfluidic device, or it may be a fluidic conduit for delivering the partitioned cells to a subsequent process operation, instrument or component.
  • a plurality of droplets not containing any field-attractable particles may also be sorted using dielectrophoresis.
  • occupied droplets and unoccupied droplets can have different dielectric properties.
  • the occupied droplets may be directed to flow through the first channel and unoccupied droplets may be directed to flow through the second channel, due at least in part to the varying interactions with (or influence of) the electric field of the occupied droplets and the unoccupied droplets having different dielectric properties.
  • Such systems and methods for dielectrophoresis may also be used to sort a plurality of particles into a first subset of occupied particles (e.g., cell beads) and a second subset of unoccupied particles.
  • the biological particle can be subjected to conditions sufficient to polymerize or gel the precursors.
  • the conditions sufficient to polymerize or gel the precursors may comprise exposure to heating, cooling, electromagnetic radiation, or light.
  • the conditions sufficient to polymerize or gel the precursors may comprise any conditions sufficient to polymerize or gel the precursors.
  • a polymer or gel may be formed around the biological particle.
  • the polymer or gel may be diffusively permeable to chemical or biochemical reagents.
  • the polymer or gel may be diffusively impermeable to macromolecular constituents of the biological particle.
  • the polymer or gel may act to allow the biological particle to be subjected to chemical or biochemical operations while spatially confining the macromolecular constituents to a region of the droplet defined by the polymer or gel.
  • the polymer or gel may include one or more of disulfide cross-linked polyacrylamide, agarose, alginate, polyvinyl alcohol, polyethylene glycol (PEG)-diacrylate, PEG-acrylate, PEG-thiol, PEG-azide, PEG-alkyne, other acrylates, chitosan, hyaluronic acid, collagen, fibrin, gelatin, or elastin.
  • the polymer or gel may comprise any other polymer or gel.
  • the polymer or gel may be functionalized to bind to targeted analytes, such as nucleic acids, proteins, or other analytes.
  • the polymer or gel may be polymerized or gelled via a passive mechanism.
  • the polymer or gel may be stable in alkaline conditions or at elevated temperature.
  • the polymer or gel may have mechanical properties similar to the mechanical properties of the bead. For instance, the polymer or gel may be of a similar size to the bead.
  • the polymer or gel may have a mechanical strength (e.g. tensile strength) similar to that of the bead.
  • the polymer or gel may be of a lower density than an oil.
  • the polymer or gel may be of a density that is roughly similar to that of a buffer.
  • the polymer or gel may have a tunable pore size.
  • the pore size may be chosen to, for instance, retain denatured nucleic acids.
  • the pore size may be chosen to maintain diffusive permeability to exogenous chemicals such as sodium hydroxide (NaOH) and/or endogenous chemicals such as inhibitors.
  • the polymer or gel may be biocompatible.
  • the polymer or gel may maintain or enhance cell viability.
  • the polymer or gel may be biochemically compatible.
  • the polymer or gel may be polymerized and/or depolymerized thermally, chemically, enzymatically, and/or optically.
  • the polymer may comprise poly(acrylamide-co-acrylic acid) crosslinked with disulfide linkages.
  • the preparation of the polymer may comprise a two-step reaction.
  • poly(acrylamide-co-acrylic acid) may be exposed to an acylating agent to convert carboxylic acids to esters.
  • the poly(acrylamide-co-acrylic acid) may be exposed to 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM).
  • DTMM 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
  • the polyacrylamide-co-acrylic acid may be exposed to other salts of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium.
  • the ester formed in the first step may be exposed to a disulfide crosslinking agent.
  • the ester may be exposed to cystamine (2,2'-dithiobis(ethylamine)).
  • the biological particle may be surrounded by polyacrylamide strands linked together by disulfide bridges.
  • the biological particle may be encased inside of or comprise a gel or matrix (e.g., polymer matrix) to form a "cell bead.”
  • a cell bead can contain biological particles (e.g., a cell) or macromolecular constituents (e.g., RNA, DNA, proteins, etc.) of biological particles.
  • a cell bead may include a single cell or multiple cells, or a derivative of the single cell or multiple cells. For example after lysing and washing the cells, inhibitory components from cell lysates can be washed away and the macromolecular constituents can be bound as cell beads.
  • Systems and methods disclosed herein can be applicable to both cell beads (and/or droplets or other partitions) containing biological particles and cell beads (and/or droplets or other partitions) containing macromolecular constituents of biological particles.
  • the cell bead may further comprise one or more field-attractable particles (e.g., paramagnetic particles, conductive particles, etc.), such as via the systems and methods described elsewhere herein, for facilitating subsequent sorting and/or solvent exchange.
  • the field-attractable particles may be trapped in the gel matrix. In some instances, the field-attractable particles may be trapped evenly throughout the gel matrix. In some instances, the field-attractable particles may be trapped throughout the gel matrix such as to subject the whole of the cell bead evenly to a force (e.g., magnetic, electric) field.
  • a force e.g., magnetic, electric
  • the partitions may be selectively polymerized based on occupancy. In some instances, the partitions may be selectively polymerized based on size.
  • FIG. 4 shows an example of a microfluidic channel structure for selective polymerization of partitions based on occupancy.
  • the majority of occupied partitions can include no more than one biological particle per occupied partition and, in some cases, some of the generated partitions can be unoccupied (of any biological particle).
  • some of the occupied partitions may include more than one biological particle.
  • the partitioning process may be controlled such that fewer than 25% of the occupied partitions contain more than one biological particle, and in many cases, fewer than 20% of the occupied partitions have more than one biological particle, while in some cases, fewer than 10% or even fewer than 5% of the occupied partitions include more than one biological particle per partition.
  • the channel structure can include channel segments 401, 402, 404, 406 and 408.
  • Channel segments 401 and 402 can communicate at a channel junction 409.
  • Channel segments 402, 404, 406, and 408 can communicate at a channel junction 410.
  • a first aqueous fluid 412 can be delivered to junction 409 from each of channel segments 402 and 401.
  • Cells 414 can be introduced into the junction 409 via the channel segment 401 as suspensions in the first aqueous fluid 412 flowing along the channel segment 401.
  • the first aqueous fluid 412 may or may not contain suspended field-attractable particles 115.
  • occupied droplets and unoccupied droplets may be sorted via the field-attractable particles 115.
  • a second fluid 416 that is immiscible with the aqueous fluid 412 is delivered to the junction 410 from each of channel segments 404 and 406 to create discrete droplets 418, 420 of the first aqueous fluid 412 flowing into channel segment 408, and flowing away from junction 410.
  • a discrete droplet generated may or may not include biological particles 414.
  • the second fluid 416 can comprise an oil, such as a fluorinated oil, and a surfactant, such as a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • Examples of particularly useful partitioning fluids and fluorosurfactants are described for example, in U.S. Patent Application Publication No. 2010/0105112 .
  • the generated droplets may comprise two subsets of droplets: (1) occupied droplets 418, containing one or more biological particles 414, and (2) unoccupied droplets 420, not containing any biological particles 414.
  • a photo polymerization light source 424 such as a laser, can be located downstream of the junction 410 to selectively polymerize occupied droplets (e.g., polymerize the biological particles therein).
  • the light source 424 can be a lamp or light emitting diode (LED).
  • the light source can be an ultraviolet (UV) radiation source.
  • the light source 424 can generate optical pulses or an electromagnetic beam at a targeted direction.
  • the light source 424 can be configured to only emit electromagnetic waves when an occupied droplet is passing by.
  • the light source 424 can be operatively coupled to a controller 426.
  • the light source 424 can receive instructions from the controller 426 on whether or not a droplet passing by the light source 424, or a droplet expected to pass by the light source at a certain time, is occupied. While FIG. 4 depicts one light source 424, it may be appreciated that there may be a plurality of light sources, each in communication with the controller 426 and/or with each other. For example, a plurality of light sources may each be located at different locations, including different upstream/downstream locations in the fluidic channels. Alternatively, a different polymerization application unit can be used to subject the droplets to a stimulus, such as to trigger polymerization via heating, cooling, electromagnetic radiation, and/or light. The stimulus can be a chemical stimulus. In some instances, a plurality of the same or different types of polymerization application units can be used at different locations.
  • a sensor 422 can be configured to sense the presence of a biological particle (or cell) 414 in the fluid flow.
  • the sensor 422 can be configured to sense the presence of a biological particle (or cell) 414 in the channel segment 401 upstream of the junction 409.
  • the sensor 422 may be located upstream of the junction 409.
  • the sensor 422 can be an impedance sensor configured to measure bulk impedance when cells 414 pass by the sensor 422. In some instances, a higher impedance can be measured when a cell 414 passes by than when only the first aqueous fluid 412 passes by.
  • the sensor 422 can be an optical sensor configured to measure optical properties of a cell 414.
  • the optical sensor and/or a supporting device may be configured to emit a detection signal configured to probe one or more droplets, including for example an electromagnetic signal (e.g., in any wavelength) and/or an acoustic signal.
  • the optical sensor and/or a supporting device may comprise an illumination source configured to illuminate the cell with one or more types of electromagnetic radiation.
  • the electromagnetic radiation can include illumination in one or more of the visible spectrum, infrared spectrum, the ultraviolet spectrum, and ionizing radiation spectrum.
  • the ionizing radiation can include x-rays.
  • the illumination can be transillumination or epi-illumination.
  • the senor 422 may be one or more devices that are configured to provide one or more of optical sensing, thermal sensing, laser imaging, infrared imaging, capacitance sensing, mass sensing, vibration sensing across at least a portion of the electromagnetic spectrum, and magnetic induction sensing.
  • the sensor 422 may collect sensor data on one or more properties (e.g., optical properties, impendence properties, etc.) or characteristics of a cell 414.
  • the sensor 422 can be operatively coupled to the controller 426.
  • the sensor 426 may transmit sensor data (e.g., on presence of one or more cells 414 ) to the controller 426.
  • the controller 426 may determine when a cell has passed by the sensor location from the sensor data.
  • the controller 426 may then use such sensor data, the location of the sensor and/or the location in the fluidic channel at which the presence of a cell 414 was detected, the time the sensor detected a presence of the cell 414 in the flow, fluid flow rate of the first aqueous fluid 412 in the channel segment 402, fluid flow rate of emulsion in the channel segment 408, location of the light source 424, time it takes for the sensor 426 to detect and/or transmit data to the controller 426, and/or time it takes for the controller 426 to send instructions to the light source 424, to send instructions to the light source 424 on whether or not to emit an electromagnetic wave to polymerize a droplet.
  • the controller 426 may determine whether a droplet created (e.g., at junction 410 ) at a certain time contains a cell or does not contain a cell. Based on the fluid flow rates in the channel segments 402 and/or 408, the controller 426 may determine whether a droplet passing by the light source 424 at a certain time (e.g., time it takes for droplet to travel from junction 410 to the location of the light source 424 site is the same every time) is occupied or unoccupied.
  • a droplet created e.g., at junction 410
  • a certain time e.g., time it takes for droplet to travel from junction 410 to the location of the light source 424 site is the same every time
  • FIG. 4 depicts one sensor 422, it may be appreciated that there may be a plurality of sensors, each in communication with the controller 426 and/or with each other. For example, there can be a plurality of sensors upstream of the junction 409 and/or upstream of the junction 410 at different locations, for example, detecting the presence of a cell 414.
  • FIG. 4 depicts one controller 426 operatively coupled to both the sensor 422 and the light source 424
  • a separate controller can be coupled to the sensor 422 and a separate controller can be coupled to the light source 424.
  • the separate controllers may or may not be in communication with each other. In some instances, there may be a plurality of controllers (e.g., two controllers to sensor 422 ), wherein each controller may or may not be in communication with each other.
  • the controller 426 may send instructions to sensor 422 and/or the light source 424 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the controller 422 may receive data from the sensor 422 and/or the light source 424 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the components can be directly or indirectly be in communication with each other, with or without going through the controller 426.
  • the sensor 422 may be directly coupled to the light source 426.
  • FIG. 5 shows another example of a microfluidic channel structure for selective polymerization of partitions (e.g., biological particles therein) based on occupancy.
  • partitions e.g., biological particles therein
  • the channel structure can include channel segments 501, 502, 504, 506 and 508.
  • Channel segments 501 and 502 can communicate at a channel junction 509.
  • Channel segments 502, 504, 506, and 508 can communicate at a channel junction 510.
  • a first aqueous fluid 512 can be delivered to junction 509 from each of channel segments 502 and 501.
  • Cells 514 can be introduced into the junction 509 via the channel segment 501 as suspensions in the first aqueous fluid 512 flowing along the channel segment 501.
  • the first aqueous fluid 512 may or may not contain suspended field-attractable particles 515.
  • occupied droplets and unoccupied droplets may be subsequently sorted via the field-attractable particles 515.
  • a second fluid 516 that is immiscible with the aqueous fluid 512 is delivered to the junction 510 from each of channel segments 504 and 506 to create discrete droplets 518, 520 of the first aqueous fluid 512 flowing into channel segment 508, and flowing away from junction 510.
  • a discrete droplet generated may or may not include biological particles 514.
  • Each cell 514 introduced into the droplet can comprise fluorescent labels (such as in accordance with the widely used Fluorescence-Activated Cell Sorting (FACS) mechanism) or other optical labels that allow for detection by an optical sensor.
  • FACS Fluorescence-Activated Cell Sorting
  • the second fluid 516 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • an oil such as a fluorinated oil
  • fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • particularly useful partitioning fluids and fluorosurfactants are described for example, in U.S. Patent Application Publication No. 2010/0105112 .
  • the generated droplets may comprise two subsets of droplets: (1) occupied droplets 518, containing one or more biological particles 514, and (2) unoccupied droplets 520, not containing any biological particles 514.
  • a photo polymerization light source 524 such as a laser, can be located downstream of the junction 510 to selectively polymerize occupied droplets.
  • the light source 524 can be a lamp or light emitting diode (LED).
  • the light source 524 can generate optical pulses or an electromagnetic beam at a targeted direction.
  • the light source 524 can be configured to only emit electromagnetic waves when an occupied droplet is passing by.
  • the light source 524 can be operatively coupled to a controller 526.
  • the light source 524 can receive instructions from the controller 526 on whether or not a droplet passing by the light source 524, or a droplet expected to pass by the light source at a certain time, is occupied. While FIG.
  • a plurality of light sources may each be located at different locations, including different upstream/downstream locations in the fluidic channels.
  • a different polymerization application unit can be used to subject the droplets to a stimulus, such as to trigger polymerization of one or more biological particles therein via heating, cooling, electromagnetic radiation, and/or light.
  • the stimulus can be a chemical stimulus.
  • a plurality of the same or different types of polymerization application units can be used at different locations.
  • a sensor 522 can be configured to sense one or more characteristics of a droplet indicative of whether the droplet is occupied or unoccupied.
  • the sensor 522 may be located downstream of the junction 510.
  • the sensor 522 can be an impedance sensor configured to measure bulk impedance when droplets pass by the sensor 522. In some instances, a higher impedance can be measured when an occupied droplet 518 passes by than when an unoccupied droplet 520 passes by.
  • the sensor 522 can be an optical sensor configured to measure optical properties of a droplet.
  • the optical sensor and/or a supporting device may be configured to emit a detection signal configured to probe one or more droplets, including for example an electromagnetic signal (e.g., in any wavelength) and/or an acoustic signal.
  • the optical sensor and/or a supporting device may comprise an illumination source configured to illuminate the droplet or droplets with one or more types of electromagnetic radiation.
  • the electromagnetic radiation can include illumination in one or more of the visible spectrum, infrared spectrum, the ultraviolet spectrum, and ionizing radiation spectrum.
  • the ionizing radiation can include x-rays.
  • the illumination can be transillumination or epi-illumination.
  • the sensor 522 may be one or more devices that are configured to provide one or more of optical sensing, thermal sensing, laser imaging, infrared imaging, capacitance sensing, mass sensing, vibration sensing across at least a portion of the electromagnetic spectrum, and magnetic induction sensing.
  • the sensor 522 may collect sensor data on one or more properties (e.g., optical properties, impendence properties, etc.) or characteristics of a droplet 414.
  • the one or more properties or characteristics determined by the sensor 522 can be indicative of a certain type of droplets, such as occupied droplets, unoccupied droplets, singularly occupied droplets, multiply occupied droplets, droplets of a certain size or size range, etc.
  • the sensor 522 can be operatively coupled to the controller 526.
  • the sensor 526 may transmit sensor data (e.g., one or more characteristics indicative of an occupancy of a droplet) to the controller 526.
  • the controller 526 may then use such data, the location of the sensor and/or the location in the fluidic channel at which the occupied droplet 518 was detected, the time the sensor 522 detected an occupied droplet 518, fluid flow in the channel segment 508, location of the light source 524, time it takes for the sensor 526 to detect and/or transmit data to the controller 526, and/or time it takes for the controller 526 to send instructions to the light source 524, to send instructions to the light source 524 on whether or not to emit an electromagnetic wave to polymerize a droplet.
  • sensor data e.g., one or more characteristics indicative of an occupancy of a droplet
  • the controller 526 may determine whether a droplet passing by the sensor 522 location at a certain time is occupied or unoccupied. Based on the fluid flow rate in channel segment 508, the controller 526 may determine whether a droplet passing by the light source 524 at a certain time (e.g., assuming time it takes for droplet to travel from the sensor 522 location to the location of the light source 524 site is the same every time) is occupied or unoccupied.
  • FIG. 5 depicts one sensor 522, it may be appreciated that there may be a plurality of sensors, each in communication with the controller 526 and/or with each other. For example, there can be a plurality of sensors upstream or downstream of the junction 510 at different locations, for example, detecting the occupancy of a droplet.
  • FIG. 5 depicts one controller 526 operatively coupled to both the sensor 522 and the light source 524
  • a separate controller can be coupled to the sensor 522 and a separate controller can be coupled to the light source 524.
  • the separate controllers may or may not be in communication with each other. In some instances, there may be a plurality of controllers (e.g., two controllers to sensor 522 ), wherein each controller may or may not be in communication with each other.
  • the controller 526 may send instructions to sensor 522 and/or the light source 524 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the controller 522 may receive data from the sensor 522 and/or the light source 524 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the components can be directly or indirectly be in communication with each other, with or without going through the controller 526.
  • the sensor 522 may be directly coupled to the light source 526.
  • FIG. 6 shows an example of a microfluidic channel structure for selective polymerization of partitions based on droplet size.
  • the channel structure can include channel segments 601, 602, 604, 606 and 608.
  • Channel segments 601 and 602 can communicate at a channel junction 609.
  • Channel segments 602, 604, 606, and 608 can communicate at a channel junction 610.
  • a first aqueous fluid 612 can be delivered to junction 609 from each of channel segments 602 and 601.
  • Cells 614 can be introduced into the junction 609 via the channel segment 601 as suspensions in the first aqueous fluid 612 flowing along the channel segment 601.
  • the first aqueous fluid 612 may or may not contain suspended field-attractable particles 615.
  • occupied droplets and unoccupied droplets may be subsequently sorted via the field-attractable particles 615.
  • a second fluid 616 that is immiscible with the aqueous fluid 612 is delivered to the junction 610 from each of channel segments 604 and 606 to create discrete droplets 618, 620 of the first aqueous fluid 612 flowing into channel segment 608, and flowing away from junction 610.
  • a discrete droplet generated may or may not include biological particles 614.
  • Each cell 614 introduced into the droplet can comprise fluorescent labels (such as in accordance with the widely used Fluorescence-Activated Cell Sorting (FACS) mechanism).
  • FACS Fluorescence-Activated Cell Sorting
  • each droplet generated by the above emulsion may be of substantially uniform size that is appropriate (and/or acceptable) for feeding to subsequent single cell applications.
  • some droplets may be of substantially uniform size, and some droplets may have different sizes.
  • the droplets generated can have a size distribution where at least about 10%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or a higher percentage of droplets generated can have a substantially uniform size.
  • less than 10% of the droplets generated can have a size distribution where less than 10% of the droplets generated have a substantially uniform size.
  • the system and methods disclosed herein may selectively polymerize only droplets (e.g., polymerize biological particles contained therein the droplets) that have the appropriate (and/or acceptable) size and/or droplets that are occupied.
  • the second fluid 616 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • an oil such as a fluorinated oil
  • fluorosurfactant for stabilizing the resulting droplets, e.g., inhibiting subsequent coalescence of the resulting droplets.
  • particularly useful partitioning fluids and fluorosurfactants are described for example, in U.S. Patent Application Publication No. 2010/0105112 .
  • the generated droplets may comprise two subsets of droplets: (1) occupied droplets 618A, 618B, containing one or more biological particles 614, and (2) unoccupied droplets 620, not containing any biological particles 614.
  • occupied droplets 618A, 618B some droplets may have the appropriate size (e.g., droplet 618A) and some droplets may have an inappropriate size (e.g., droplet 618B).
  • a photo polymerization light source 624 such as a laser, can be located downstream of the junction 610 to selectively polymerize occupied droplets.
  • the light source 624 can be a lamp or light emitting diode (LED).
  • the light source 624 can generate optical pulses or an electromagnetic beam at a targeted direction.
  • the light source 624 can be configured to only emit electromagnetic waves when an occupied droplet is passing by.
  • the light source 624 can be operatively coupled to a controller 626.
  • the light source 624 can receive instructions from the controller 626 on whether or not a droplet passing by the light source 624, or a droplet expected to pass by the light source at a certain time, is occupied. While FIG.
  • a plurality of light sources may each be located at different locations, including different upstream/downstream locations in the fluidic channels.
  • a different polymerization application unit can be used to subject the droplets to a stimulus, such as to trigger polymerization via heating, cooling, electromagnetic radiation, and/or light.
  • the stimulus can be a chemical stimulus.
  • a plurality of the same or different types of polymerization application units can be used at different locations.
  • a sensor 622 can be configured to sense one or more characteristics of a droplet indicative of whether the droplet is occupied or unoccupied.
  • the sensor 622 may be located downstream of the junction 610.
  • the sensor 622 can be an impedance sensor configured to measure bulk impedance when droplets pass by the sensor 622.
  • a higher impedance can be measured when a larger droplet (e.g., droplet 618B ) passes by than when a smaller droplet (e.g., droplet 618A or droplet 620 ) passes by.
  • a higher impedance can be measured when an occupied droplet (e.g., droplets 618A, 618B ) passes by than when an unoccupied droplet (e.g., droplet 620 ) passes by.
  • the sensor 622 can be an optical sensor configured to measure optical properties of a droplet.
  • the optical sensor and/or a supporting device may be configured to emit a detection signal configured to probe one or more droplets, including for example an electromagnetic signal (e.g., in any wavelength) and/or an acoustic signal.
  • the optical sensor and/or a supporting device may comprise an illumination source configured to illuminate the droplet or droplets with one or more types of electromagnetic radiation.
  • the electromagnetic radiation can include illumination in one or more of the visible spectrum, infrared spectrum, the ultraviolet spectrum, and ionizing radiation spectrum.
  • the ionizing radiation can include x-rays.
  • the illumination can be transillumination or epi-illumination.
  • the sensor 622 may be one or more devices that are configured to provide one or more of optical sensing, thermal sensing, laser imaging, infrared imaging, capacitance sensing, mass sensing, vibration sensing across at least a portion of the electromagnetic spectrum, and magnetic induction sensing.
  • the sensor 622 may collect sensor data on one or more properties (e.g., optical properties, impendence properties, etc.) or characteristics of a droplet.
  • the one or more properties and/or other characteristics of a droplet measured by the sensor 622 can be indicative of a size and/or an occupancy of the droplet.
  • the sensor 622 can be operatively coupled to the controller 626.
  • the sensor 626 may transmit sensor data (e.g., size and/or occupancy of a droplet) to the controller 626.
  • the controller 626 may then use such data, the location of the sensor and/or the location in the fluidic channel at which the occupancy and/or size of a droplet was detected, the time the sensor 622 detected, fluid flow in the channel segment 608, location of the light source 624, time it takes for the sensor 626 to detect and/or transmit data to the controller 626, and/or time it takes for the controller 626 to send instructions to the light source 624, to send instructions to the light source 624 on whether or not to emit an electromagnetic wave to polymerize a droplet.
  • sensor data e.g., size and/or occupancy of a droplet
  • the controller 626 may determine whether a droplet passing by a sensor 622 location at a certain time is occupied or unoccupied. Based on the fluid flow rate in channel segment 608, the controller 626 may determine whether a droplet passing by the light source 624 at a certain time (e.g., assuming time it takes for droplet to travel from the sensor 622 location to the location of the light source 624 site is the same every time) is occupied or unoccupied.
  • FIG. 6 depicts one sensor 622, it may be appreciated that there may be a plurality of sensors, each in communication with the controller 626 and/or with each other. For example, there can be a plurality of sensors upstream or downstream of the junction 610 at different locations, for example, detecting the occupancy of a droplet. In some instances, a separate sensor can detect occupancy of a droplet and a separate sensor can detect size of the droplet. The separate sensors may or may not detect such characteristics at the same upstream/downstream location of the fluid channel.
  • FIG. 6 depicts one controller 626 operatively coupled to both the sensor 622 and the light source 624
  • a separate controller can be coupled to the sensor 622 and a separate controller can be coupled to the light source 624.
  • the separate controllers may or may not be in communication with each other. In some instances, there may be a plurality of controllers (e.g., two controllers to sensor 622 ), wherein each controller may or may not be in communication with each other.
  • the controller 626 may send instructions to sensor 622 and/or the light source 624 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the controller 622 may receive data from the sensor 622 and/or the light source 624 via wired connection and/or wireless connection (e.g., Wi-Fi, Bluetooth, NFC, etc.).
  • the components can be directly or indirectly be in communication with each other, with or without going through the controller 626.
  • the sensor 622 may be directly coupled to the light source 626.
  • a plurality of droplets wherein a first subset comprises polymerized droplets and a second subset comprises pre-polymerized droplets can be further sorted based on polymerization status, such as via solvent exchange.
  • the pre-polymerized droplets can be washed away during solvent exchange to isolate the polymerized droplets.
  • the separation systems and methods for sorting and/or selective polymerization described above and further below may achieve super Poissonian loading.
  • the droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are occupied droplets (e.g., containing at least one biological particle).
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of droplets can be occupied droplets.
  • at least about 97%, 98%, 99%, or a higher percentage of a second subset of droplets that is isolated are unoccupied droplets (e.g., not containing any biological particle and not containing any barcode carrying beads).
  • less than about 97% of the second subset of droplets can be unoccupied droplets.
  • the droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are within a given droplet size range.
  • Such monodispersity may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of droplets can be within a given droplet size range.
  • a cell bead can be formed after the polymerization process, such as via the selective polymerization systems and methods described herein. Alternatively, a different polymerization procedure can be used.
  • a cell bead can be formed by polymerizing one or more biological particles that are suspended in a first solvent, such as oil.
  • a plurality of biological particles e.g., cells
  • a stimulus e.g., light, chemical, temperature, etc.
  • a plurality of cell beads may be surrounded by the first solvent, such as an oil.
  • the cell bead may be placed into an aqueous environment by a solvent exchange process.
  • the solvent exchange process may comprise the operations of collecting a plurality of cell beads surrounded by oil (for instance, in an Eppendorf tube or other collection vessel), removing excess oil (for instance, by pipetting), adding a ligation buffer (such as a 3x ligation buffer), vortexing, adding a buffer (such as a 1x 1H,1H,2H,2H-perfluoro-1-octanol (PFO) buffer), vortexing, centrifugation, and separation.
  • the separation operation may comprise magnetic separation.
  • Each of the cell beads may comprise field-attractable particles (e.g., paramagnetic particles).
  • cell beads comprising field-attractable particles can be formed using the systems and methods described elsewhere herein (e.g., field-attractable particles 115 in FIG. 1 are suspended in fluids that form emulsion droplets which can be polymerized to form cell beads).
  • the magnetic separation may be accomplished by using a magnetic separating apparatus to pull cell beads containing paramagnetic particles away from unwanted remaining oil and solvents.
  • the magnetic separating apparatus can be a field application unit as described elsewhere herein (e.g., the same type of field application unit 216 in FIG. 2A , field application unit 316 in FIG. 3 ).
  • the magnetic separation apparatus may be used to pull cell beads containing paramagnetic particles away from the ligation buffer and PFO to allow removal of the ligation buffer and PFO (for instance by pipetting).
  • the cell beads containing paramagnetic particles may then be suspended in a ligation buffer and vortexed.
  • the cell beads containing paramagnetic particles may again be separated magnetically and the ligation buffer may be removed.
  • This cycle of re-suspension, vortexing, and magnetic separation may be repeated until the cell beads are clean. For instance, the cycle may be repeated 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 times.
  • the cell beads may then be placed into an aqueous medium.
  • the cell beads may be further treated. For instance, the cell beads in aqueous solution may be filtered (for instance, using a 70 ⁇ m filter) to remove clumps and/or large cell beads from the solution. In some cases, additional reagents may be added to and/or removed from the aqueous medium to further process the cell beads. The cell beads may then be combined into droplets with gel beads, as described herein.
  • microfluidic devices used for partitioning the cells as described above.
  • Such microfluidic devices can comprise channel networks for carrying out the partitioning process like those set forth in FIGS. 1 , 4 , 5 , and 6 .
  • These microfluidic devices can comprise channel networks, such as those disclosed herein, for partitioning cells into separate partitions, and co-partitioning such cells with oligonucleotide barcode library members, e.g., disposed on beads.
  • channel networks can be disposed within a solid body, e.g., a glass, semiconductor or polymer body structure in which the channels are defined, where those channels communicate at their termini with reservoirs for receiving the various input fluids, and for the ultimate deposition of the partitioned cells, etc., from the output of the channel networks.
  • a reservoir fluidly coupled to channel 102 may be provided with an aqueous suspension of cells 114, while a reservoir coupled to another channel (not shown) may be provided with an aqueous suspension of beads carrying the oligonucleotides.
  • Channel segments 106 and 108 may be provided with a non-aqueous solution, e.g., an oil, into which the aqueous fluids are partitioned as droplets at the channel junction 110.
  • a non-aqueous solution e.g., an oil
  • an outlet reservoir may be fluidly coupled to channel 108 into which the partitioned cells and beads can be delivered and from which they may be harvested.
  • the channel segments may be coupled to any of a variety of different fluid sources or receiving components, including tubing, manifolds, or fluidic components of other systems.
  • the systems and methods described herein may allow for the production of one or more droplets containing a single biological particle and/or a single bead.
  • the systems and methods may also allow for the production of one or more droplets containing a single biological particle and more than one bead, one or more droplets containing more than one biological particle and a single bead, or one or more droplets containing more than one biological particle and more than one bead.
  • the systems and methods described herein may allow for the production of one or more cell beads containing a single biological particle and/or a single bead.
  • the systems and methods may also allow for selective polymerization of occupied droplets and/or appropriately sized droplets, which mixture of polymerized and pre-polymerized droplets may or may not be subjected to subsequent sorting.
  • FIG. 7 shows a flowchart for a method of sorting occupied droplets and unoccupied droplets, wherein an occupied droplet contains at least a biological particle (cell) and/or a barcode carrying bead (particle).
  • a plurality of droplets are generated upon bringing a first phase in contact with a second phase, wherein the first phase and the second phase are immiscible.
  • Each of the plurality of droplets comprises some number and/or concentration of field-attractable particles.
  • a first subset of the plurality of droplets contains therein cells and/or barcode carrying particles, and a second subset of the plurality of droplets does not contains therein cells and/or barcode carrying particles.
  • a given droplet in the first subset of the plurality of droplets may contain a single cell or a plurality of cells.
  • a given droplet in the first subset of the plurality of droplets may contain a single barcode carrying particle or a plurality of barcode carrying particles.
  • a given droplet of the first subset of the plurality of droplets may contain a fewer number and/or lower concentration of field-attractable particles than a given droplet of the second subset of the plurality of droplets, on account of the volume occupied by the cell and/or barcode carrying particles contained in the occupied droplet.
  • the plurality of droplets is directed along the first channel towards an intersection of the first channel.
  • the intersection can be between the first channel, a second channel, and a third channel.
  • the plurality of droplets may be directed along one or more channels in a flow of fluid (e.g., either the first phase or the second phase used to generate the droplets), such as via a fluid flow unit.
  • the plurality of droplets is subject to a force field, such as via a field application unit, at or near the intersection.
  • the force field can be a magnetic field and/or an electric field.
  • the plurality of droplets can be subjected to the force field under conditions sufficient to separate the first subset of droplets from the second subset of the droplets, wherein upon separation, the first subset of droplets flows along the second channel, and the second subset of droplets flows along the third channel.
  • the field-attractable particles can be paramagnetic particles when a magnetic field is applied.
  • the field-attractable particles can be conductive particles when an electric field is applied.
  • a stronger force can act on a given droplet in the second subset of droplets than on a given droplet in the first subset of droplets.
  • the force differential may separate the two subsets, such as by influencing a greater deviation in fluid flow path direction for a given droplet in the second subset of droplets than for a given droplet in the first subset of droplets.
  • the method of FIG. 7 may isolate occupied droplets (e.g., first subset of droplets) with super-Poissonian loading.
  • a plurality of droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are occupied droplets (e.g., containing at least one biological particle).
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of droplets of a separated subset of the plurality of droplets may be occupied droplets.
  • the method of FIG. 7 may be similarly used to isolate occupied particles from a plurality of particles containing occupied and unoccupied particles.
  • a plurality of particles may be generated to comprise a first subset of occupied particles (containing a biological particle and/or a barcode carrying particle therein) and a second subset of unoccupied particles, wherein particles of both the first subset and the second subset comprise field-attractable particles.
  • a given particle of the first subset may contain a fewer number and/or lower concentration of field-attractable particles than a given particle of the second subset, on account of the volume occupied by the cell and/or barcode carrying particles contained in the occupied particle.
  • the plurality of particles may be directed along a first channel towards an intersection of the first channel. The intersection can be between the first channel, a second channel, and a third channel.
  • the plurality of particles can be subject to a force field, such as via a field application unit, at or near the intersection.
  • the force field can be a magnetic field and/or an electric field.
  • the plurality of particles can be subjected to the force field under conditions sufficient to separate the first subset from the second subset, wherein upon separation, the first subset of particles flows along the second channel, and the second subset of particles flows along the third channel.
  • the field-attractable particles can be paramagnetic particles when a magnetic field is applied.
  • the field-attractable particles can be conductive particles when an electric field is applied.
  • a stronger force can act on a given particle in the second subset than on a given particle in the first subset.
  • the force differential may separate the two subsets, such as by influencing a greater deviation in fluid flow path direction for a given particle in the second subset than for a given particle in the first subset.
  • the method of FIG. 7 may isolate occupied particles (e.g., first subset of particles) with super-Poissonian loading.
  • a plurality of particles can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of particles that is isolated are occupied particles (e.g., containing at least one biological particle).
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of particles of a separated subset of the plurality of particles may be occupied particles.
  • FIG. 8 shows a flowchart for a method of sorting occupied droplets and unoccupied droplets, wherein an occupied droplet contains at least a biological particle (cell) and/or a barcode carrying bead (particle).
  • a plurality of droplets are generated upon bringing a first phase in contact with a second phase, wherein the first phase and the second phase are immiscible.
  • Each of the plurality of droplets comprises may or may not comprise some number and/or concentration of field-attractable particles. The presence of field-attractable particles is not required.
  • a first subset of the plurality of droplets contains therein cells and/or barcode carrying particles, and a second subset of the plurality of droplets does not contain therein cells and/or barcode carrying particles.
  • a given droplet in the first subset of the plurality of droplets may contain a single cell or a plurality of cells.
  • a given droplet in the first subset of the plurality of droplets may contain a single barcode carrying particle or a plurality of barcode carrying particles.
  • the plurality of droplets is directed along the first channel towards an intersection of the first channel.
  • the intersection can be between the first channel, a second channel, and a third channel.
  • the plurality of droplets may be directed along one or more channels in a flow of fluid (e.g., either the first phase or the second phase used to generate the droplets), such as via a fluid flow unit.
  • the plurality of droplets is subject to a pressure pulse, such as via a pressure application unit, at or near the intersection.
  • the pressure pulse can be provided as a positive pressure pulse or a negative pressure pulse.
  • the plurality of droplets can be subjected to the pressure pulse under conditions sufficient to separate the first subset of droplets from the second subset of the droplets, wherein upon separation, the first subset of droplets flows along the second channel, and the second subset of droplets flows along the third channel.
  • a given droplet in the second subset of the plurality of droplets has different particle and/or suspension characteristics in the fluid than a given droplet in the first subset of the plurality of droplets
  • a different hydrodynamic force can act on a given droplet in the second subset of droplets than on a given droplet in the first subset of droplets.
  • the pressure pulse may separate the two subsets, such as by influencing a greater deviation in fluid flow path direction for a given droplet in the second subset of droplets than for a given droplet in the first subset of droplets.
  • a sensor such as an impedance sensor or an optical sensor, may measure one or more characteristics of a droplet at an upstream location of the intersection.
  • the sensing data may be indicative of the occupancy of the droplet.
  • the sensing data may be transmitted to a controller.
  • the controller may use the sensing data to determine the occupancy of the droplet and instruct the pressure application unit to generate or not generate pressure pulses to separate the first subset from the second subset.
  • the method of FIG. 8 may isolate occupied droplets (e.g., first subset of droplets) with super-Poissonian loading.
  • a plurality of droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are occupied droplets (e.g., containing at least one biological particle).
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of droplets of a separated subset of the plurality of droplets may be occupied droplets.
  • the method of FIG. 8 may be similarly used to isolate cell beads from a plurality of particles containing both cell beads and unoccupied particles.
  • a plurality of particles may be generated to comprise a first subset of occupied particles (containing a biological particle and/or a barcode carrying particle therein) and a second subset of unoccupied particles.
  • the presence of field-attractable particles is not required.
  • the plurality of particles may be directed along a first channel towards an intersection of the first channel. The intersection can be between the first channel, a second channel, and a third channel.
  • the plurality of particles may be subject to a pressure pulse, such as via a pressure application unit, at or near the intersection.
  • the pressure pulse can be provided as a positive pressure pulse or a negative pressure pulse.
  • the plurality of particles can be subjected to the pressure pulse under conditions sufficient to separate the first subset of particles (e.g., cell beads) from the second subset of the particles (e.g., unoccupied particles), wherein upon separation, the first subset of particles flows along the second channel, and the second subset of particles flows along the third channel. Because a given particle in the second subset of the plurality of particles has different particle and/or suspension characteristics in the fluid than a given particle in the first subset of the plurality of particles, for the same pressure pulse applied, a different hydrodynamic force can act on a given particle in the second subset of particles than on a given particle in the first subset of particles.
  • the pressure pulse may separate the two subsets, such as by influencing a greater deviation in fluid flow path direction for a given particle in the second subset of particles than for a given particle in the first subset of particles.
  • a sensor such as an impedance sensor or an optical sensor, may measure one or more characteristics of a particle at an upstream location of the intersection.
  • the sensing data may be indicative of the occupancy of the particle.
  • the sensing data may be transmitted to a controller.
  • the controller may use the sensing data to determine the occupancy of the particle and instruct the pressure application unit to generate or not generate pressure pulses to separate the first subset from the second subset.
  • the method of FIG. 8 may isolate cell beads (e.g., first subset of particles) with super-Poissonian loading.
  • a plurality of particles can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of particles that is isolated are cell beads (e.g., containing at least one biological particle).
  • Such occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of particles of a separated subset of the plurality of particles may be cell beads.
  • FIG. 9 shows a flowchart for a method of selectively polymerizing occupied droplets, wherein an occupied droplet contains at least a biological particle (cell) and/or a barcode carrying bead (particle).
  • a plurality of droplets are generated upon bringing a first phase in contact with a second phase, wherein the first phase and the second phase are immiscible.
  • Each of the plurality of droplets comprises may or may not comprise some number and/or concentration of field-attractable particles. The presence of field-attractable particles is not required.
  • a first subset of the plurality of droplets contains therein cells and/or barcode carrying particles, and a second subset of the plurality of droplets does not contain therein cells and/or barcode carrying particles.
  • a given droplet in the first subset of the plurality of droplets may contain a single cell or a plurality of cells.
  • a given droplet in the first subset of the plurality of droplets may contain a single barcode carrying particle or a plurality of barcode carrying particles.
  • a sensor detects and/or measures one or more characteristics of a droplet passing through the upstream location.
  • the one or more characteristics can be indicative of the occupancy of the droplet.
  • the sensor can be an impedance sensor configured to detect bulk impedance as a droplet or a plurality of droplets passes through the upstream location. A higher impedance can be measured for occupied droplets than for unoccupied droplets.
  • the sensor can be an optical sensor configured to detect one or more optical characteristics of the droplet as the droplet passes through the upstream location. Alternatively, a plurality of the same or different types of sensors can be used to detect and/or measure one or more characteristics of the droplet passing through the upstream location.
  • the sensing data may transmitted to a controller.
  • the sensor can be operatively coupled to the controller.
  • the controller can determine, based at least in part on the sensor data, whether a droplet passing through a downstream location is occupied or unoccupied.
  • the controller may use such sensor data, the location of the sensor and/or the location in the fluidic channel at which the occupancy of a droplet was detected, the time the sensor detected the occupancy of a droplet, fluid flow rate of one or more channels, location of the light source, time it takes for the sensor to detect and/or transmit data to the controller, and/or time it takes for the controller to send instructions to the light source, to send instructions to the light source on whether or not to emit an electromagnetic wave to polymerize a droplet.
  • the senor may detect the presence of a cell suspended in a fluid flow before the droplets are generated (e.g., at the intersection), and use such sensor data of the presence of the cell, and other information (e.g., location, times, fluid flow rates) to determine whether a droplet at a downstream location is occupied.
  • a cell suspended in a fluid flow before the droplets are generated e.g., at the intersection
  • other information e.g., location, times, fluid flow rates
  • the controller may transmit instruction to a light source at a downstream location to emit electromagnetic waves to polymerize a droplet if the droplet is occupied, and not to emit electromagnetic waves if the droplet is unoccupied, thus letting the unoccupied droplet pass through unpolymerized.
  • a light source at a downstream location to emit electromagnetic waves to polymerize a droplet if the droplet is occupied, and not to emit electromagnetic waves if the droplet is unoccupied, thus letting the unoccupied droplet pass through unpolymerized.
  • other polymerization application units can be used in place of, or in conjunction with the light source.
  • the method of FIG. 9 may polymerize occupied droplets (e.g., first subset of droplets) with super-Poissonian distribution.
  • the separation systems and methods disclosed herein may achieve super Poisson loading. For example, at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a plurality of droplets that are polymerized can be occupied droplets.
  • Such occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of polymerized droplets may be occupied droplets.
  • FIG. 10 shows a flowchart for a method of selectively polymerizing appropriately sized droplets.
  • a plurality of droplets are generated upon bringing a first phase in contact with a second phase, wherein the first phase and the second phase are immiscible.
  • Each of the plurality of droplets comprises may or may not comprise some number and/or concentration of field-attractable particles. The presence of field-attractable particles is not required.
  • a first subset of the plurality of droplets contains therein cells and/or barcode carrying particles, and a second subset of the plurality of droplets does not contain therein cells and/or barcode carrying particles.
  • a given droplet in the first subset of the plurality of droplets may contain a single cell or a plurality of cells.
  • a given droplet in the first subset of the plurality of droplets may contain a single barcode carrying particle or a plurality of barcode carrying particles.
  • a sensor detects and/or measures one or more characteristics of a droplet passing through the upstream location.
  • the one or more characteristics can be indicative of a size of the droplet.
  • the sensor can be an impedance sensor configured to detect bulk impedance as a droplet or a plurality of droplets passes through the upstream location. A higher impedance can be measured for larger droplets than for smaller droplets.
  • the sensor can be an optical sensor configured to detect one or more optical characteristics of the droplet as the droplet passes through the upstream location. Alternatively, a plurality of the same or different types of sensors can be used to detect and/or measure one or more characteristics of the droplet passing through the upstream location.
  • the sensing data may transmitted to a controller.
  • the sensor can be operatively coupled to the controller.
  • the controller can determine, based at least in part on the sensor data, whether a droplet passing through a downstream location is appropriately sized or inappropriately sized.
  • the controller may use such sensor data, the location of the sensor and/or the location in the fluidic channel at which the size of a droplet was detected, the time the sensor detected the size of a droplet, fluid flow rate of one or more channels, location of the light source, time it takes for the sensor to detect and/or transmit data to the controller, and/or time it takes for the controller to send instructions to the light source, to send instructions to the light source on whether or not to emit an electromagnetic wave to polymerize a droplet.
  • the controller may transmit instruction to a light source at a downstream location to emit electromagnetic waves to polymerize a droplet if the droplet is appropriately sized, and not to emit electromagnetic waves if the droplet is inappropriately sized, thus letting the inappropriately sized droplet pass through unpolymerized.
  • a light source at a downstream location to emit electromagnetic waves to polymerize a droplet if the droplet is appropriately sized, and not to emit electromagnetic waves if the droplet is inappropriately sized, thus letting the inappropriately sized droplet pass through unpolymerized.
  • other polymerization application units can be used in place of, or in conjunction with the light source.
  • the method of FIG. 10 may polymerize appropriately sized droplets (e.g., first subset of droplets) with super-Poissonian distribution. For example, at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a plurality of droplets that is polymerized can be appropriately sized droplets. Alternatively, less than about 97% of polymerized droplets may be appropriately sized droplets.
  • the methods of FIG. 9 and FIG. 10 can be combined such that one or more sensors detect one or more characteristics of a droplet at an upstream location (or upstream locations), wherein the one or more characteristics of the droplet are indicative of both a size and an occupancy of the droplet, and transmits the sensor data to a controller.
  • the controller transmits instructions to a light source at a downstream location to polymerize the droplet only if the droplet is both appropriately sized and occupied.
  • the passive mechanism may not require application of external forces (e.g., magnetic field, electric field, pressure pulse, etc.) on the droplets to achieve sorting.
  • the passive mechanism may sort droplets based at least in part on mechanical properties of the droplets.
  • the passive mechanism may sort droplets based at least in part on properties such as deformability and surface tension (e.g., surface interface energy) of the droplets.
  • the occupied droplet may demonstrate lower deformability and/or higher surface tension properties than unoccupied droplets, making occupied droplets 'harder' or 'stiffer' than unoccupied droplets.
  • a plurality of droplets comprising both a first subset of occupied droplets and a second subset of unoccupied droplets is directed to pass through an aperture which is smaller in size than a diameter of a given droplet in the plurality of droplets
  • only those droplets capable of deforming e.g., unoccupied droplets having higher deformability properties
  • FIG. 11 shows a schematic example of a microfluidic channel structure for separating occupied droplets from unoccupied droplets.
  • the droplets may additionally contain one or more barcode carrying beads.
  • a droplet may have only a biological particle
  • a droplet may have only a barcode carrying bead
  • a droplet may have both a biological particle and a barcode carrying bead
  • a droplet may have neither biological particles nor barcode carrying beads.
  • the majority of occupied partitions can include no more than one biological particle per occupied partition and, in some cases, some of the generated partitions can be unoccupied (e.g., by any biological particle). In some cases, though, some of the occupied partitions may include more than one biological particle. In some cases, the partitioning process may be controlled such that fewer than 25% of the occupied partitions contain more than one biological particle, fewer than 20% of the occupied partitions have more than one biological particle, or fewer than 10% or even fewer than 5% of the occupied partitions include more than one biological particle per partition.
  • the channel structure can include a channel segment 1100 with an entrance 1102 and exit 1104.
  • the outflow channel 108 of the emulsion carrying the generated droplets in FIG. 1 can be upstream of the channel segment 1100.
  • a fluid flow unit (not shown) can be configured to facilitate flow of fluid in the channel structure.
  • a plurality of discrete droplets each comprising a first aqueous fluid 1100 can flow as emulsions in a second fluid 1112, wherein the second fluid 1112 is immiscible to the first aqueous fluid 1110.
  • the droplets being transported along channel segment 1100 can comprise a first subset of droplets 1108 that are each occupied with at least a biological particle and/or a barcode carrying bead and a second subset of droplets 1110 that are each unoccupied.
  • a given unoccupied droplet can have a higher deformability and/or lower surface tension property than a given occupied droplet, due to the presence of one or more biological particles in the occupied droplet.
  • the channel segment 1100 can comprise a plurality of entrapment structures 1114.
  • An entrapment structure can define an aperture.
  • a size of the aperture may be less than a diameter (or other size dimension) of a droplet.
  • a size of the aperture may be less than a minimum dimension of a droplet.
  • the size of the aperture can be at most about 90%, 80%, 70%, 60%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, or 5% of the diameter of a droplet (in a pre-deformed state).
  • the size of the aperture can be less than about 5% of the diameter of a droplet.
  • the size of the aperture can be greater than 50%, 60%, 70%, 80%, 90%, 100%, 150%, or 200% of the diameter of a droplet.
  • the size of the aperture can be greater than the diameter of the droplet.
  • occupied droplets 1108 may be 'harder' or 'stiffer,' due to a presence of one or more biological particles in the droplets, the occupied droplets may resist deformation, at least from deforming to a size smaller than a size of the aperture, and remain trapped by the entrapment structures 1114.
  • the entrapment structures 1114 may retain from the plurality of droplets only the first subset of occupied droplets 1108.
  • the unoccupied droplets 1104 may flow through all entrapment structures 1114 and exit the channel segment 1100 to a separate compartment, such as for recycling or discarding. While FIG.
  • an entrapment structure can be a single plate with a plurality of apertures (e.g., holes) defined in the plate.
  • the plate can be planar, curved, and/or a combination thereof.
  • the channel structure and the entrapment structures 1114 can be configured such that a droplet from the plurality of droplets passes through at least one entrapment structure (and aperture defined therein).
  • the fluid flow unit (not shown) can be configured to reverse a fluid flow direction to collect the occupied droplets from the entrapment structures.
  • the fluid flow unit may comprise a compressor to provide positive pressure at an upstream location to direct the fluid from the upstream location to flow to a downstream location.
  • the fluid flow unit may comprise a pump to provide negative pressure at a downstream location to direct the fluid from an upstream location to flow to the downstream location.
  • the fluid flow unit may comprise both a compressor and a pump, each at different locations.
  • the fluid flow unit may comprise different devices at different locations.
  • the fluid flow unit may comprise an actuator.
  • occupied particles e.g., cell beads
  • a plurality of particles may comprise a first subset of particles occupied by biological particles (e.g., cells) and a second subset of particles unoccupied by biological particles.
  • a given unoccupied particle can have a higher deformability and/or lower surface tension property than a given occupied particle (e.g., cell bead) due to the presence of one or more biological particles in the occupied particle.
  • the plurality of particles may be directed to flow (e.g., as suspensions in a fluid, e.g., aqueous fluid) along the channel segment 1100 from entrance 1102 to exit 1104 across the plurality of entrapment structures 1114.
  • An entrapment structure can define an aperture.
  • a size of the aperture may be less than a diameter (or other size dimension) of a particle.
  • a size of the aperture may be less than a minimum dimension of a particle.
  • the size of the aperture can be at most about 90%, 80%, 70%, 60%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, or 5% of the diameter of a particle (in a pre-deformed state).
  • the size of the aperture can be less than about 5% of the diameter of a particle.
  • the size of the aperture can be greater than 50%, 60%, 70%, 80%, 90%, 100%, 150%, or 200% of the diameter of a particle.
  • the size of the aperture can be greater than the diameter of the particle.
  • entrapment structures 1114 When a plurality of particles comprising both a first subset of occupied particles 1108 and a second subset of unoccupied particles 1110 is directed to pass through entrapment structures 1114 defining apertures which is smaller in size than a diameter of a given particle in the plurality of particles, only those particles deforming 1118 (e.g., unoccupied particles 1110 having higher deformability properties) such that at least one dimension of the particle is less than a size of the aperture may pass through one or more apertures defined by the entrapment structures 1114.
  • occupied particles 1108 e.g., cell beads
  • the occupied particles may resist deformation, at least from deforming to a size smaller than a size of the aperture, and remain trapped by the entrapment structures 1114.
  • the entrapment structures 1114 may retain from the plurality of particles only the first subset of occupied particles 1108.
  • the unoccupied particles 1104 may flow through all entrapment structures 1114 and exit the channel segment 1100 to a separate compartment, such as for recycling or discarding.
  • the separation systems and methods disclosed herein may achieve super Poisson loading.
  • the droplets can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of droplets that is isolated are occupied droplets (e.g., containing at least one biological particle).
  • occupied droplets e.g., containing at least one biological particle.
  • occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of droplets can be occupied droplets.
  • At least about 97%, 98%, 99%, or a higher percentage of a second subset of droplets that is isolated can be unoccupied droplets (e.g., not containing any biological particle and not containing any barcode carrying beads).
  • less than about 97% of the second subset of droplets can be unoccupied droplets.
  • the plurality of particles can be separated into two subsets such that at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of a first subset of particles that is isolated are cell beads (e.g., containing at least one biological particle).
  • Such occupancy may be greater than or equal to 1%, 2%, 3%, 4%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or higher.
  • less than about 97% of the first subset of particles can be cell beads.
  • at least about 97%, 98%, 99%, or a higher percentage of a second subset of particles that is isolated can be unoccupied particles (e.g., not containing any biological particle and not containing any barcode carrying beads).
  • less than about 97% of the second subset of particles can be unoccupied particles.
  • microfluidic architectures that can be used in conjunction with the systems and methods described herein.
  • FIG. 12 shows an example of a microfluidic channel structure 1200 for delivering barcode carrying beads to droplets.
  • the channel structure 1200 can include channel segments 1201, 1202, 1204, 1206 and 1208 communicating at a channel junction 1210.
  • the channel segment 1201 may transport an aqueous fluid 1212 that includes a plurality of beads 1214 (e.g., with nucleic acid molecules, oligonucleotides, molecular tags) along the channel segment 1201 into junction 1210.
  • the plurality of beads 1214 may be sourced from a suspension of beads.
  • the channel segment 1201 may be connected to a reservoir comprising an aqueous suspension of beads 1214.
  • the channel segment 1202 may transport the aqueous fluid 1212 that includes a plurality of biological particles 1216 along the channel segment 1202 into junction 1210.
  • the plurality of biological particles 1216 may be sourced from a suspension of biological particles.
  • the channel segment 1202 may be connected to a reservoir comprising an aqueous suspension of biological particles 1216.
  • the aqueous fluid 1212 in either the first channel segment 1201 or the second channel segment 1202, or in both segments can include one or more reagents, as further described below.
  • a second fluid 1218 that is immiscible with the aqueous fluid 1212 e.g., oil
  • the aqueous fluid 1212 can be partitioned as discrete droplets 1220 in the second fluid 1218 and flow away from the junction 1210 along channel segment 1208.
  • the channel segment 1208 may deliver the discrete droplets to an outlet reservoir fluidly coupled to the channel segment 1208, where they may be harvested.
  • the channel segments 1201 and 1202 may meet at another junction upstream of the junction 1210.
  • beads and biological particles may form a mixture that is directed along another channel to the junction 1210 to yield droplets 1220.
  • the mixture may provide the beads and biological particles in an alternating fashion, such that, for example, a droplet comprises a single bead and a single biological particle.
  • Beads, biological particles and droplets may flow along channels at substantially regular flow profiles (e.g., at regular flow rates). Such regular flow profiles may permit a droplet to include a single bead and a single biological particle. Such regular flow profiles may permit the droplets to have an occupancy (e.g., droplets having beads and biological particles) greater than 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95%.
  • occupancy e.g., droplets having beads and biological particles
  • the second fluid 1218 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets 1220.
  • an oil such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets 1220.
  • a discrete droplet that is generated may include an individual biological particle 1216.
  • a discrete droplet that is generated may include a barcode or other reagent carrying bead 1214.
  • a discrete droplet generated may include both an individual biological particle and a barcode carrying bead, such as droplets 1220.
  • a discrete droplet may include more than one individual biological particle or no biological particle.
  • a discrete droplet may include more than one bead or no bead.
  • a discrete droplet may be unoccupied (e.g., no beads, no biological particles).
  • a discrete droplet partitioning a biological particle and a barcode carrying bead may effectively allow the attribution of the barcode to macromolecular constituents of the biological particle within the partition.
  • the contents of a partition may remain discrete from the contents of other partitions.
  • the channel segments described herein may be coupled to any of a variety of different fluid sources or receiving components, including reservoirs, tubing, manifolds, or fluidic components of other systems.
  • the microfluidic channel structure 1200 may have other geometries.
  • a microfluidic channel structure can have more than one channel junctions.
  • a microfluidic channel structure can have 2, 3, 4, or 5 channel segments each carrying beads that meet at a channel junction.
  • Fluid may be directed flow along one or more channels or reservoirs via one or more fluid flow units.
  • a fluid flow unit can comprise compressors (e.g., providing positive pressure), pumps (e.g., providing negative pressure), actuators, and the like to control flow of the fluid. Fluid may also or otherwise be controlled via applied pressure differentials, centrifugal force, electrokinetic pumping, vacuum, capillary or gravity flow, or the like.
  • biological particles may be partitioned along with lysis reagents in order to release the contents of the biological particles within the partition.
  • the lysis agents can be contacted with the biological particle suspension concurrently with, or immediately prior to, the introduction of the biological particles into the partitioning junction/droplet generation zone, such as through an additional channel or channels upstream of the channel junction.
  • biological particles may be partitioned along with other reagents.
  • FIG. 13 shows an example of a microfluidic channel structure 1300 for co-partitioning biological particles and reagents.
  • the channel structure 1300 can include channel segments 1301, 1302, 1304, 1306 and 1308.
  • Channel segments 1301 and 1302 communicate at a first channel junction 1309.
  • Channel segments 1302, 1304, 1306, and 1308 communicate at a second channel junction 1310.
  • the channel segment 1301 may transport an aqueous fluid 1312 that includes a plurality of biological particles 1314 along the channel segment 1301 into the second junction 1310.
  • channel segment 1301 may transport beads (e.g., gel beads).
  • the beads may comprise barcode molecules.
  • the channel segment 1301 may be connected to a reservoir comprising an aqueous suspension of biological particles 1314. Upstream of, and immediately prior to reaching, the second junction 1310, the channel segment 1301 may meet the channel segment 1302 at the first junction 1309.
  • the channel segment 1302 may transport a plurality of reagents 1315 (e.g., lysis agents) suspended in the aqueous fluid 1312 along the channel segment 1302 into the first junction 1309.
  • the channel segment 1302 may be connected to a reservoir comprising the reagents 1315.
  • the aqueous fluid 1312 in the channel segment 1301 can carry both the biological particles 1314 and the reagents 1315 towards the second junction 1310.
  • the aqueous fluid 1312 in the channel segment 1301 can include one or more reagents, which can be the same or different reagents as the reagents 1315.
  • a second fluid 1316 that is immiscible with the aqueous fluid 1312 e.g., oil
  • the aqueous fluid 1312 can be partitioned as discrete droplets 1318 in the second fluid 1316 and flow away from the second junction 1310 along channel segment 1308.
  • the channel segment 1308 may deliver the discrete droplets 1318 to an outlet reservoir fluidly coupled to the channel segment 1308, where they may be harvested.
  • the second fluid 1316 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets 1318.
  • an oil such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets 1318.
  • a discrete droplet generated may include an individual biological particle 1314 and/or one or more reagents 1315.
  • a discrete droplet generated may include a barcode carrying bead (not shown), such as via other microfluidics structures described elsewhere herein.
  • a discrete droplet may be unoccupied (e.g., no reagents, no biological particles).
  • the lysis reagents can facilitate the release of the contents of the biological particles within the partition.
  • the contents released in a partition may remain discrete from the contents of other partitions.
  • the channel segments described herein may be coupled to any of a variety of different fluid sources or receiving components, including reservoirs, tubing, manifolds, or fluidic components of other systems.
  • the microfluidic channel structure 1300 may have other geometries.
  • a microfluidic channel structure can have more than two channel junctions.
  • a microfluidic channel structure can have 2, 3, 4, 5 channel segments or more each carrying the same or different types of beads, reagents, and/or biological particles that meet at a channel junction.
  • Fluid flow in each channel segment may be controlled to control the partitioning of the different elements into droplets. Fluid may be directed flow along one or more channels or reservoirs via one or more fluid flow units.
  • a fluid flow unit can comprise compressors (e.g., providing positive pressure), pumps (e.g., providing negative pressure), actuators, and the like to control flow of the fluid. Fluid may also or otherwise be controlled via applied pressure differentials, centrifugal force, electrokinetic pumping, vacuum, capillary or gravity flow, or the like.
  • Droplet size may be controlled by adjusting certain geometric features in channel architecture (e.g., microfluidics channel architecture). For example, an expansion angle, width, and/or length of a channel may be adjusted to control droplet size.
  • channel architecture e.g., microfluidics channel architecture
  • FIG. 14 shows an example of a microfluidic channel structure for the controlled partitioning of beads into discrete droplets.
  • a channel structure 1400 can include a channel segment 1402 communicating at a channel junction 1406 (or intersection) with a reservoir 1404.
  • the reservoir 1404 can be a chamber. Any reference to "reservoir,” as used herein, can also refer to a "chamber.”
  • an aqueous fluid 1408 that includes suspended beads 1412 may be transported along the channel segment 1402 into the junction 1406 to meet a second fluid 1410 that is immiscible with the aqueous fluid 1408 in the reservoir 1404 to create droplets 1416, 1418 of the aqueous fluid 1408 flowing into the reservoir 1404.
  • droplets can form based on factors such as the hydrodynamic forces at the junction 1406, flow rates of the two fluids 1408, 1410, fluid properties, and certain geometric parameters (e.g., w, h 0 , ⁇ , etc.) of the channel structure 1400.
  • a plurality of droplets can be collected in the reservoir 1404 by continuously injecting the aqueous fluid 1408 from the channel segment 1402 through the junction 1406.
  • a discrete droplet generated may include a bead (e.g., as in occupied droplets 1416). Alternatively, a discrete droplet generated may include more than one bead. Alternatively, a discrete droplet generated may not include any beads (e.g., as in unoccupied droplet 1418 ) . In some instances, a discrete droplet generated may contain one or more biological particles, as described elsewhere herein. In some instances, a discrete droplet generated may comprise one or more reagents, as described elsewhere herein.
  • the aqueous fluid 1408 can have a substantially uniform concentration or frequency of beads 1412.
  • the beads 1412 can be introduced into the channel segment 1402 from a separate channel (not shown in FIG. 14 ).
  • the frequency of beads 1412 in the channel segment 1402 may be controlled by controlling the frequency in which the beads 1412 are introduced into the channel segment 1402 and/or the relative flow rates of the fluids in the channel segment 1402 and the separate channel.
  • the beads can be introduced into the channel segment 1402 from a plurality of different channels, and the frequency controlled accordingly.
  • the aqueous fluid 1408 in the channel segment 1402 can comprise biological particles. In some instances, the aqueous fluid 1408 can have a substantially uniform concentration or frequency of biological particles. As with the beads, the biological particles can be introduced into the channel segment 1402 from a separate channel. The frequency or concentration of the biological particles in the aqueous fluid 1408 in the channel segment 1402 may be controlled by controlling the frequency in which the biological particles are introduced into the channel segment 1402 and/or the relative flow rates of the fluids in the channel segment 1402 and the separate channel. In some instances, the biological particles can be introduced into the channel segment 1402 from a plurality of different channels, and the frequency controlled accordingly. In some instances, a first separate channel can introduce beads and a second separate channel can introduce biological particles into the channel segment 1402. The first separate channel introducing the beads may be upstream or downstream of the second separate channel introducing the biological particles.
  • the second fluid 1410 can comprise an oil, such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets.
  • an oil such as a fluorinated oil, that includes a fluorosurfactant for stabilizing the resulting droplets, for example, inhibiting subsequent coalescence of the resulting droplets.
  • the second fluid 1410 may not be subjected to and/or directed to any flow in or out of the reservoir 1404.
  • the second fluid 1410 may be substantially stationary in the reservoir 1404.
  • the second fluid 1410 may be subjected to flow within the reservoir 1404, but not in or out of the reservoir 1404, such as via application of pressure to the reservoir 1404 and/or as affected by the incoming flow of the aqueous fluid 1408 at the junction 1406.
  • the second fluid 1410 may be subjected and/or directed to flow in or out of the reservoir 1404.
  • the reservoir 1404 can be a channel directing the second fluid 1410 from upstream to downstream, transporting the generated droplets.
  • the channel structure 1400 at or near the junction 1406 may have certain geometric features that at least partly determine the sizes of the droplets formed by the channel structure 1400.
  • the channel segment 1402 can have a height, ho and width, w, at or near the junction 1406.
  • the channel segment 1402 can comprise a rectangular cross-section that leads to a reservoir 1404 having a wider cross-section (such as in width or diameter).
  • the cross-section of the channel segment 1402 can be other shapes, such as a circular shape, trapezoidal shape, polygonal shape, or any other shapes.
  • the top and bottom walls of the reservoir 1404 at or near the junction 1406 can be inclined at an expansion angle, ⁇ .
  • the expansion angle, ⁇ allows the tongue (portion of the aqueous fluid 1408 leaving channel segment 1402 at junction 1406 and entering the reservoir 1404 before droplet formation) to increase in depth and facilitate decrease in curvature of the intermediately formed droplet.
  • Droplet size may decrease with increasing expansion angle.
  • the resulting droplet radius, R d may be predicted by the following equation for the aforementioned geometric parameters of h 0 , w , and ⁇ : R d ⁇ 0.44 1 + 2.2 tan ⁇ w h 0 h 0 tan ⁇
  • the predicted droplet size is 121 ⁇ m.
  • the predicted droplet size is 123 ⁇ m.
  • the predicted droplet size is 124 ⁇ m.
  • the expansion angle, ⁇ may be between a range of from about 0.5° to about 4°, from about 0.1° to about 10°, or from about 0° to about 90°.
  • the expansion angle can be at least about 0.01°, 0.1°, 0.2°, 0.3°, 0.4°, 0.5°, 0.6°, 0.7°, 0.8°, 0.9°, 1°, 2°, 3°, 4°, 5°, 6°, 7°, 8°, 9°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, or higher.
  • the expansion angle can be at most about 89°, 88°, 87°, 86°, 85°, 84°, 83°, 82°, 81°, 80°, 75°, 70°, 65°, 60°, 55°, 50°, 45°, 40°, 35°, 30°, 25°, 20°, 15°, 10°, 9°, 8°, 7°, 6°, 5°, 4°, 3°, 2°, 1°, 0.1°, 0.01°, or less.
  • the width, w can be between a range of from about 100 micrometers ( ⁇ m) to about 500 ⁇ m.
  • the width, w can be between a range of from about 10 ⁇ m to about 200 ⁇ m. Alternatively, the width can be less than about 10 ⁇ m. Alternatively, the width can be greater than about 500 ⁇ m.
  • the flow rate of the aqueous fluid 1408 entering the junction 1406 can be between about 0.04 microliters ( ⁇ L)/minute (min) and about 40 ⁇ L/min. In some instances, the flow rate of the aqueous fluid 1408 entering the junction 1406 can be between about 0.01 microliters ( ⁇ L)/minute (min) and about 100 ⁇ L/min. Alternatively, the flow rate of the aqueous fluid 1408 entering the junction 1406 can be less than about 0.01 ⁇ L/min.
  • the flow rate of the aqueous fluid 1408 entering the junction 1406 can be greater than about 40 ⁇ L/min, such as 45 ⁇ L/min, 50 ⁇ L/min, 55 ⁇ L/min, 60 ⁇ L/min, 65 ⁇ L/min, 70 ⁇ L/min, 75 ⁇ L/min, 80 ⁇ L/min, 85 ⁇ L/min, 90 ⁇ L/min, 95 ⁇ L/min, 100 ⁇ L/min, 110 ⁇ L/min , 120 ⁇ L/min , 130 ⁇ L/min , 140 ⁇ L/min , 150 ⁇ L/min, or greater.
  • the droplet radius may not be dependent on the flow rate of the aqueous fluid 1408 entering the junction 1406.
  • At least about 50% of the droplets generated can have uniform size. In some instances, at least about 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of the droplets generated can have uniform size. Alternatively, less than about 50% of the droplets generated can have uniform size.
  • the throughput of droplet generation can be increased by increasing the points of generation, such as increasing the number of junctions (e.g., junction 1406) between aqueous fluid 1408 channel segments (e.g., channel segment 1402) and the reservoir 1404. Alternatively or in addition, the throughput of droplet generation can be increased by increasing the flow rate of the aqueous fluid 1408 in the channel segment 1402.
  • FIG. 15 shows an example of a microfluidic channel structure for increased droplet generation throughput.
  • a microfluidic channel structure 1500 can comprise a plurality of channel segments 1502 and a reservoir 1504. Each of the plurality of channel segments 1502 may be in fluid communication with the reservoir 1504.
  • the channel structure 1500 can comprise a plurality of channel junctions 1506 between the plurality of channel segments 1502 and the reservoir 1504. Each channel junction can be a point of droplet generation.
  • the channel segment 1402 from the channel structure 1400 in FIG. 14 and any description to the components thereof may correspond to a given channel segment of the plurality of channel segments 1502 in channel structure 1500 and any description to the corresponding components thereof.
  • the reservoir 1404 from the channel structure 1400 and any description to the components thereof may correspond to the reservoir 1504 from the channel structure 1500 and any description to the corresponding components thereof.
  • Each channel segment of the plurality of channel segments 1502 may comprise an aqueous fluid 1508 that includes suspended beads 1512.
  • the reservoir 1504 may comprise a second fluid 1510 that is immiscible with the aqueous fluid 1508.
  • the second fluid 1510 may not be subjected to and/or directed to any flow in or out of the reservoir 1504.
  • the second fluid 1510 may be substantially stationary in the reservoir 1504.
  • the second fluid 1510 may be subjected to flow within the reservoir 1504, but not in or out of the reservoir 1504, such as via application of pressure to the reservoir 1504 and/or as affected by the incoming flow of the aqueous fluid 1508 at the junctions.
  • the second fluid 1510 may be subjected and/or directed to flow in or out of the reservoir 1504.
  • the reservoir 1504 can be a channel directing the second fluid 1510 from upstream to downstream, transporting the generated droplets.
  • the aqueous fluid 1508 that includes suspended beads 1512 may be transported along the plurality of channel segments 1502 into the plurality of junctions 1506 to meet the second fluid 1510 in the reservoir 1504 to create droplets 1516, 1518.
  • a droplet may form from each channel segment at each corresponding junction with the reservoir 1504.
  • droplets can form based on factors such as the hydrodynamic forces at the junction, flow rates of the two fluids 1508, 1510, fluid properties, and certain geometric parameters (e.g., w, h 0 , ⁇ , etc.) of the channel structure 1500, as described elsewhere herein.
  • a plurality of droplets can be collected in the reservoir 1504 by continuously injecting the aqueous fluid 1508 from the plurality of channel segments 1502 through the plurality of junctions 1506.
  • Throughput may significantly increase with the parallel channel configuration of channel structure 1500.
  • a channel structure having five inlet channel segments comprising the aqueous fluid 1508 may generate droplets five times as frequently than a channel structure having one inlet channel segment, provided that the fluid flow rate in the channel segments are substantially the same.
  • the fluid flow rate in the different inlet channel segments may or may not be substantially the same.
  • a channel structure may have as many parallel channel segments as is practical and allowed for the size of the reservoir.
  • the channel structure may have at least about 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500, 600, 700, 800, 900, 1000, 1500, 5000 or more parallel or substantially parallel channel segments.
  • the geometric parameters, w, h 0 , and ⁇ may or may not be uniform for each of the channel segments in the plurality of channel segments 1502.
  • each channel segment may have the same or different widths at or near its respective channel junction with the reservoir 1504.
  • each channel segment may have the same or different height at or near its respective channel junction with the reservoir 1504.
  • the reservoir 1504 may have the same or different expansion angle at the different channel junctions with the plurality of channel segments 1502.
  • At least about 50% of the droplets generated can have uniform size. In some instances, at least about 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of the droplets generated can have uniform size. Alternatively, less than about 50% of the droplets generated can have uniform size.
  • FIG. 16 shows another example of a microfluidic channel structure for increased droplet generation throughput.
  • a microfluidic channel structure 1600 can comprise a plurality of channel segments 1602 arranged generally circularly around the perimeter of a reservoir 1604. Each of the plurality of channel segments 1602 may be in fluid communication with the reservoir 1604.
  • the channel structure 1600 can comprise a plurality of channel junctions 1606 between the plurality of channel segments 1602 and the reservoir 1604. Each channel junction can be a point of droplet generation.
  • the channel segment 1402 from the channel structure 1400 in FIG. 14 and any description to the components thereof may correspond to a given channel segment of the plurality of channel segments 1602 in channel structure 1600 and any description to the corresponding components thereof.
  • the reservoir 1404 from the channel structure 1400 and any description to the components thereof may correspond to the reservoir 1604 from the channel structure 1600 and any description to the corresponding components thereof.
  • Each channel segment of the plurality of channel segments 1602 may comprise an aqueous fluid 1608 that includes suspended beads 1612.
  • the reservoir 1604 may comprise a second fluid 1610 that is immiscible with the aqueous fluid 1608.
  • the second fluid 1610 may not be subjected to and/or directed to any flow in or out of the reservoir 1604.
  • the second fluid 1610 may be substantially stationary in the reservoir 1604.
  • the second fluid 1610 may be subjected to flow within the reservoir 1604, but not in or out of the reservoir 1604, such as via application of pressure to the reservoir 1604 and/or as affected by the incoming flow of the aqueous fluid 1608 at the junctions.
  • the second fluid 1610 may be subjected and/or directed to flow in or out of the reservoir 1604.
  • the reservoir 1604 can be a channel directing the second fluid 1610 from upstream to downstream, transporting the generated droplets.
  • the aqueous fluid 1608 that includes suspended beads 1612 may be transported along the plurality of channel segments 1602 into the plurality of junctions 1606 to meet the second fluid 1610 in the reservoir 1604 to create a plurality of droplets 1616.
  • a droplet may form from each channel segment at each corresponding junction with the reservoir 1604.
  • droplets can form based on factors such as the hydrodynamic forces at the junction, flow rates of the two fluids 1608, 1610, fluid properties, and certain geometric parameters (e.g., widths and heights of the channel segments 1602, expansion angle of the reservoir 1604, etc.) of the channel structure 1600, as described elsewhere herein.
  • a plurality of droplets can be collected in the reservoir 1604 by continuously injecting the aqueous fluid 1608 from the plurality of channel segments 1602 through the plurality of junctions 1606.
  • Throughput may significantly increase with the substantially parallel channel configuration of the channel structure 1600.
  • a channel structure may have as many substantially parallel channel segments as is practical and allowed for by the size of the reservoir.
  • the channel structure may have at least about 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500, 600, 700, 800, 900, 1000, 1500, 5000 or more parallel or substantially parallel channel segments.
  • the plurality of channel segments may be substantially evenly spaced apart, for example, around an edge or perimeter of the reservoir. Alternatively, the spacing of the plurality of channel segments may be uneven.
  • the reservoir 1604 may have an expansion angle, ⁇ (not shown in FIG. 16 ) at or near each channel junction.
  • Each channel segment of the plurality of channel segments 1602 may have a width, w , and a height, h 0 , at or near the channel junction.
  • the geometric parameters, w, h 0 , and ⁇ may or may not be uniform for each of the channel segments in the plurality of channel segments 1602.
  • each channel segment may have the same or different widths at or near its respective channel junction with the reservoir 1604.
  • each channel segment may have the same or different height at or near its respective channel junction with the reservoir 1604.
  • the reservoir 1604 may have the same or different expansion angle at the different channel junctions with the plurality of channel segments 1602.
  • a circular reservoir (as shown in FIG. 16 ) may have a conical, dome-like, or hemispherical ceiling (e.g., top wall) to provide the same or substantially same expansion angle for each channel segments 1602 at or near the plurality of channel junctions 1606.
  • the geometric parameters are uniform, beneficially, resulting droplet size may be controlled to be uniform even with the increased throughput.
  • the geometric parameters for the plurality of channel segments 1602 may be varied accordingly.
  • At least about 50% of the droplets generated can have uniform size. In some instances, at least about 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of the droplets generated can have uniform size. Alternatively, less than about 50% of the droplets generated can have uniform size.
  • the beads and/or biological particle injected into the droplets may or may not have uniform size.
  • FIG. 17A shows a cross-section view of another example of a microfluidic channel structure with a geometric feature for controlled partitioning.
  • a channel structure 1700 can include a channel segment 1702 communicating at a channel junction 1706 (or intersection) with a reservoir 1704.
  • the channel structure 1700 and one or more of its components can correspond to any other channel structure described herein and one or more of its components.
  • FIG. 17B shows a perspective view of the channel structure 1700 of FIG. 17A .
  • An aqueous fluid 1712 comprising a plurality of particles 1716 may be transported along the channel segment 1702 into the junction 1706 to meet a second fluid 1714 (e.g., oil, etc.) that is immiscible with the aqueous fluid 1712 in the reservoir 1704 to create droplets 720 of the aqueous fluid 1712 flowing into the reservoir 1704.
  • a second fluid 1714 e.g., oil, etc.
  • droplets can form based on factors such as the hydrodynamic forces at the junction 1706, relative flow rates of the two fluids 1712, 1714, fluid properties, and certain geometric parameters (e.g., ⁇ h, etc.) of the channel structure 1700.
  • a plurality of droplets can be collected in the reservoir 1704 by continuously injecting the aqueous fluid 1712 from the channel segment 1702 at the junction 1706.
  • a discrete droplet generated may comprise one or more particles of the plurality of particles 1716.
  • a particle may be any particle, such as a bead, cell bead, gel bead, biological particle, macromolecular constituents of biological particle, or other particles.
  • a discrete droplet generated may not include any particles.
  • the aqueous fluid 1712 can have a substantially uniform concentration or frequency of particles 1716.
  • the particles 1716 e.g., beads
  • the frequency of particles 1716 in the channel segment 1702 may be controlled by controlling the frequency in which the particles 1716 are introduced into the channel segment 1702 and/or the relative flow rates of the fluids in the channel segment 1702 and the separate channel.
  • the particles 1716 can be introduced into the channel segment 1702 from a plurality of different channels, and the frequency controlled accordingly.
  • different particles may be introduced via separate channels.
  • a first separate channel can introduce beads and a second separate channel can introduce biological particles into the channel segment 1702.
  • the first separate channel introducing the beads may be upstream or downstream of the second separate channel introducing the biological particles.
  • the second fluid 1714 may not be subjected to and/or directed to any flow in or out of the reservoir 1704.
  • the second fluid 1714 may be substantially stationary in the reservoir 1704.
  • the second fluid 1714 may be subjected to flow within the reservoir 1704, but not in or out of the reservoir 1704, such as via application of pressure to the reservoir 1704 and/or as affected by the incoming flow of the aqueous fluid 1712 at the junction 1706.
  • the second fluid 1714 may be subjected and/or directed to flow in or out of the reservoir 1704.
  • the reservoir 1704 can be a channel directing the second fluid 1714 from upstream to downstream, transporting the generated droplets.
  • the channel structure 1700 at or near the junction 1706 may have certain geometric features that at least partly determine the sizes and/or shapes of the droplets formed by the channel structure 1700.
  • the channel segment 1702 can have a first cross-section height, h 1
  • the reservoir 1704 can have a second cross-section height, h 2 .
  • the first cross-section height, h 1 , and the second cross-section height, h 2 may be different, such that at the junction 1706, there is a height difference of ⁇ h.
  • the second cross-section height, h 2 may be greater than the first cross-section height, h 1 .
  • the reservoir may thereafter gradually increase in cross-section height, for example, the more distant it is from the junction 1706.
  • the cross-section height of the reservoir may increase in accordance with expansion angle, ⁇ , at or near the junction 1706.
  • the height difference, ⁇ h, and/or expansion angle, ⁇ can allow the tongue (portion of the aqueous fluid 1712 leaving channel segment 1702 at junction 1706 and entering the reservoir 1704 before droplet formation) to increase in depth and facilitate decrease in curvature of the intermediately formed droplet.
  • droplet size may decrease with increasing height difference and/or increasing expansion angle.
  • the height difference, ⁇ h can be at least about 1 ⁇ m.
  • the height difference can be at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 200, 300, 400, 500 ⁇ m or more.
  • the height difference can be at most about 500, 400, 300, 200, 100, 90, 80, 70, 60, 50, 45, 40, 35, 30, 25, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1 ⁇ m or less.
  • the expansion angle, ⁇ may be between a range of from about 0.5° to about 4°, from about 0.1° to about 10°, or from about 0° to about 90°.
  • the expansion angle can be at least about 0.01°, 0.1°, 0.2°, 0.3°, 0.4°, 0.5°, 0.6°, 0.7°, 0.8°, 0.9°, 1°, 2°, 3°, 4°, 5°, 6°, 7°, 8°, 9°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, or higher.
  • the expansion angle can be at most about 89°, 88°, 87°, 86°, 85°, 84°, 83°, 82°, 81°, 80°, 75°, 70°, 65°, 60°, 55°, 50°, 45°, 40°, 35°, 30°, 25°, 20°, 15°, 10°, 9°, 8°, 7°, 6°, 5°, 4°, 3°, 2°, 1°, 0.1°, 0.01°, or less.
  • the flow rate of the aqueous fluid 1712 entering the junction 1706 can be between about 0.04 microliters ( ⁇ L)/minute (min) and about 40 ⁇ L/min. In some instances, the flow rate of the aqueous fluid 1712 entering the junction 1706 can be between about 0.01 microliters ( ⁇ L)/minute (min) and about 100 ⁇ L/min. Alternatively, the flow rate of the aqueous fluid 1712 entering the junction 1706 can be less than about 0.01 ⁇ L/min.
  • the flow rate of the aqueous fluid 1712 entering the junction 1706 can be greater than about 40 ⁇ L/min, such as 45 ⁇ L/min, 50 ⁇ L/min, 55 ⁇ L/min, 60 ⁇ L/min, 65 ⁇ L/min, 70 ⁇ L/min, 75 ⁇ L/min, 80 ⁇ L/min, 85 ⁇ L/min, 90 ⁇ L/min, 95 ⁇ L/min, 100 ⁇ L/min, 110 ⁇ L/min , 120 ⁇ L/min , 130 ⁇ L/min , 140 ⁇ L/min , 150 ⁇ L/min, or greater.
  • the droplet radius may not be dependent on the flow rate of the aqueous fluid 1712 entering the junction 1706.
  • the second fluid 1714 may be stationary, or substantially stationary, in the reservoir 1704. Alternatively, the second fluid 1714 may be flowing, such as at the above flow rates described for the aqueous fluid 1712.
  • At least about 50% of the droplets generated can have uniform size. In some instances, at least about 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or greater of the droplets generated can have uniform size. Alternatively, less than about 50% of the droplets generated can have uniform size.
  • FIGs. 7A and 7B illustrate the height difference, ⁇ h, being abrupt at the junction 1706 (e.g., a step increase)
  • the height difference may increase gradually (e.g., from about 0 ⁇ m to a maximum height difference).
  • the height difference may decrease gradually (e.g., taper) from a maximum height difference.
  • a gradual increase or decrease in height difference may refer to a continuous incremental increase or decrease in height difference, wherein an angle between any one differential segment of a height profile and an immediately adjacent differential segment of the height profile is greater than 90°.
  • a bottom wall of the channel and a bottom wall of the reservoir can meet at an angle greater than 90°.
  • a top wall (e.g., ceiling) of the channel and a top wall (e.g., ceiling) of the reservoir can meet an angle greater than 90°.
  • a gradual increase or decrease may be linear or non-linear (e.g., exponential, sinusoidal, etc.).
  • the height difference may variably increase and/or decrease linearly or non-linearly. While FIGs. 7A and 7B illustrate the expanding reservoir cross-section height as linear (e.g., constant expansion angle, ⁇ ), the cross-section height may expand non-linearly.
  • the reservoir may be defined at least partially by a dome-like (e.g., hemispherical) shape having variable expansion angles.
  • the cross-section height may expand in any shape.
  • the channel networks can be fluidly coupled to appropriate fluidic components.
  • the inlet channel segments are fluidly coupled to appropriate sources of the materials they are to deliver to a channel junction.
  • These sources may include any of a variety of different fluidic components, from simple reservoirs defined in or connected to a body structure of a microfluidic device, to fluid conduits that deliver fluids from off-device sources, manifolds, fluid flow units (e.g., actuators, pumps, compressors) or the like.
  • the outlet channel segment e.g., channel segment 1208, reservoir 1604, etc.
  • this may be a reservoir defined in the body of a microfluidic device, or it may be a fluidic conduit for delivering the partitioned cells to a subsequent process operation, instrument or component.
  • the methods and systems described herein may be used to greatly increase the efficiency of single cell applications and/or other applications receiving droplet-based input.
  • subsequent operations that can be performed can include generation of amplification products, purification (e.g., via solid phase reversible immobilization (SPRI)), further processing (e.g., shearing, ligation of functional sequences, and subsequent amplification (e.g., via PCR)).
  • SPRI solid phase reversible immobilization
  • further processing e.g., shearing, ligation of functional sequences
  • subsequent amplification e.g., via PCR
  • Additional reagents that may be co-partitioned along with the barcode bearing bead may include oligonucleotides to block ribosomal RNA (rRNA) and nucleases to digest genomic DNA from cells. Alternatively, rRNA removal agents may be applied during additional processing operations.
  • the configuration of the constructs generated by such a method can help minimize (or avoid) sequencing of the poly-T sequence during sequencing and/or sequence the 5' end of a polynucleotide sequence.
  • the amplification products for example, first amplification products and/or second amplification products, may be subject to sequencing for sequence analysis. In some cases, amplification may be performed using the Partial Hairpin Amplification for Sequencing (PHASE) method.
  • a variety of applications require the evaluation of the presence and quantification of different biological particle or organism types within a population of biological particles, including, for example, microbiome analysis and characterization, environmental testing, food safety testing, epidemiological analysis, e.g., in tracing contamination or the like.
  • FIG. 18 shows a computer system 1801 that is programmed or otherwise configured to (i) sort occupied droplets from unoccupied droplets by including field-attractable particles in each droplet and applying a force field, (ii) sort occupied droplets from unoccupied droplets by applying a pressure pulse, (iii) sort occupied particles (e.g., cell beads) from unoccupied particles using field-attractable particles by applying a force field, (iv) sort occupied particles (e.g., cell beads) from unoccupied particles by applying a pressure pulse, (v) selectively polymerize occupied droplets, and/or (vi) selectively polymerize appropriately sized droplets.
  • sort occupied droplets from unoccupied droplets by including field-attractable particles in each droplet and applying a force field
  • sort occupied droplets from unoccupied droplets by applying a pressure pulse
  • sort occupied particles e.g., cell beads
  • sort occupied particles e.g., cell beads
  • the computer system 1801 can regulate various aspects of the present disclosure, such as, for example, the timed exposure of the single biological particle to a variety of chemical or biological operations, regulating fluid flow rate in one or more channels in a microfluidic structure, regulating field strength applied by one or more field application units, regulating pressure pulses applied by one or more pressure application units, and/or regulating timing of polymerization application units.
  • the computer system 1801 can be an electronic device of a user or a computer system that is remotely located with respect to the electronic device.
  • the electronic device can be a mobile electronic device.
  • the computer system 1801 includes a central processing unit (CPU, also "processor” and “computer processor” herein) 1805, which can be a single core or multi core processor, or a plurality of processors for parallel processing.
  • the computer system 1801 also includes memory or memory location 1810 (e.g., random-access memory, read-only memory, flash memory), electronic storage unit 1815 (e.g., hard disk), communication interface 1820 (e.g., network adapter) for communicating with one or more other systems, and peripheral devices 1825, such as cache, other memory, data storage and/or electronic display adapters.
  • the memory 1810, storage unit 1815, interface 1820 and peripheral devices 1825 are in communication with the CPU 1805 through a communication bus (solid lines), such as a motherboard.
  • the storage unit 1815 can be a data storage unit (or data repository) for storing data.
  • the computer system 1801 can be operatively coupled to a computer network ("network") 1830 with the aid of the communication interface 1820.
  • the network 1830 can be the Internet, an internet and/or extranet, or an intranet and/or extranet that is in communication with the Internet.
  • the network 1830 in some cases is a telecommunication and/or data network.
  • the network 1830 can include one or more computer servers, which can enable distributed computing, such as cloud computing.
  • the network 1830, in some cases with the aid of the computer system 1801, can implement a peer-to-peer network, which may enable devices coupled to the computer system 1801 to behave as a client or a server.
  • the CPU 1805 can execute a sequence of machine-readable instructions, which can be embodied in a program or software.
  • the instructions may be stored in a memory location, such as the memory 1810.
  • the instructions can be directed to the CPU 1805, which can subsequently program or otherwise configure the CPU 1805 to implement methods of the present disclosure. Examples of operations performed by the CPU 1805 can include fetch, decode, execute, and writeback.
  • the CPU 1805 can be part of a circuit, such as an integrated circuit.
  • a circuit such as an integrated circuit.
  • One or more other components of the system 1801 can be included in the circuit.
  • the circuit is an application specific integrated circuit (ASIC).
  • the storage unit 1815 can store files, such as drivers, libraries and saved programs.
  • the storage unit 1815 can store user data, e.g., user preferences and user programs.
  • the computer system 1801 in some cases can include one or more additional data storage units that are external to the computer system 1801, such as located on a remote server that is in communication with the computer system 1801 through an intranet or the Internet.
  • the computer system 1801 can communicate with one or more remote computer systems through the network 1830.
  • the computer system 1801 can communicate with a remote computer system of a user (e.g., operator).
  • remote computer systems include personal computers (e.g., portable PC), slate or tablet PC's (e.g., Apple ® iPad, Samsung ® Galaxy Tab), telephones, Smart phones (e.g., Apple ® iPhone, Android-enabled device, Blackberry ® ), or personal digital assistants.
  • the user can access the computer system 1801 via the network 1830.
  • Methods as described herein can be implemented by way of machine (e.g., computer processor) executable code stored on an electronic storage location of the computer system 1801, such as, for example, on the memory 1810 or electronic storage unit 1815.
  • the machine executable or machine readable code can be provided in the form of software.
  • the code can be executed by the processor 1805.
  • the code can be retrieved from the storage unit 1815 and stored on the memory 1810 for ready access by the processor 1805.
  • the electronic storage unit 1815 can be precluded, and machine-executable instructions are stored on memory 1810.
  • the code can be pre-compiled and configured for use with a machine having a processor adapted to execute the code, or can be compiled during runtime.
  • the code can be supplied in a programming language that can be selected to enable the code to execute in a pre-compiled or as-compiled fashion.
  • the computer system 1801 disclosed herein can be embodied in programming.
  • Various aspects of the technology may be thought of as “products” or “articles of manufacture” typically in the form of machine (or processor) executable code and/or associated data that is carried on or embodied in a type of machine readable medium.
  • Machine-executable code can be stored on an electronic storage unit, such as memory (e.g., read-only memory, random-access memory, flash memory) or a hard disk.
  • "Storage” type media can include any or all of the tangible memory of the computers, processors or the like, or associated modules thereof, such as various semiconductor memories, tape drives, disk drives and the like, which may provide non-transitory storage at any time for the software programming.
  • All or portions of the software may at times be communicated through the Internet or various other telecommunication networks. Such communications, for example, may enable loading of the software from one computer or processor into another, for example, from a management server or host computer into the computer platform of an application server.
  • another type of media that may bear the software elements includes optical, electrical and electromagnetic waves, such as used across physical interfaces between local devices, through wired and optical landline networks and over various air-links.
  • the physical elements that carry such waves, such as wired or wireless links, optical links or the like, also may be considered as media bearing the software.
  • terms such as computer or machine "readable medium” refer to any medium that participates in providing instructions to a processor for execution.
  • a machine readable medium such as computer-executable code
  • a tangible storage medium such as computer-executable code
  • Non-volatile storage media include, for example, optical or magnetic disks, such as any of the storage devices in any computer(s) or the like, such as may be used to implement the databases, etc. shown in the drawings.
  • Volatile storage media include dynamic memory, such as main memory of such a computer platform.
  • Tangible transmission media include coaxial cables; copper wire and fiber optics, including the wires that comprise a bus within a computer system.
  • Carrier-wave transmission media may take the form of electric or electromagnetic signals, or acoustic or light waves such as those generated during radio frequency (RF) and infrared (IR) data communications.
  • RF radio frequency
  • IR infrared
  • Common forms of computer-readable media therefore include for example: a floppy disk, a flexible disk, hard disk, magnetic tape, any other magnetic medium, a CD-ROM, DVD or DVD-ROM, any other optical medium, punch cards paper tape, any other physical storage medium with patterns of holes, a RAM, a ROM, a PROM and EPROM, a FLASH-EPROM, any other memory chip or cartridge, a carrier wave transporting data or instructions, cables or links transporting such a carrier wave, or any other medium from which a computer may read programming code and/or data.
  • Many of these forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to a processor for execution.
  • the computer system 1801 can include or be in communication with an electronic display 1835 that comprises a user interface (UI) 1840 for providing, for example, fluid control options (e.g., fluid flow rate, timing of applying polymerization source (e.g., light), strength of magnetic of electric force field, strength and/or frequency of pressure pulses, etc.).
  • UI user interface
  • fluid control options e.g., fluid flow rate, timing of applying polymerization source (e.g., light), strength of magnetic of electric force field, strength and/or frequency of pressure pulses, etc.
  • GUI graphical user interface
  • web-based user interface graphical user interface
  • An algorithm can be implemented by way of software upon execution by the central processing unit 1805.
  • the algorithm can, for example, (i) sort occupied droplets from unoccupied droplets by including field-attractable particles in each droplet and applying a force field, (ii) sort occupied droplets from unoccupied droplets by applying a pressure pulse, (iii) sort occupied particles (e.g., cell beads) from unoccupied particles using field-attractable particles by applying a force field, (iv) sort occupied particles (e.g., cell beads) from unoccupied particles by applying a pressure pulse, (v) selectively polymerize occupied droplets, and/or (vi) selectively polymerize appropriately sized droplets.
  • the algorithm can also, for example, generate a plurality of droplets that may or may not contain biological particles (cells) and/or barcode carrying beads (particles).

Claims (14)

  1. Procédé de tri de gouttelettes, comprenant les étapes consistant à :
    (a) amener une première phase en contact avec une seconde phase pour générer une pluralité de gouttelettes, dans lequel ladite première phase et ladite seconde phase ne sont pas miscibles, dans lequel la pluralité de gouttelettes comprend des particules pouvant être attirées par un champ et dans lequel la pluralité de gouttelettes comprend (i) un premier sous-ensemble de gouttelettes incluant chacune une particule biologique et pas plus, et (ii) un second sous-ensemble de gouttelettes incluant chacune plus d'une particule biologique, dans lequel la particule biologique est une cellule, un dérivé d'une cellule, ou un constituant d'une cellule ;
    (b) diriger la pluralité de gouttelettes le long d'un premier canal vers une intersection du premier canal avec un deuxième canal et un troisième canal ; et
    (c) soumettre la pluralité de gouttelettes comprenant les particules pouvant être attirées par un champ à un champ électrique ou magnétique dans des conditions suffisantes pour séparer tout ou partie du premier sous-ensemble de la pluralité de gouttelettes de tout ou partie du second sous-ensemble de la pluralité de gouttelettes, dans lequel lors de la séparation, tout ou partie du premier sous-ensemble de la pluralité de gouttelettes s'écoule le long du deuxième canal et tout ou partie du second sous-ensemble de la pluralité de gouttelettes s'écoule le long du troisième canal.
  2. Procédé selon la revendication 1, dans lequel le premier sous-ensemble de la pluralité de gouttelettes inclut des particules auxquelles sont couplées des molécules comprenant des séquences de codes-barres.
  3. Procédé selon la revendication 2, dans lequel les particules sont des billes de gel.
  4. Procédé selon l'une quelconque des revendications 1 à 3, comprenant en outre la détection de gouttelettes individuelles du premier sous-ensemble de la pluralité de gouttelettes, et la soumission des gouttelettes individuelles à un stimulus pour faciliter une polymérisation lors de la détection des gouttelettes individuelles.
  5. Procédé selon la revendication 4, dans lequel le stimulus est appliqué avant l'intersection.
  6. Procédé selon la revendication 4, dans lequel le stimulus est appliqué après l'intersection.
  7. Procédé selon la revendication 4, dans lequel le stimulus est un stimulus optique ou un stimulus chimique.
  8. Procédé selon l'une quelconque des revendications 1 à 7, dans lequel les particules biologiques sont des cellules enfermées dans ou comprenant une matrice de gel ou polymère.
  9. Procédé selon la revendication 1, dans lequel chaque gouttelette du premier sous-ensemble de la pluralité de gouttelettes comprend plus de particules pouvant être attirées par un champ que chaque gouttelette du second sous-ensemble de la pluralité de gouttelettes incluant plus d'une particule biologique.
  10. Procédé selon la revendication 9, dans lequel des forces induites sur le premier sous-ensemble sont supérieures à des forces induites sur des gouttelettes du second sous-ensemble incluant plus d'une particule biologique.
  11. Procédé selon la revendication 1, 9 ou 10, dans lequel les particules pouvant être attirées par un champ sont des particules pouvant être attirées par un champ magnétique.
  12. Procédé selon la revendication 1, 9 ou 10, dans lequel les conditions du champ électrique ou magnétique suffisantes pour séparer tout ou partie du premier sous-ensemble et tout ou partie du second sous-ensemble sont déterminées sur la base au moins en partie d'un rapport entre des tailles de la pluralité de gouttelettes et des tailles des particules biologiques dans le premier sous-ensemble de la pluralité de gouttelettes.
  13. Procédé selon l'une quelconque des revendications 1 à 12, comprenant en outre, à la suite de (c), la soumission de molécules d'acide nucléique dérivées des particules biologiques dans le premier sous-ensemble à un séquençage d'acide nucléique.
  14. Procédé selon la revendication 13, comprenant en outre, à la suite de (c), la soumission du premier sous-ensemble de la pluralité de gouttelettes à des conditions suffisantes pour produire des produits d'extension des molécules d'acide nucléique à partir des particules biologiques dans le premier sous-ensemble, et la soumission des produits d'extension ou dérivés de ceux-ci à un séquençage d'acide nucléique.
EP18802877.3A 2017-05-18 2018-05-17 Méthodes et systèmes de tri de gouttelettes et de billes Active EP3625353B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP22209419.5A EP4215616A1 (fr) 2017-05-18 2018-05-17 Procédés et systèmes de tri de gouttelettes et de billes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762508219P 2017-05-18 2017-05-18
PCT/US2018/033280 WO2018213643A1 (fr) 2017-05-18 2018-05-17 Méthodes et systèmes de tri de gouttelettes et de billes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP22209419.5A Division EP4215616A1 (fr) 2017-05-18 2018-05-17 Procédés et systèmes de tri de gouttelettes et de billes

Publications (3)

Publication Number Publication Date
EP3625353A1 EP3625353A1 (fr) 2020-03-25
EP3625353A4 EP3625353A4 (fr) 2021-04-14
EP3625353B1 true EP3625353B1 (fr) 2022-11-30

Family

ID=64274878

Family Applications (2)

Application Number Title Priority Date Filing Date
EP22209419.5A Pending EP4215616A1 (fr) 2017-05-18 2018-05-17 Procédés et systèmes de tri de gouttelettes et de billes
EP18802877.3A Active EP3625353B1 (fr) 2017-05-18 2018-05-17 Méthodes et systèmes de tri de gouttelettes et de billes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP22209419.5A Pending EP4215616A1 (fr) 2017-05-18 2018-05-17 Procédés et systèmes de tri de gouttelettes et de billes

Country Status (4)

Country Link
US (2) US11660601B2 (fr)
EP (2) EP4215616A1 (fr)
CN (2) CN110945139B (fr)
WO (1) WO2018213643A1 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9388465B2 (en) 2013-02-08 2016-07-12 10X Genomics, Inc. Polynucleotide barcode generation
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10584381B2 (en) 2012-08-14 2020-03-10 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
CN113249435A (zh) 2014-06-26 2021-08-13 10X基因组学有限公司 分析来自单个细胞或细胞群体的核酸的方法
AU2016207023B2 (en) 2015-01-12 2019-12-05 10X Genomics, Inc. Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same
US11371094B2 (en) 2015-11-19 2022-06-28 10X Genomics, Inc. Systems and methods for nucleic acid processing using degenerate nucleotides
JP6735348B2 (ja) 2016-02-11 2020-08-05 １０エックス ジェノミクス， インコーポレイテッド 全ゲノム配列データのデノボアセンブリのためのシステム、方法及び媒体
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
CN117512066A (zh) 2017-01-30 2024-02-06 10X基因组学有限公司 用于基于微滴的单细胞条形编码的方法和系统
US10995333B2 (en) 2017-02-06 2021-05-04 10X Genomics, Inc. Systems and methods for nucleic acid preparation
EP4215616A1 (fr) 2017-05-18 2023-07-26 10X Genomics, Inc. Procédés et systèmes de tri de gouttelettes et de billes
US10544413B2 (en) 2017-05-18 2020-01-28 10X Genomics, Inc. Methods and systems for sorting droplets and beads
US10357771B2 (en) 2017-08-22 2019-07-23 10X Genomics, Inc. Method of producing emulsions
US10590244B2 (en) 2017-10-04 2020-03-17 10X Genomics, Inc. Compositions, methods, and systems for bead formation using improved polymers
US10837047B2 (en) 2017-10-04 2020-11-17 10X Genomics, Inc. Compositions, methods, and systems for bead formation using improved polymers
WO2019084043A1 (fr) 2017-10-26 2019-05-02 10X Genomics, Inc. Méthodes et systèmes de préparation d'acide nucléique et d'analyse de chromatine
WO2019083852A1 (fr) 2017-10-26 2019-05-02 10X Genomics, Inc. Réseaux de canaux microfluidiques pour partitionnement
WO2019084165A1 (fr) 2017-10-27 2019-05-02 10X Genomics, Inc. Procédés et systèmes de préparation et d'analyse d'échantillons
SG11201913654QA (en) 2017-11-15 2020-01-30 10X Genomics Inc Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019108851A1 (fr) 2017-11-30 2019-06-06 10X Genomics, Inc. Systèmes et procédés de préparation et d'analyse d'acides nucléiques
CN112005115A (zh) 2018-02-12 2020-11-27 10X基因组学有限公司 表征来自单个细胞或细胞群体的多种分析物的方法
US11639928B2 (en) 2018-02-22 2023-05-02 10X Genomics, Inc. Methods and systems for characterizing analytes from individual cells or cell populations
EP3775271A1 (fr) 2018-04-06 2021-02-17 10X Genomics, Inc. Systèmes et procédés de contrôle de qualité dans un traitement de cellules uniques
US11932899B2 (en) 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
FR3082440B1 (fr) * 2018-06-14 2020-12-11 Paris Sciences Lettres Quartier Latin Methode de transfert de matiere dans un dispositif microfluidique ou millifluidique
US11703427B2 (en) 2018-06-25 2023-07-18 10X Genomics, Inc. Methods and systems for cell and bead processing
US20200032335A1 (en) 2018-07-27 2020-01-30 10X Genomics, Inc. Systems and methods for metabolome analysis
US11459607B1 (en) 2018-12-10 2022-10-04 10X Genomics, Inc. Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes
US11845983B1 (en) 2019-01-09 2023-12-19 10X Genomics, Inc. Methods and systems for multiplexing of droplet based assays
US11467153B2 (en) 2019-02-12 2022-10-11 10X Genomics, Inc. Methods for processing nucleic acid molecules
US11851683B1 (en) 2019-02-12 2023-12-26 10X Genomics, Inc. Methods and systems for selective analysis of cellular samples
SG11202108788TA (en) 2019-02-12 2021-09-29 10X Genomics Inc Methods for processing nucleic acid molecules
US11655499B1 (en) 2019-02-25 2023-05-23 10X Genomics, Inc. Detection of sequence elements in nucleic acid molecules
WO2020185791A1 (fr) 2019-03-11 2020-09-17 10X Genomics, Inc. Systèmes et procédés de traitement de billes marquées optiquement
CN110302849B (zh) * 2019-05-31 2021-04-30 昆明理工大学 一种基于介电电泳原理分选液滴的微流控装置及方法
US11857981B2 (en) 2019-12-23 2024-01-02 10X Genomics, Inc. Magnetic separator for an automated single cell sequencing system
WO2021112841A1 (fr) * 2019-12-04 2021-06-10 Hewlett-Packard Development Company, L.P. Tri d'une gouttelette comprenant un échantillon biologique
US11701668B1 (en) 2020-05-08 2023-07-18 10X Genomics, Inc. Methods and devices for magnetic separation
US11851700B1 (en) 2020-05-13 2023-12-26 10X Genomics, Inc. Methods, kits, and compositions for processing extracellular molecules
US11946038B1 (en) 2020-05-29 2024-04-02 10X Genomics, Inc. Methods and systems including flow and magnetic modules
EP4298244A1 (fr) 2021-02-23 2024-01-03 10X Genomics, Inc. Analyse à base de sonde d'acides nucléiques et de protéines
CN113604344B (zh) * 2021-08-11 2024-03-22 北京慧智医疗器械有限公司 一种高通量一体式微液滴数字pcr的实现系统
WO2023076528A2 (fr) * 2021-10-28 2023-05-04 10X Genomics, Inc. Méthodes de préparation d'échantillons
CN117089458A (zh) * 2023-10-19 2023-11-21 南京溯远基因科技有限公司 一种自动化细胞培养、基因编辑、细胞分选和分装的装置及方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3605109A1 (fr) * 2017-03-24 2020-02-05 Enplas Corporation Dispositif, procédé et système de manipulation de liquide

Family Cites Families (250)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2097692B (en) 1981-01-10 1985-05-22 Shaw Stewart P D Combining chemical reagents
US6176962B1 (en) 1990-02-28 2001-01-23 Aclara Biosciences, Inc. Methods for fabricating enclosed microchannel structures
US5700692A (en) 1994-09-27 1997-12-23 Becton Dickinson And Company Flow sorter with video-regulated droplet spacing
DE19520298A1 (de) 1995-06-02 1996-12-05 Bayer Ag Sortiervorrichtung für biologische Zellen oder Viren
US6057149A (en) 1995-09-15 2000-05-02 The University Of Michigan Microscale devices and reactions in microscale devices
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
US6281018B1 (en) 1998-02-26 2001-08-28 Coulter International Corp. Selective purification and enrichment sorting of flow cytometer droplets based upon analysis of droplet precursor regions
JP3081880B2 (ja) 1998-03-30 2000-08-28 農林水産省食品総合研究所長 マイクロスフィアの連続製造装置
US6123798A (en) 1998-05-06 2000-09-26 Caliper Technologies Corp. Methods of fabricating polymeric structures incorporating microscale fluidic elements
ATE382858T1 (de) 2000-02-23 2008-01-15 Caliper Life Sciences Inc Mehrfach-reservoir-drucksteuersystem
AU2001290879A1 (en) 2000-09-15 2002-03-26 California Institute Of Technology Microfabricated crossflow devices and methods
EP1322936A2 (fr) 2000-10-03 2003-07-02 California Institute Of Technology Dispositifs microfluidiques et procedes d'utilisation
US20030045005A1 (en) 2000-10-17 2003-03-06 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
US6778724B2 (en) 2000-11-28 2004-08-17 The Regents Of The University Of California Optical switching and sorting of biological samples and microparticles transported in a micro-fluidic device, including integrated bio-chip devices
DE60211857T2 (de) 2001-02-23 2006-12-21 Japan Science And Technology Agency, Kawaguchi Verfahren zur herstellung einer emulsion und vorrichtung dafür
US7452725B2 (en) 2002-01-10 2008-11-18 Board Of Regents, The University Of Texas System Flow sorting system and methods regarding same
US20040109793A1 (en) 2002-02-07 2004-06-10 Mcneely Michael R Three-dimensional microfluidics incorporating passive fluid control structures
JP2004000144A (ja) 2002-03-29 2004-01-08 Aisin Seiki Co Ltd 細胞分離選別装置、細胞整列用基板
US6808075B2 (en) 2002-04-17 2004-10-26 Cytonome, Inc. Method and apparatus for sorting particles
US6877528B2 (en) 2002-04-17 2005-04-12 Cytonome, Inc. Microfluidic system including a bubble valve for regulating fluid flow through a microchannel
US20070065808A1 (en) 2002-04-17 2007-03-22 Cytonome, Inc. Method and apparatus for sorting particles
US9943847B2 (en) 2002-04-17 2018-04-17 Cytonome/St, Llc Microfluidic system including a bubble valve for regulating fluid flow through a microchannel
US6976590B2 (en) 2002-06-24 2005-12-20 Cytonome, Inc. Method and apparatus for sorting particles
JP2006507921A (ja) 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 流体分散のための方法および装置
US6838056B2 (en) 2002-07-08 2005-01-04 Innovative Micro Technology Method and apparatus for sorting biological cells with a MEMS device
US7150834B2 (en) 2003-07-31 2006-12-19 Arryx, Inc. Multiple laminar flow-based rate zonal or isopycnic separation with holographic optical trapping of blood cells and other static components
US7699767B2 (en) 2002-07-31 2010-04-20 Arryx, Inc. Multiple laminar flow-based particle and cellular separation with laser steering
ES2451765T3 (es) 2002-07-31 2014-03-28 Premium Genetics (Uk) Limited Sistema y procedimiento de clasificación de materiales usando orientación holográfica con láser
US20050266582A1 (en) 2002-12-16 2005-12-01 Modlin Douglas N Microfluidic system with integrated permeable membrane
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
EP2308420B1 (fr) 2003-03-28 2016-10-05 Inguran, LLC Système de cytométrie en flux pour fournir du sperme d'animaux triés selon le sexe
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
CA2784762A1 (fr) 2003-04-10 2004-10-28 President And Fellows Of Harvard College Formation et regulation d'especes fluidiques
AU2004242121B2 (en) * 2003-05-15 2010-06-24 Xy, Llc. Efficient haploid cell sorting for flow cytometer systems
WO2005023427A1 (fr) 2003-09-05 2005-03-17 Stokes Bio Limited Systeme d'analyse microfluide
EP1533605A3 (fr) 2003-11-19 2006-05-31 Aisin Seiki Kabushiki Kaisha Microsystème de commande pour le transfert de liquide
ES2432040T3 (es) 2004-01-28 2013-11-29 454 Life Sciences Corporation Amplificación de ácido nucleico con emulsión de flujo continuo
US8741192B2 (en) 2004-03-23 2014-06-03 Japan Science And Technology Agency Method and device for producing micro-droplets
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US20050249636A1 (en) 2004-05-04 2005-11-10 Tacklind Christopher A Bubble valve for sorting of cells and the like
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP2248578B1 (fr) 2005-03-04 2012-06-06 President and Fellows of Harvard College Procédé pour former des émulsions multiples
US7767444B2 (en) 2005-05-31 2010-08-03 Nanyang Technological University Cell analysis using laser with external cavity
DE102005037401B4 (de) 2005-08-08 2007-09-27 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Bildung einer Emulsion in einem fluidischen Mikrosystem
EP2660482B1 (fr) 2005-08-22 2019-08-07 Life Technologies Corporation Appareil, système et procédé utilisant des volumes discrets de fluides non miscibles
US7556776B2 (en) 2005-09-08 2009-07-07 President And Fellows Of Harvard College Microfluidic manipulation of fluids and reactions
CN101310169B (zh) 2005-11-16 2011-06-08 株式会社日立制作所 液滴生成运送方法和装置以及粒子操作装置
JP4713397B2 (ja) 2006-01-18 2011-06-29 株式会社リコー 微小流路構造体及び微小液滴生成システム
US7976795B2 (en) 2006-01-19 2011-07-12 Rheonix, Inc. Microfluidic systems
US9995668B2 (en) * 2006-02-01 2018-06-12 Ecole polytechnique fédérale de Lausanne (EPFL) Apparatus for manipulating, modifying and characterizing particles in a micro channel
US7816121B2 (en) 2006-04-18 2010-10-19 Advanced Liquid Logic, Inc. Droplet actuation system and method
US7901947B2 (en) * 2006-04-18 2011-03-08 Advanced Liquid Logic, Inc. Droplet-based particle sorting
JP2010506136A (ja) 2006-05-11 2010-02-25 レインダンス テクノロジーズ， インコーポレイテッド 微小流体デバイス
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2029781A4 (fr) * 2006-05-26 2010-06-30 Althea Technologies Inc Analyse biochimique de cellules partagées
WO2007150030A2 (fr) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Synthèse microfluidique de nanoparticules organiques
EP3536396B1 (fr) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Tensioactifs fluorocarbonés stabilisateurs d'émulsions
US8524173B2 (en) 2006-09-01 2013-09-03 Tosoh Corporation Microchannel structure and fine-particle production method using the same
US9278321B2 (en) 2006-09-06 2016-03-08 Canon U.S. Life Sciences, Inc. Chip and cartridge design configuration for performing micro-fluidic assays
US20080166720A1 (en) 2006-10-06 2008-07-10 The Regents Of The University Of California Method and apparatus for rapid nucleic acid analysis
US8841116B2 (en) 2006-10-25 2014-09-23 The Regents Of The University Of California Inline-injection microdevice and microfabricated integrated DNA analysis system using same
US8765076B2 (en) 2006-11-14 2014-07-01 Handylab, Inc. Microfluidic valve and method of making same
US20080138876A1 (en) 2006-12-11 2008-06-12 Bio-Rad Laboratories, Inc. Transfection in electronically driven continuous flow
WO2008097559A2 (fr) 2007-02-06 2008-08-14 Brandeis University Manipulation de fluides et de réactions dans des systèmes microfluidiques
WO2008109176A2 (fr) 2007-03-07 2008-09-12 President And Fellows Of Harvard College Dosages et autres réactions comprenant des gouttelettes
EP2136786B8 (fr) 2007-03-28 2012-11-14 President and Fellows of Harvard College Dispositif de formation de gouttelettes
EP2142279A2 (fr) 2007-04-16 2010-01-13 The General Hospital Corporation d/b/a Massachusetts General Hospital Systèmes et procédés de focalisation de particules dans des micro-canaux
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20080295909A1 (en) 2007-05-24 2008-12-04 Locascio Laurie E Microfluidic Device for Passive Sorting and Storage of Liquid Plugs Using Capillary Force
US8476382B2 (en) 2007-06-05 2013-07-02 Eugenia Kumacheva Multiple continuous microfluidic reactors for the scaled up synthesis of gel or polymer particles
WO2009011808A1 (fr) * 2007-07-13 2009-01-22 President And Fellows Of Harvard College Sélection basée sur des gouttelettes
WO2009015296A1 (fr) 2007-07-24 2009-01-29 The Regents Of The University Of California Générateur de gouttelettes microfabriqué
AU2008293652B2 (en) 2007-08-24 2013-02-21 Advanced Liquid Logic, Inc. Bead manipulations on a droplet actuator
US8334013B2 (en) 2007-11-02 2012-12-18 Stc.Unm Mesoporous metal oxide microspheres and method for forming same
CN101946010B (zh) 2007-12-21 2014-08-20 哈佛大学 用于核酸测序的系统和方法
US9011777B2 (en) 2008-03-21 2015-04-21 Lawrence Livermore National Security, Llc Monodisperse microdroplet generation and stopping without coalescence
US8961902B2 (en) 2008-04-23 2015-02-24 Bioscale, Inc. Method and apparatus for analyte processing
KR100942184B1 (ko) 2008-04-25 2010-02-11 한국과학기술연구원 마이크로 캡슐 제조장치 및 방법
JP4572973B2 (ja) 2008-06-16 2010-11-04 ソニー株式会社 マイクロチップ及びマイクロチップにおける送流方法
EP2304020B1 (fr) 2008-06-30 2018-11-07 Microbix Biosystems Inc. Procédé et appareil pour trier des cellules
JP2010038866A (ja) 2008-08-08 2010-02-18 Sony Corp マイクロチップ、微小粒子分取装置及び送流方法
US8387803B2 (en) 2008-08-26 2013-03-05 Ge Healthcare Bio-Sciences Ab Particle sorting
US20140179544A1 (en) 2012-09-07 2014-06-26 Bio-Rad Laboratories, Inc. Compositions, systems and methods for droplet formation, spacing and detection
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US20130084572A1 (en) 2011-09-30 2013-04-04 Quantalife, Inc. Calibrations and controls for droplet-based assays
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US20110159499A1 (en) 2009-11-25 2011-06-30 Quantalife, Inc. Methods and compositions for detecting genetic material
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US20140024023A1 (en) 2012-07-23 2014-01-23 Bio- Rad Laboratories, Inc Droplet generation system with features for sample positioning
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
WO2010042744A1 (fr) 2008-10-08 2010-04-15 Universite De Strasbourg Dispositifs microfluidiques pour une incubation sur puce fiable de gouttelettes dans des lignes de retard
JP5487638B2 (ja) 2009-02-17 2014-05-07 ソニー株式会社 微小粒子分取のための装置及びマイクロチップ
WO2010104597A2 (fr) 2009-03-13 2010-09-16 President And Fellows Of Harvard College Mise à l'échelle de dispositifs microfluidiques
WO2010104604A1 (fr) 2009-03-13 2010-09-16 President And Fellows Of Harvard College Procédé destiné à la création contrôlée d'émulsions, comprenant des émulsions multiples
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2010110843A1 (fr) 2009-03-25 2010-09-30 Eastman Kodak Company Générateur de gouttelettes
WO2010115167A2 (fr) 2009-04-03 2010-10-07 The Regents Of The University Of California Procédés et dispositifs adaptés pour trier des cellules et d'autres particules biologiques
NL2002862C2 (en) 2009-05-08 2010-11-09 Friesland Brands Bv Microfluidic apparatus and method for generating a dispersion.
JP5446563B2 (ja) 2009-08-06 2014-03-19 ソニー株式会社 微小粒子分取装置、および該微小粒子分取装置を用いたフローサイトメーター
EP2467479B1 (fr) 2009-08-20 2016-01-06 Population Genetics Technologies Ltd Compositions et procédés de réarrangement d'acide nucléique intramoléculaire
US20120211084A1 (en) 2009-09-02 2012-08-23 President And Fellows Of Harvard College Multiple emulsions created using jetting and other techniques
JP6155418B2 (ja) 2009-09-02 2017-07-05 バイオ−ラッド・ラボラトリーズ・インコーポレーテッド 多重エマルジョンの合体による、流体を混合するためのシステム
BR112012004715A2 (pt) 2009-09-02 2017-05-23 Basf Se emulsões múltiplas criadas por uso de junções
WO2011042564A1 (fr) 2009-10-09 2011-04-14 Universite De Strasbourg Nanomatériau marqué à base de silice à propriétés améliorées et ses utilisations
CA2778816C (fr) 2009-10-27 2018-07-31 President And Fellows Of Harvard College Techniques de creation de gouttelettes
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US8399198B2 (en) 2010-03-02 2013-03-19 Bio-Rad Laboratories, Inc. Assays with droplets transformed into capsules
US20110223314A1 (en) 2010-03-10 2011-09-15 Xiaoxiao Zhang Efficient microencapsulation
CA2767114A1 (fr) 2010-03-25 2011-09-29 Bio-Rad Laboratories, Inc. Systeme de transport de gouttelettes a des fins de detection
JP2013524171A (ja) 2010-03-25 2013-06-17 クァンタライフ・インコーポレーテッド 液滴ベースのアッセイのための液滴の発生
FR2958186A1 (fr) 2010-03-30 2011-10-07 Ecole Polytech Dispositif de formation de gouttes dans un circuit microfluide.
DE102010032203A1 (de) 2010-07-26 2012-01-26 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren und Vorrichtung zur passiven Trennung und Sortierung von Tropfen, insbesondere in einem mikrofluidischen System, durch Verwendung von nicht-optischen Markern für Reaktionen innerhalb der Tropfen
EP2616551B1 (fr) 2010-09-14 2020-08-19 The Regents of The University of California Procédé pour isoler des cellules d'une solution hétérogène en utilisant des pièges à tourbillon microfluidique
EP3447155A1 (fr) * 2010-09-30 2019-02-27 Raindance Technologies, Inc. Dosages en sandwich dans des gouttelettes
EP2436444A1 (fr) 2010-10-01 2012-04-04 Centre National de la Recherche Scientifique (C.N.R.S.) Dispositif microfluidique pour la production et la collecte de gouttelettes de liquide
US8969071B2 (en) 2010-10-13 2015-03-03 Lawrence Livermore National Security, Llc Passive chip-based droplet sorting
US9090865B2 (en) 2010-10-29 2015-07-28 The Regents Of The University Of California Systems and methods for particle classification and sorting
DE202011110979U1 (de) 2010-11-01 2017-12-04 Bio-Rad Laboratories, Inc. System zum Bilden von Emulsionen
US9394511B2 (en) 2010-12-05 2016-07-19 Wenbin Jiang Rapid single cell based parallel biological cell sorter
US8871500B2 (en) 2011-01-21 2014-10-28 Innovative Micro Technology MEMS particle sorting actuator and method of manufacturing
US8765455B2 (en) * 2011-01-27 2014-07-01 Lawrence Livermore National Security, Llc Chip-based droplet sorting
WO2012109604A1 (fr) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Dispositif de thermocyclage pour l'amplification des acides nucléiques et procédés d'utilisation
US9176504B2 (en) 2011-02-11 2015-11-03 The Regents Of The University Of California High-speed on demand droplet generation and single cell encapsulation driven by induced cavitation
EP3412778A1 (fr) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Procédés permettant de former des gouttelettes mélangées
WO2012112804A1 (fr) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions et méthodes de marquage moléculaire
US20140087412A1 (en) 2011-04-20 2014-03-27 4Dx Pty Ltd Method and Device for Application of Fluid Forces to Cells
GB201108259D0 (en) * 2011-05-17 2011-06-29 Cambridge Entpr Ltd Gel beads in microfluidic droplets
JP6122843B2 (ja) 2011-05-23 2017-04-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 多重エマルジョンを含むエマルジョンの制御
US20120301869A1 (en) 2011-05-25 2012-11-29 Inguran, Llc Particle separation devices, methods and systems
EP3709018A1 (fr) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Appareil microfluidique pour l'identification de composants d'une reaction chimique
US8944083B2 (en) 2011-06-15 2015-02-03 Ut-Battelle, Llc Generation of monodisperse droplets by shape-induced shear and interfacial controlled fusion of individual droplets on-demand
JP2014522718A (ja) 2011-07-06 2014-09-08 プレジデント アンド フェローズ オブ ハーバード カレッジ 多相エマルションおよび多相エマルション形成法
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013095737A2 (fr) 2011-09-28 2013-06-27 President And Fellows Of Harvard College Systèmes et procédés de production de gouttelettes et/ou de manipulation de fluides
US9469874B2 (en) 2011-10-18 2016-10-18 The Regents Of The University Of California Long-range barcode labeling-sequencing
WO2013096643A1 (fr) 2011-12-23 2013-06-27 Gigagen Procédés et appareils pour mélanger des gouttelettes
KR20140122751A (ko) 2012-02-08 2014-10-20 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 유체 파열을 사용한 액적 형성
US20130203172A1 (en) 2012-02-08 2013-08-08 Bio-Rad Laboratories, Inc. Self-contained multi-reagent assay device
EP2812671B1 (fr) 2012-02-09 2019-12-25 Beckman Coulter, Inc. Cytomètre en flux de tri de cellules, procédé et support lisible par ordinateur
US9803237B2 (en) 2012-04-24 2017-10-31 California Institute Of Technology Slip-induced compartmentalization
US9696257B2 (en) 2012-06-07 2017-07-04 Bio-Rad Laboratories, Inc. Automated and accurate drop delay for flow cytometry
WO2013192351A1 (fr) 2012-06-20 2013-12-27 Bio-Rad Laboratories, Inc. Gouttelettes stabilisées pour le calibrage et l'essai
WO2014004577A1 (fr) * 2012-06-25 2014-01-03 The General Hospital Corporation Tri de particules au moyen de champs magnétiques à gradient élevé
CN110643681A (zh) 2012-08-13 2020-01-03 加利福尼亚大学董事会 用于检测生物组分的方法和系统
US9388465B2 (en) 2013-02-08 2016-07-12 10X Genomics, Inc. Polynucleotide barcode generation
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20140378345A1 (en) 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
US20150005199A1 (en) 2012-08-14 2015-01-01 10X Technologies, Inc. Compositions and methods for sample processing
US20150005200A1 (en) 2012-08-14 2015-01-01 10X Technologies, Inc. Compositions and methods for sample processing
US20140378322A1 (en) 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
CN114891871A (zh) 2012-08-14 2022-08-12 10X基因组学有限公司 微胶囊组合物及方法
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US20140378349A1 (en) 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9328376B2 (en) 2012-09-05 2016-05-03 Bio-Rad Laboratories, Inc. Systems and methods for stabilizing droplets
WO2014047365A1 (fr) 2012-09-19 2014-03-27 Bio-Rad Laboratories, Inc. Système de transport de fluide comprenant un joint d'étanchéité
FR2996545B1 (fr) 2012-10-08 2016-03-25 Ecole Polytech Procede microfluidique de traitement et d'analyse d'une solution contenant un materiel biologique, et circuit microfluidique correspondant.
FR2996544B1 (fr) 2012-10-08 2015-03-13 Ecole Polytech Circuit microfluidique permettant la mise en contact de gouttes de plusieurs fluides, et procede microfluidique correspondant.
US9464977B2 (en) 2012-10-24 2016-10-11 The Regents Of The University Of California System and method for deforming, imaging and analyzing particles
TWI499552B (zh) 2012-12-07 2015-09-11 Univ Nat Cheng Kung 液滴產生方法及裝置
WO2014093714A1 (fr) 2012-12-14 2014-06-19 Bio-Rad Laboratories, Inc. Procédés et compositions pour l'utilisation d'huiles pour l'analyse et la détection de molécules
EP3567116A1 (fr) 2012-12-14 2019-11-13 10X Genomics, Inc. Procédés et systèmes de traitement de polynucléotides
EP3473905B1 (fr) 2013-01-25 2020-07-29 Bio-rad Laboratories, Inc. Système et procédé pour la réalisation de gonflage de gouttelettes
WO2014121241A1 (fr) 2013-02-01 2014-08-07 Bio-Rad Laboratories, Inc. Système de détection de gouttelettes espacées
WO2014117784A1 (fr) 2013-02-04 2014-08-07 Danmarks Tekniske Universitet Système pour tri optique d'objets microscopiques
WO2014130727A1 (fr) 2013-02-22 2014-08-28 Bio-Rad Laboratories, Inc. Dispositifs, systèmes et procédés de commande thermique de détection de gouttelettes
JP2014176304A (ja) 2013-03-13 2014-09-25 Seiko Epson Corp 核酸増幅反応用カートリッジ
JP2014176305A (ja) 2013-03-13 2014-09-25 Seiko Epson Corp 核酸増幅反応用カートリッジ
JP2014176306A (ja) 2013-03-13 2014-09-25 Seiko Epson Corp 核酸増幅反応用カートリッジ
WO2014145760A1 (fr) 2013-03-15 2014-09-18 Bio-Rad Laboratories, Inc. Générateur de gouttelettes pourvu d'un tube de collecte
EP2981349A4 (fr) 2013-04-02 2016-11-16 Raindance Technologies Inc Systèmes et procédés de manipulation de gouttelettes microfluidiques
WO2014172586A2 (fr) 2013-04-17 2014-10-23 Bio-Rad Laboratories, Inc. Procédé de fabrication d'un dispositif de génération de gouttelettes
US10151429B2 (en) 2013-05-14 2018-12-11 President And Fellows Of Harvard College Rapid production of droplets
US9409174B2 (en) 2013-06-21 2016-08-09 Bio-Rad Laboratories, Inc. Microfluidic system with fluid pickups
CA2915499A1 (fr) 2013-06-27 2014-12-31 10X Genomics, Inc. Compositions et procedes de traitement d'echantillon
GB2516684A (en) 2013-07-30 2015-02-04 Sphere Fluidics Ltd Microfluidic devices and systems
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
EP3060905A4 (fr) 2013-10-25 2017-08-02 Monash University Déplacement latéral déterministe virtuel pour une séparation de particules à l'aide d'ondes acoustiques de surface
WO2015076251A1 (fr) 2013-11-21 2015-05-28 国立大学法人東京大学 Appareil de sélection et d'élimination de cellules, et procédé de sélection et d'élimination de cellules
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
CN106029233B (zh) 2014-01-24 2018-10-23 约翰霍普金斯大学 用于组合液滴的高生产量的生产的系统和设备及使用方法
WO2015134523A1 (fr) 2014-03-03 2015-09-11 The Board Of Trustees Of The University Of Illinois Dispositifs d'immunocapture de chromatines et procédés d'utilisation
US9453787B2 (en) 2014-03-05 2016-09-27 Owl biomedical, Inc. MEMS-based single particle separation system
US9895693B2 (en) 2014-03-07 2018-02-20 Bio-Rad Laboratories, Inc. Automated blotting using sliding devices
US8820538B1 (en) 2014-03-17 2014-09-02 Namocell LLC Method and apparatus for particle sorting
US20170122861A1 (en) 2014-03-17 2017-05-04 Namocell Inc. Method and apparatus for particle sorting
US9694361B2 (en) 2014-04-10 2017-07-04 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
WO2015160919A1 (fr) 2014-04-16 2015-10-22 President And Fellows Of Harvard College Systèmes et procédés de production d'émulsions de gouttelettes ayant des coques relativement minces
LT3456846T (lt) 2014-04-21 2022-09-12 President And Fellows Of Harvard College Nukleorūgšties unikalios sekos įvedimo sistemos ir būdai
US20150298091A1 (en) 2014-04-21 2015-10-22 President And Fellows Of Harvard College Systems and methods for barcoding nucleic acids
EP3151967A2 (fr) 2014-06-09 2017-04-12 Ascent Bio-Nano Technologies, Inc. Système pour la manipulation et le tri de particules
WO2015200891A1 (fr) 2014-06-26 2015-12-30 10X Technologies, Inc. Procédés et systèmes pour l'assemblage de séquences d'acide nucléique
EP3161162A4 (fr) 2014-06-26 2018-01-10 10X Genomics, Inc. Analyse de séquences d'acides nucléiques
CN113249435A (zh) 2014-06-26 2021-08-13 10X基因组学有限公司 分析来自单个细胞或细胞群体的核酸的方法
WO2015200871A1 (fr) 2014-06-26 2015-12-30 10X Genomics, Inc. Méthodes et compositions pour l'identification d'échantillons
EP3160654A4 (fr) * 2014-06-27 2017-11-15 The Regents of The University of California Tri activé par pcr (pas)
WO2016004022A2 (fr) 2014-06-30 2016-01-07 Gnubio, Inc. Pcr activé par contact thermique flottant
US20160024558A1 (en) 2014-07-23 2016-01-28 10X Genomics, Inc. Nucleic acid binding proteins and uses thereof
JP6657625B2 (ja) 2014-09-05 2020-03-04 ソニー株式会社 液滴分取装置、液滴分取方法及びプログラム
CA2997906A1 (fr) 2014-09-09 2016-03-17 The Broad Institute, Inc. Procede a base de gouttelettes et appareil pour l'analyse composite d'acide nucleique de cellules uniques
DK3000528T3 (da) 2014-09-25 2021-03-15 European Molecular Biology Laboratory Mikrofluidindretning til generering af en sekvens af kombinatoriske prøver
WO2016065056A1 (fr) 2014-10-22 2016-04-28 The Regents Of The University Of California Imprimante à microgouttelettes haute définition
BR112017008877A2 (pt) 2014-10-29 2018-07-03 10X Genomics Inc métodos e composições para sequenciamento de ácido nucleico-alvo
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
DE102014116567A1 (de) 2014-11-12 2016-05-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und Vorrichtung zum Sortieren von Mikropartikeln in einem Fluidstrom
WO2016085743A1 (fr) 2014-11-24 2016-06-02 President And Fellows Of Harvard College Procédés et systèmes pour encapsuler des agents actifs dans des gouttelettes et autres compartiments
DE102014224664B3 (de) 2014-12-02 2015-10-08 Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. Vorrichtung und verfahren zur tropfenerzeugung
AU2016207023B2 (en) 2015-01-12 2019-12-05 10X Genomics, Inc. Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same
CN107209814B (zh) 2015-01-13 2021-10-15 10X基因组学有限公司 用于使结构变异和相位信息可视化的系统和方法
CN107530654A (zh) 2015-02-04 2018-01-02 加利福尼亚大学董事会 通过在离散实体中条形码化对核酸进行测序
MX2017010142A (es) 2015-02-09 2017-12-11 10X Genomics Inc Sistemas y metodos para determinar variacion estructural y ajuste de fases con datos de recuperacion de variantes.
CN115651972A (zh) 2015-02-24 2023-01-31 10X 基因组学有限公司 用于靶向核酸序列覆盖的方法
WO2016137973A1 (fr) 2015-02-24 2016-09-01 10X Genomics Inc Procédés et systèmes de traitement de cloisonnement
WO2016149096A1 (fr) 2015-03-13 2016-09-22 President And Fellows Of Harvard College Détermination de cellules à l'aide d'amplification
KR102528348B1 (ko) 2015-03-16 2023-05-03 루미넥스 코포레이션 다중-단차부 채널 에멀젼화를 위한 디바이스 및 방법
EP3072595A1 (fr) 2015-03-24 2016-09-28 European Molecular Biology Laboratory Dispositif de tri microfluidique
JP2018511341A (ja) 2015-04-17 2018-04-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子配列決定および他の適用のためのバーコード化システムおよび方法
US20160314242A1 (en) 2015-04-23 2016-10-27 10X Genomics, Inc. Sample indexing methods and compositions for sequencing applications
PT3289362T (pt) 2015-04-30 2022-06-21 European Molecular Biology Laboratory Deteção e classificação de gotas microfluídicas
WO2016187179A1 (fr) 2015-05-18 2016-11-24 10X Genomics, Inc. Agents réducteurs stabilisés et leurs procédés d'utilisation
WO2016187256A2 (fr) 2015-05-18 2016-11-24 10X Genomics, Inc. Compositions en phase solide mobile destinées à être utilisées dans des réactions et des analyses biochimiques
GB201509640D0 (en) * 2015-06-03 2015-07-15 Sphere Fluidics Ltd Systems and methods
FR3038530B1 (fr) 2015-07-07 2017-08-18 Ecole Superieure Physique & Chimie Ind Ville De Paris Procede de recuperation de gouttes et systeme de recuperation de gouttes associe
EP3325964A1 (fr) 2015-07-17 2018-05-30 Lawrence M. Boyd Appareil et procédé permettant de trier des cellules
WO2017060876A1 (fr) 2015-10-09 2017-04-13 King Abdullah University Of Science And Technology Générateur de gouttelettes microfluidiques avec mécanisme de rupture commandé
CN108368522A (zh) 2015-10-20 2018-08-03 10X 基因组学有限公司 用于高通量单细胞遗传操作的方法和系统
WO2017075297A1 (fr) 2015-10-28 2017-05-04 The Broad Institute Inc. Système de distribution de réactif dynamique à rendement élevé
US20170128940A1 (en) 2015-11-10 2017-05-11 Illumina, Inc. Inertial droplet generation and particle encapsulation
US9700891B2 (en) 2015-11-13 2017-07-11 International Business Machines Corporation Integrated nanofluidic arrays for high capacity colloid separation
SG11201803983UA (en) 2015-11-19 2018-06-28 10X Genomics Inc Transformable tagging compositions, methods, and processes incorporating same
EP3384048B1 (fr) 2015-12-04 2021-03-24 10X Genomics, Inc. Procédés et compositions pour l'analyse d'acide nucléique
TWI557163B (zh) 2015-12-15 2016-11-11 國立清華大學 用於微流道晶片裝置的模具
US20170189908A1 (en) 2015-12-30 2017-07-06 Bio-Rad Laboratories, Inc. Droplet assay system with automatic calibration
US20170260584A1 (en) 2016-02-11 2017-09-14 10X Genomics, Inc. Cell population analysis using single nucleotide polymorphisms from single cell transcriptomes
JP6735348B2 (ja) 2016-02-11 2020-08-05 １０エックス ジェノミクス， インコーポレイテッド 全ゲノム配列データのデノボアセンブリのためのシステム、方法及び媒体
EP3442707B1 (fr) 2016-04-15 2023-10-04 President and Fellows of Harvard College Systèmes permettant la collecte de gouttelettes et/ou d'autres entités
US20190127789A1 (en) 2016-04-19 2019-05-02 President And Fellows Of Harvard College Immobilization-based systems and methods for genetic analysis and other applications
WO2017197343A2 (fr) 2016-05-12 2017-11-16 10X Genomics, Inc. Filtres microfluidiques sur puce
WO2017197338A1 (fr) 2016-05-13 2017-11-16 10X Genomics, Inc. Systèmes microfluidiques et procédés d'utilisation
WO2018039338A1 (fr) 2016-08-23 2018-03-01 10X Genomics, Inc. Contrôle de la stabilité d'une émulsion induite en de surface microfluidique
US10717086B2 (en) 2016-08-29 2020-07-21 The Regents Of The University Of California Integrated system for isolation and emulsification of particles and cells
EP4026905B1 (fr) 2016-10-19 2024-04-17 10X Genomics, Inc. Procédés de codage à barres de molécules d'acide nucléique à partir de cellules individuelles ou de populations de cellules
US10544413B2 (en) 2017-05-18 2020-01-28 10X Genomics, Inc. Methods and systems for sorting droplets and beads
EP4215616A1 (fr) 2017-05-18 2023-07-26 10X Genomics, Inc. Procédés et systèmes de tri de gouttelettes et de billes
WO2018226546A1 (fr) 2017-06-05 2018-12-13 10X Genomics, Inc. Joints pour la distribution de pressions dans un système microfluidique
US9946577B1 (en) 2017-08-14 2018-04-17 10X Genomics, Inc. Systems and methods for distributed resource management
US10357771B2 (en) 2017-08-22 2019-07-23 10X Genomics, Inc. Method of producing emulsions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3605109A1 (fr) * 2017-03-24 2020-02-05 Enplas Corporation Dispositif, procédé et système de manipulation de liquide

Also Published As

Publication number Publication date
EP3625353A4 (fr) 2021-04-14
CN110945139B (zh) 2023-09-05
WO2018213643A1 (fr) 2018-11-22
US11660601B2 (en) 2023-05-30
CN110945139A (zh) 2020-03-31
US20220410162A1 (en) 2022-12-29
EP3625353A1 (fr) 2020-03-25
US20230271187A1 (en) 2023-08-31
EP4215616A1 (fr) 2023-07-26
CN117143960A (zh) 2023-12-01

Similar Documents

Publication Publication Date Title
US11660601B2 (en) Methods for sorting particles
US10544413B2 (en) Methods and systems for sorting droplets and beads
US20200378961A1 (en) Systems and methods for single cell processing
US10829815B2 (en) Methods and systems for associating physical and genetic properties of biological particles
EP3700672B1 (fr) Procédés de préparation et d'analyse d'échantillons
US11155881B2 (en) Systems and methods for quality control in single cell processing
US20210180044A1 (en) Methods and systems for molecular composition generation
US20240052397A1 (en) Methods and systems for nucleic acid preparation and chromatin analysis
US20190330694A1 (en) Systems and methods for processing nucleic acid molecules from one or more cells
US11459607B1 (en) Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes
US20190345636A1 (en) Methods and systems for molecular library generation
EP3559272B1 (fr) Procédés et systèmes pour associer des propriétés physiques et génétiques de particules biologiques
US11655499B1 (en) Detection of sequence elements in nucleic acid molecules
EP3830829A1 (fr) Systèmes et procédés d'analyse du métabolome
WO2019108851A1 (fr) Systèmes et procédés de préparation et d'analyse d'acides nucléiques
WO2019084328A1 (fr) Procédés de préparation de molécules d'acides nucléiques
US11845983B1 (en) Methods and systems for multiplexing of droplet based assays
US11851683B1 (en) Methods and systems for selective analysis of cellular samples

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SCHNALL-LEVIN, MICHAEL

Inventor name: MAKAREWICZ, ANTHONY

Inventor name: SHORT, STEVEN

Inventor name: BHARADWAJ, RAJIV

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: 10X GENOMICS, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SCHNALL-LEVIN, MICHAEL

Inventor name: MAKAREWICZ, ANTHONY

Inventor name: BHARADWAJ, RAJIV

Inventor name: SHORT, STEVEN

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/02 20060101ALI20201118BHEP

Ipc: G01N 15/14 20060101ALI20201118BHEP

Ipc: C12P 21/00 20060101AFI20201118BHEP

Ipc: B01F 3/08 20060101ALI20201118BHEP

Ipc: C12Q 1/68 20180101ALI20201118BHEP

Ipc: B01J 19/00 20060101ALI20201118BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20210316

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/00 20060101AFI20210310BHEP

Ipc: C12Q 1/02 20060101ALI20210310BHEP

Ipc: C12Q 1/68 20180101ALI20210310BHEP

Ipc: G01N 15/14 20060101ALI20210310BHEP

Ipc: B01F 3/08 20060101ALI20210310BHEP

Ipc: B01J 19/00 20060101ALI20210310BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20211122

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602018043734

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C12P0021000000

Ipc: C12Q0001680600

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/6806 20180101AFI20220502BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220614

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1534717

Country of ref document: AT

Kind code of ref document: T

Effective date: 20221215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018043734

Country of ref document: DE

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230331

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230228

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1534717

Country of ref document: AT

Kind code of ref document: T

Effective date: 20221130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230330

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20230526

Year of fee payment: 6

Ref country code: FR

Payment date: 20230525

Year of fee payment: 6

Ref country code: DE

Payment date: 20230530

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20230527

Year of fee payment: 6

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018043734

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230529

Year of fee payment: 6

26N No opposition filed

Effective date: 20230831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221130

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230517

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230531

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A